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Abstract 
PhoH2 proteins are found in a diverse range of organisms. To date little is 
known about these proteins and the role they play in the organisms in which 
they reside. PhoH2 is a PIN-PhoH domain fusion, and these proteins are 
currently annotated as having unknown function and are described as 
PhoH-like. PhoH-domains are thought to be ATPases and all characterised 
PIN-domain proteins are RNases. Most efforts have focussed on determining 
the role of PIN-domain proteins that comprise the toxic component (VapC) of 
VapBC toxin-antitoxin systems, in which the PIN-domain is coexpressed as 
part of an operon with an inhibitor (VapB). In the remaining cases where 
PIN-domain proteins can be found such as PIN-PhoH domain fusions, these 
cases remain unexamined. This thesis describes the biological and 
biochemical characterisation of the PIN-PhoH protein, PhoH2 from 
Mycobacterium tuberculosis and Mycobacterium smegmatis, along with a 
preliminary structural characterisation of a thermophilic PhoH2 protein 
homologue.  
 
The phoH2 gene from both mycobacterial organisms was found to be 
expressed as part of a long mRNA transcript. Examination of these 
transcripts revealed possible alternative 5’ start sites out of frame with the 
phoH2 gene. For protein overexpression, and ‘normal’ growth and colony 
formation with conditional overexpression, phoH2 from M. tuberculosis 
required 152 bp of the 5’ sequence directly upstream of the annotated phoH2 
gene (annotated here as phoH2alt). PhoH2 proteins: PhoH2alt MTB, 
PhoH2alt MSMEG and PhoH2MSMEG show ATP/Mg2+-dependent, sequence-specific 
RNA unwinding and cleavage. The sequence (A C) (A/U) (A/U) (G/C) U was 
deduced as a substrate for PhoH2, and PhoH2alt MTB also demonstrated 
unwinding and cleavage activity on its upstream ~152 base RNA transcript, 
suggesting a potential autoregulatory mechanism. Structural analysis of a 
thermophilic PhoH2 protein homologue has provided preliminary 
crystallographic data which along with electron microscopy suggest a 
ring-like hexameric PhoH2 oligomer.   
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Chapter One   1 
 
1 Chapter One: Introduction  
1.1 Infectious diseases and the problem of persistence 
Devastating life threatening illnesses are caused by a number of pathogenic 
organisms. One of the most common and serious bacterial infections is 
caused by Mycobacterium tuberculosis. The disease tuberculosis (TB) is 
transmitted in the air when infected individuals with active infection expel 
TB bacteria. Typically, it affects the lungs causing pulmonary disease but it 
can also affect other sites of the body and, if left untreated, the rate of 
mortality is high (WHO 2012). Treatment involves a 6 month course of 
combinations of four first-line antibiotics: isoniazid, rifampicin, ethambutol 
and pyrazinamide. For multi-drug resistant TB (MDR-TB) (resistant to 
isoniazid and rifampicin) the course is longer and requires more costly and 
toxic treatments/regimes (WHO 2012). Globally, the burden of this disease is 
high. In 2011, the disease caused 1.4 million deaths and 5.8 million new 
incidences of TB were reported to national TB control programmes; 13 % of 
these were individuals also infected with HIV, and 3.7 % of these incidences 
were MDR-TB (WHO 2012).  
 
The prevalence of this disease is in part due to this organism’s ability to enter 
a non-replicative, persistent state that is less susceptible to treatment with 
antibiotics (Connolly et al. 2007), and the more recent escalation of MDR and 
extensively drug resistant (XDR) strains of M. tuberculosis, along with the 
vulnerability of HIV-infected patients (WHO 2007).  
 
M. tuberculosis has to survive in a number of stressful environments such as 
under hypoxia and nutrient stress, in order to persist within its host. In the 
genome of M. tuberculosis there is a high occurrence of proteins belonging to 
the PIN-domain family (Arcus et al. 2011). Members of this family are 
proposed to be stress response proteins and have been implicated in a 
number of stress related states such as the thermal stress reponse of 
Sulfolobus solfataricus (Cooper et al. 2009). They are also involved with 
pathogen trafficking (Mattison et al. 2006), and with metabolic regulation in 
M. smegmatis by virtue of their biochemical activity (McKenzie et al. 2012b). 
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The repertoire of PIN-domain proteins found within M. tuberculosis has led 
many researchers to speculate on the involvement of this protein family in 
the stress response and persistence of M. tuberculosis (Gerdes 2000; Hayes 
2003; Arcus et al. 2005; Buts et al. 2005; Gerdes et al. 2005).  
 
1.2 PhoH2 from M. tuberculosis 
In the genome of M. tuberculosis there is a single copy of a phoH2 gene 
(Rv1095). Annotations from the Comprehensive Microbial Resource (CMR) 
and the National Center for Biotechnology Information (NCBI) for this 
protein include: “unknown function but similar to proteins described as 
PhoH-like”; “phosphate starvation inducible protein” and “putative PhoH-like 
protein”. Figure 1.1 shows the relative organisation of the two domains that 
make up phoH2. 
 
Figure 1.1 PhoH2 protein domain annotation  
Domains identified in PhoH2 and their known and predicted biochemical functions. 
(http://www.ncbi.nlm.nih.gov/) 
 
1.2.1 phoH2 gene architecture 
PFam lists 967 sequences with PIN-PhoH (PIN_4-PhoH) architecture (Punta 
et al. 2012). These sequences are found in many diverse bacterial phyla 
including Chlamydiae, beta, delta, and gamma Proteobacteria, Cyanobacteria, 
Lentispharae, Elusimicrobia, Verruccmicrobia, Thermotogae, Spirochaeta, 
Planctomycetes and Deferribacteres, and in the archaeal phylum 
Euyarchaeota. No sequences fall within the eukaryotes. The domain 
arrangement makes up COG 1875: NYN (Nedd4-BPI, YacP nuclease) 
ribonuclease and ATPase of PhoH family domain 
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(http://www.ncbi.nlm.nih.gov/). PhoH-like proteins are predicted to be 
ATPases that are induced under phosphate starvation (Marchler-Bauer et al. 
2011). They are categorised in PFam as clan CL0023, which is part of the 
P-loop NTPase superfamily consisting of 193 families (Punta et al. 2012).  
 
1.3 PIN-domain proteins 
The PIN-domain family of proteins are found in a diverse range of organisms, 
and were first observed and annotated based on sequence similarity to the 
N-terminal domain of the type IV pilus protein, PilT (PilT N-terminus), from 
Myxococcus xanthus (Wall & Kaiser 1999). PIN-domain proteins are small 
proteins of ~130 amino acids that share three strictly conserved acidic 
residues at positions 4, 40 and 93, and a less well conserved residue at 
position 112 (Figure 1.2). Small polar residues (Asp N, Ser S, Thr T) following 
the first conserved aspartic acid at positions i + 1 or i + 2, also play a 
structural role within this family (positions 5 and 6 in Figure 1.2). 
Structurally, PIN-domain proteins are described as a 3-layer α/β/α sandwich 
with a central 5-stranded parallel β sheet (Andreeva et al. 2008). This 
conformation causes the conserved acidic residues to group together to form 
a putative active site (Arcus et al. 2011), which binds Mg2+ or Mn2+ and 
facilitates cleavage of RNA (Arcus et al. 2004; Arcus et al. 2005). 
 
Figure 1.2 Hidden Markov Model that defines PIN-domain proteins  
Based on a multiple sequence alignment the height of each letter defines the significance 
of the amino acid at that position within the PIN-domain family. The width of each letter 
defines the significance of this position in the identification of the PIN-domain family. 
The dark and light pink regions are where insertions have occurred. The 4 highly 
conserved amino acids (D, E, D, D) at positions 4, 40, 93 and 112 characterise the 
PIN-domain protein family. Generated using PFam (Finn et al. 2010).   
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Structural studies indicate that PIN-domain proteins have homology to 5’- 3’ 
nucleases, T4 RNase H, Taq polymerase and flap endonucleases (Arcus et al. 
2004), suggesting that PIN-domains are likely to exhibit nuclease activity. 
The majority (~95 %) of PIN-domain proteins are single domain proteins 
that are found in the genome with a transcription factor upstream that 
creates an operon with the PIN-domain gene. In ~5% of cases, however they 
are fused with TRAM domains, KH domains and AAA+ ATPase domains 
(Arcus et al. 2011). TRAM and KH domains are annotated as RNA-binding 
domains (Musco et al. 1997; Anantharaman et al. 2001) and the AAA+ 
ATPase domains belong to the AAA+ superfamily of ring-shaped P-loop 
NTPases (Iyer et al. 2004), which oligomerise into hexameric rings and are 
involved in remodelling or translocating macromolecules in an energy 
dependent manner.  
 
Eukaryotic PIN-domain proteins are reported to be involved with nonsense 
mediated decay (NMD) of RNA (Takeshita et al. 2007; Huntzinger et al. 2008) 
and processing of rRNA pre-18S fragments (Lamanna & Karbstein 2009). The 
human PIN-domains SMG5 and SMG6 are involved in pathways that degrade 
mRNAs that have premature stop codons. Both have similar overall folds, 
however SMG6 contains all four conserved acidic residues required for 
activity, whereas SMG5 is missing three of the four residues (Glavan et al. 
2006). SMG6 displays endoribonuclease activity on single-stranded RNA 
(ssRNA) in the presence of Mn2+ and, to a lesser extent, in the presence of 
Mg2+ but not on ssDNA or double-stranded RNA (dsRNA), and SMG5 does not 
show catalytic activity (Glavan et al. 2006). The yeast Nob1 protein also 
contains a PIN-domain that is required for processing of pre-18S rRNA 
fragments. The PIN-domain binds to cleavage site D of the ss pre-18S rRNA 
fragment and is responsible for cleavage at the ss 3’ end (Lamanna & 
Karbstein 2009). Human, Est1A protein also contains a PIN-domain but is 
involved in the regulation of telomere elongation and NMD of RNA (Takeshita 
et al. 2006). 
 
M. tuberculosis has 48 PIN-domain proteins in its genome (Anantharaman & 
Aravind 2003; Arcus et al. 2005; Arcus et al. 2011). These PIN-domains are 
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exactly conserved in Mycobacterium bovis (Pandey & Gerdes 2005), yet in 
other mycobacterial genomes such as that of Mycobacterium smegmatis and 
Mycobacterium leprae, far fewer or even no homologues of PIN-domains are 
found (Arcus et al. 2011). 
 
Most structures of prokaryotic PIN-domains are dimers (Figure 1.3b). This 
arrangement positions the active sites into a groove along the long axis of the 
structure (Figure 1.3b). The PIN-domain PAE2754 from Pyrobaculum 
aerophilum forms a tetramer of two dimers and so organises the active sites 
into a tunnel conformation, that is suitable for the binding of ssRNA to the 
positively charged lysine residues that protrude into the tunnel (Figure 1.3c) 
(Arcus et al. 2004; Bunker et al. 2008). 
 
 
Figure 1.3 PIN-domain protein structures 
a) Ribbon diagram of PAE2754 monomer. The four conserved acidic residues and polar 
residue are shown as sticks. b) Ribbon diagram of PAE2754 dimer. The four conserved 
acidic residues and polar residue are shown as sticks which form a groove. c) 
Electrostatic surface diagram of PAE2754 tetramer. Negative (red) and Positive (blue) 
charges show where ssRNA may bind to positively charged residues at the entrance of 
the tunnel. Images were made in PyMOL using PDB IV8P. 
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The structure of the PIN-domain of MJ1533 from Methanocaldococcus 
jannaschii (PDB 3I8O) adopts a different monomeric and higher order 
conformation to previously crystallised PIN-domain proteins (Figure 1.4). 
This PIN-domain is found at the N-terminus of MJ1533 which is annotated as a 
PIN_VirB11L-ATPase (http://www.ncbi.nlm.nih.gov/). VirB11 proteins are 
part of the type IV secretory pathway involved in T-pilus biogenesis and 
virulence (Marchler-Bauer et al. 2011) and these ATPases form dynamic 
hexameric structures  (Savvides et al. 2003). The structure of this 
PIN-domain protein forms an eight stranded β barrel with four-fold 
symmetry which creates a central channel (Figure 1.4c and d).      
 
Figure 1.4 Structure of PIN-domain protein of MJ1533 
a) Ribbon diagram of MJ1533 PIN-domain monomer showing the long tail. The four 
conserved acidic residues are shown as sticks. b) The same structure rotated 45 ° to 
show the position of the conserved residues. c) Symmetry mates of monomer 
conformation showing the possible interaction of multiple monomers and the central 
channel that is formed. d) The same structure rotated 90 ° to show the tunnel formed by 
the tails. Images were made in PyMOL using PDB 3I8O. 
 
It is unknown how the PIN-domain in this higher order oligomeric state 
would interact with its ATPase domain, if the ATPase domain is hexameric. A 
hexameric protein would not adopt four-fold symmetry. This PIN-domain 
structure, however demonstrates that PIN-domain proteins can adopt a 
range of oligomeric states.  
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Despite being found in many important pathogens such as M. tuberculosis 
(Arcus et al. 2005; Ramage et al. 2009), the functional role of PIN-domain 
proteins in this bacterium is not understood.  
 
1.4 P-loop NTPases, helicases and PhoH-like ATPases 
1.4.1 P-loop NTPases 
The P-loop NTPases are a superfamily of proteins involved in a diverse range 
of cellular functions. They are classified based on their structure into two 
main classes: the kinase-GTPase (KG) class and the additional strand catalytic 
E (ASCE) class. Proteins belonging to these classes include the Ras-like 
GTPases and the circularly permutated YlqF-like GTPase proteins, and the 
ATPase Binding Cassette (ABC), DExD/H-like helicases, 4Fe-4S iron sulphur 
cluster binding proteins of the NifH family, RecA-like F1-ATPases, and AAA+ 
ATPases, respectively (Marchler-Bauer et al. 2011).  
 
Proteins that belong to the P-loop NTPase superfamily are characterised by 
two conserved nucleotide phosphate-binding motifs: the Walker A 
(GxxxxGK[ST], where x is any residue) and Walker B motifs (hhhh[DE], 
where h is a hydrophobic residue) (Figure 1.5). The Walker A motif adopts a 
flexible loop conformation that enables correct positioning of the 
triphosphate moiety of the bound nucleotide triphosphate (NTP). The 
conserved aspartic acid (D) in the Walker B motif is involved with 
coordination of a Mg2+ cation and securing the two phosphate binding motifs 
through a bond to the threonine or serine (T/S) of Walker A (Walker et al. 
1982; Leipe et al. 2002; Marchler-Bauer et al. 2011).  
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Figure 1.5 Walker A and B motifs of P-loop NTPase 
a) Respective positions of the Walker A (yellow) and Walker B (magenta) motifs and b) 
positions of the conserved threonine (T) of Walker A and aspartic acid (D) of the Walker 
B motifs involved with positioning of the two nucleotide phosphate binding motifs 
(Walker et al. 1982). Images were made in PyMOL using PDB 3B85. 
 
The P-loop superfamily contains a number of families which contain helicase 
proteins and other motor proteins. 
 
1.4.2 Helicase superfamilies 
Helicases are enzymes that couple the hydrolysis of ATP to the unwinding of 
double stranded nucleic acid into its respective single strands (Singleton et 
al. 2007). 
 
Amino acid sequence comparisons were used in the early classification of 
helicases which revealed three distinct and diverse superfamilies (SF1, SF2 
and SF3) and two smaller families (SF4 and SF5) (Gorbalenya & Koonin 
1993). All helicases carry the Walker A and Walker B motifs. SF1 and SF2 are 
the largest of the superfamilies, and contain similar sets of seven conserved 
motifs scattered across the sequence. The third superfamily (SF3) is made up 
of viral helicases that share four conserved motifs. The DnaB-like family 
(SF4) contains helicases that carry the Walker A and B motifs plus three 
distinct conserved motifs. The Rho-like family (SF5), despite its similarity to 
SF4 helicases, is categorised as a separate family on the basis of sequence 
(Singleton et al. 2007). Singleton (2007) has proposed the addition of the 
AAA+ class as SF6 to encompass the nucleic acid motors that are categorised 
in this family. The signature sequences of amino acids used for the early 
identification of helicase proteins found by Gorbalenya & Koonin (1993) are 
listed in Table 1.1. 
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Table 1.1 Signature amino acid sequences used to identify helicase proteins 
Motif Amino acid pattern Helicase Group 
I 
II/V 
VI 
hx4GxGK[TS]x2[hA] SF1 
[hH][hA]D[DE]xn[TSN]x4[QK]Gx7[hA] 
xn[VT]x[UTC][TS]R 
I 
II 
VI  
 
relaxed pattern 
GxGK[ST]xn SF2 
[hA][hAC]DEx[DHQ]xn 
[QH]x3Rx2R 
I 
II 
VI 
 
strict pattern 
GxGK[ST]xn SF2 
[hA][hAC]DEx[DH]xn 
[QH]Gx2Rx2R 
I/II  UUx3UGK[ST]xnUUhxD[YH]UxnUx2U DnaB family 
III  x3U[KR][GA]hA 
h - bulky hydrophobic residue (I, L, V, M, F, Y, W), U - bulky aliphatic amino acid residue 
(I, L, V, M), x - any residue, alternate residues in square brackets. 
 
Helicases are either toroidal, hexameric structures, or non-ring forming 
(Singleton et al. 2007). SF1 and SF2 helicases are non-ring forming and the 
remaining SF3-5 families plus the AAA+ class, contain those helicases that are 
toroidal in nature. Translocation of nucleic acid can occur with 3’ to 5’ (type 
A) or 5’ to 3’ (type B) polarity. SF1, SF2 and the AAA+ class contain examples 
of both types A and B. Thus far, SF3 are type A and all members of SF4 and 
SF5 are type B.  
 
1.4.2.1 SF1 and SF2  
The SF1 and SF2 helicases contain a signature core of tandem RecA-like folds 
(α/β/α) either within one polypeptide chain or between subunits (Singleton 
et al. 2007). The highest level of sequence conservation between SF1 and SF2 
occurs in the residues that coordinate binding and hydrolysis of the 
triphosphate (motifs I, II and VI) (Table 1.1) identified by Gorbalenya & 
Koonin (1993). These motifs are positioned in the cleft between the two 
conserved RecA-like domains. Figure 1.6 illustrates the respective sequence 
and locations of the seven conserved motifs identified for the SF1 helicase 
PcrA (Caruthers & McKay 2002).  
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Figure 1.6 Structure and conserved motifs of the representative SF1/SF2 
helicase PcrA 
a) Illustration of the conserved motifs (Gorbalenya & Koonin 1993) with sequences from 
Bacillus stearothermophilus PcrA (SF1). Motifs I and II are the Walker A and B motifs 
respectively. b) Ribbon diagram of PcrA. The conserved motifs are coloured as in a). 
Images were made in PyMOL using PDB 1PJR.  
 
Residues in motif Ia, III, IV, and V are involved in nucleic acid binding 
(Caruthers & McKay 2002). The signature motifs of SF1 and SF2 helicases 
have increased to include motifs such as TxGx (nucleic acid binding) that 
precedes the Walker B motif, and the Q motif (coordination of adenine base) 
that precedes the Walker A motif, which can be specific to each superfamily 
or subfamily (Singleton et al. 2007). Despite some complexity around the 
motifs, across all families the motifs contain universal features: a) residues 
involved in the binding and hydrolysis of the NTP that are equivalent to the 
Walker A and B motifs and b) an ‘arginine finger’ (motif VI) that plays a role 
in energy coupling.  
 
The remaining helicase families (SF3-5 and AAA+) are toroidal composed of 
six individual RecA-like folds. 
 
1.4.2.2 SF3 
The SF3 helicases were initially identified in small DNA and RNA viruses 
(Gorbalenya & Koonin 1993). Helicases from this family form single or 
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double hexamers and unwind nucleic acid with 3’ to 5’ directionality. SF3 
helicases share four conserved motifs: Walker A, Walker B, B’ 
(oligonucleotide interactions) and C (analogous to sensor I AAA+). The 
conserved arginine finger is located after motif C (Hickman & Dyda 2005; 
Singleton et al. 2007). Figure 1.7a shows the five conserved motifs identified 
for the SF3 helicase SV40 (Hickman & Dyda 2005). The monomeric and 
hexameric structures (Figure 1.7b and c) show the position of the motifs and 
the nature of the toroidal structure.  
 
 
Figure 1.7 SF3 helicase SV40 Large T antigen helicase domain 
a) Illustration of the conserved motifs with sequences from Simian virus 40 (SF3). Motifs 
I and II are the Walker A and B motifs respectively. b) Ribbon diagram of SV40. The 
conserved motifs are coloured as in a). The conserved arginine residue is shown as a 
stick (black). c) Hexamer of SV40. Images were made in PyMOL using PDB IN25.  
 
SF3 helicases have an ori DNA-binding domain preceding the helicase 
domain, and the helicase domain is a modified AAA+ core that contains the 
nucleotide binding motifs in the central β strands and a set of inserted loops 
that are involved with DNA binding or protein-protein interactions 
(Singleton et al. 2007).  
 
1.4.2.3 SF4  
Helicases in this family were initially identified in bacteria and 
bacteriophages, and are replicative helicases. Gorbalenya & Koonin (1993) 
classed these helicases as DnaB-like and they are functionally and physically 
associated with DNA primases (Gorbalenya & Koonin 1993). These helicases 
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contain the Walker A (H1) and B motifs (H2) plus three distinct motifs (H1a, 
H3 and H4). These latter motifs have no obvious counterparts in any of the 
other helicase families (Singleton et al. 2007). Figure 1.8 shows the 
monomeric and hexameric structure of the SF4 helicase T7 gp4D. The 
coloured regions in the central pore shown in Figure 1.8c are thought to be 
involved with DNA binding (excluding H1 and H2, coloured yellow and 
magenta respectively) (Donmez & Patel 2006). 
 
 
Figure 1.8 SF4 helicase T7 gp4D  
Ribbon diagrams of a) T7 gp4D monomer showing the positions of the H1 and H2 motifs 
(Walker A and B motifs, coloured yellow and magenta respectively). b) T7 gp4D 
monomer showing the additional motifs thought to be involved with DNA binding 
coloured in red, orange and green (residues 424-429, 464-475, 503-513 respectively 
(Donmez & Patel 2006)). c) T7 gp4D hexamer. The motifs thought to be involved with 
DNA binding are positioned in the channel of the central pore. Images were made in 
PyMOL using PDB 1E0K. 
 
1.4.2.4 SF5 Rho 
The Rho-like helicases are categorised as a separate family based on 
differences in their amino acid sequences, despite their close relatedness to 
SF4 (Singleton et al. 2007). Rho carries out the termination of bacterial 
transcription through binding to specific sequences on the nascent RNA and 
then unwinding the DNA/RNA hybrid (Singleton et al. 2007). Figure 1.9 
depicts the hexameric structure of Rho.  
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Figure 1.9 SF5 helicase Rho 
Hexameric structure of Rho SF5 helicase. The colours show the six individual RecA-like 
folds that coordinate into the hexameric ring. Image was made in PyMOL using PDB 
1PV4. 
 
Rho adopts an open notched hexameric ring which is thought to represent its 
natural functional state for the loading of RNA into the hole of the hexamer 
(Yu et al. 2000). 
 
1.4.2.5 AAA and AAA+ (SF6) 
A subset of NTPases are distinguished as the additional strand catalytic E 
(ASCE) based on the insertion of a β-strand between the Walker A and B 
motifs, as well as conservation of a second conserved acidic residue in the 
Walker B motif (DE) (Erzberger & Berger 2006). Many are described as being 
RecA-like as the first ASCE protein to be characterised was RecA. The 
differences between ASCE protein families arise from small insertions and 
rearrangements of secondary structural elements that are specific to distinct 
groups and that help determine the relative organisation of subunits within 
higher order assemblies.  
 
For AAA+ proteins, the primary distinguishing feature is the absence of β 
strand additions to the ASCE core and a small helical bundle fused to the 
C-terminus of the central α/β/α fold (Erzberger & Berger 2006). In AAA+ 
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proteins, the arginine finger occupies a defined position generally at the end 
of α5 and is known as the second region of homology (SRH). Two other 
nucleotide interaction motifs, sensor I, a polar residue (N, D, T, or H) at the 
top of β4, and sensor II, an arginine residue at the base of α7 in the helical lid, 
compose the conserved motifs (Erzberger & Berger 2006) (Figure 1.10).  
 
 
Figure 1.10 SF6/AAA+ helicase RuvB 
a) Annotated RuvB amino acid sequence showing the locations of the conserved motifs. 
Secondary structure predictions: α helix (pink), β strand (yellow), coil (grey), turn 
(blue). b) Ribbon diagram of RuvB monomer showing the positions of the Walker A and 
B motifs (coloured yellow and magenta respectively), sensor I (orange stick) and II (blue 
stick), and arginine finger SRH (red stick). c) RuvB monomer with ADP (green), the 
other motifs coloured as in b). Annotated sequence was made using GeneiousPro (V 
5.1.7). Images were made in PyMOL using PDB 1IN4. 
 
 
For AAA proteins, the point of difference lies with the SRH which is 
positioned between β4 and β5 (Lupas & Martin 2002). Both AAA+ and AAA 
proteins have β strand topology 51432 (Figure 1.11). 
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Figure 1.11 AAA+ helicase RuvB N-terminal domain 
topology 
Topology diagram of AAA+ helicase RuvB N-terminal 
domain showing β strand topology 51432.  
Image was generated using PDBsum 
(http://www.ebi.ac.uk/pdbsum/). 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.2.6  Mechanisms of NTP hydrolysis 
The ASCE  assembly of hexameric helicases generally places the ATP binding 
motifs of one subunit near the γ phosphate sensor elements of an adjacent 
subunit, leading to a radial arrangement of active sites that cooperate to 
hydrolyse ATP (Thomsen & Berger 2009). The cycles of nucleotide binding 
and hydrolysis are coupled to conformational rearrangements of 
substrate-binding elements in all ring-translocases and three major types of 
mechanisms have been proposed for the progression of nucleotide turnover 
within the system: 1) Sequential 2) Concerted and 3) Stochastic (Lyubimov et 
al. 2011) (Figure 1.12).   
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Figure 1.12 Models of NTP turnover by hexameric helicases 
a) All sites sequential (symmetric) b) All sites sequential (asymmetric) c) Concerted and 
d) Stochastic. Each subunit of the helicase is represented by a coloured circle. NTP 
bound (Blue), NDP bound (Purple) and Empty (Green). Models were adapted from 
Singleton (2007), Rabhi (2010) and Lyubimov (2011).  
 
In the contemporary sequential model, all subunits in the hexamer are 
catalytic and cycle through NTP bound, nucleotide diphosphate (NDP) bound 
and empty states (Figure 1.12a and b). NTP hydrolysis is coordinated 
between adjacent subunits either NTP bound, NDP bound and empty states at 
any given time. This model may be symmetric or asymmetric. In the presence 
of DNA or RNA the nucleotide-binding pattern and symmetry of the system 
may be affected, and all subunits would interact with the substrate at some 
point during the translocation cycle (Singleton et al. 2007).  
 
The concerted model proposes that all six subunits are in the same state and 
that all interchange between NTP bound, NDP bound and empty 
simultaneously (Figure 1.12c). This model is suggested to represent SF3 
SV40 and may be applicable to AAA+ translocases (Singleton et al. 2007). 
 
For the stochastic model all subunits are active, however, there is no 
stringent sequential order of their firing. In this case any single subunit may 
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independently hydrolyse ATP and translocate the substrate (Figure 1.12d). A 
consequence of this type of activity is that stalling or inactivation of any 
single subunit will not completely inhibit the enzyme. This model is reported 
to work well for ClpX but not for any helicases (Singleton et al. 2007). 
 
A more detailed mechanism has been elucidated for E1 and Rho proteins 
whereby the NTPase state influences the polarity of unwinding (Thomsen & 
Berger 2009; Rabhi et al. 2010; Lyubimov et al. 2011). The organisation of 
the ATPase state with each subunit dictates the relative position of hairpins 
or loops that line the central channel. These form a right handed ‘spiral 
staircase’ conformation, which curls around the 5’ or 3’ face of the 
phosphodiester backbone and acts to tug and chaperone the substrate 
through the central pore. This occurs in a single direction owing to the 
sequential firing around the helicase ring and arrangement of 
substrate-binding loops. The direction of movement is influenced by 
reversing the substrate binding orientation, reversing the chirality of the 
pore loop staircase and by reversing the NTPase cycle progression 
(Lyubimov et al. 2011). Both these proteins share a common substrate 
binding orientation, however based on the differences in NTPase state upon 
substrate binding and the consequent firing order, the directionality is 
reversed between these two proteins.  
 
For Rho, the six catalytic ATPase sites are split into four distinct states 
representing an empty or nucleotide exchange state (E), a tightly NTP-bound 
state (T), a weakly NTP-bound state (D) and a hydrolysis competent state 
(T*). The relative order of flanking active sites in E1 is flipped with respect to 
Rho (Figure 1.13). 
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Figure 1.13 Schematic of Rho and E1  
Schematic of sequential ATP hydrolysis cycle for a) Rho and b) E1. Each subunit of the 
hexamer is coloured differently. Phosphates from the nucleic acid are shown as open 
circles with the incoming phosphate shown with a dashed open circle. The interface 
between subunits represents the bipartite active site which is either empty or exchange 
(E), NTP tightly bound (T), NTP weakly bound (D) or in a hydrolysis competent state 
(T*). Subunits that lock (touch) represent the insertion of the arginine finger in the ATP 
bound state. The solid arrows dictate the direction of ATPase cycle. The dotted arrow 
represents the movement of the mobile subunit upon NTP binding, in the direction of a 
partner subunit that is locked in place by ATP-dependent contacts in the ring. Models 
were adapted from (Thomsen & Berger 2009).   
 
The exact mechanism of how hexameric motor proteins coordinate ATP 
turnover between 6 catalytic sites to processive translocation of a polymeric 
substrate is unknown. 
 
1.4.3 PhoH-like ATPases 
The PhoH family of ATPases are thought to have evolved in bacteria 
(Anantharaman et al. 2002). As a result of a gene duplication event within the 
bacterial lineage (Figure 1.14), there are two orthologous groups of 
PhoH-like ATPases: PhoH and YlaK (Anantharaman et al. 2002).  
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Figure 1.14 Predicted evolution of PhoH-like ATPases 
Scheme adapted from Anantharaman (2002) “an evolutionary scheme for RNA helicases 
and related ATPases”. K-homology domain (KH). 
 
An in silico study has shown that orthologues of Bacillus subtilis YlaK 
(BS-YlaK) proteins are present in most aerobic species and in actinobacteria, 
where they were shown to be linked to regulons involved with fatty-acid 
beta-oxidation (Kazakov et al. 2003). Positional analysis showed that BS-YlaK 
orthologues are part of non-conserved loci, however they are found 
co-localised with genes encoding oxidative stress proteins. It was later 
identified that BS-YlaK orthologs were only observed in organisms with 
aerobic metabolism (Kazakov et al. 2003).  
 
Using computer methods, Koonin and Rudd (1996) tested the hypothesis that 
proteins exist that are homologous to the N-terminus and C-terminus of SF1 
helicases. They suggested that the evolution of PhoH-like ATPases has come 
about through the loss of the C-terminal α/β domain of SF1 and SF2 helicases 
that was apparent in the last common ancestor of these two superfamilies. A 
conserved sequence was identified that is shared specifically by PhoH from 
Escherichia coli and its homologue in M. leprae, hx2[GA]x2GxGK[TS]xn 
hx2DExQXnhx2GDx2Q (x any amino acid and h any hydrophobic amino acid (A, 
V, L, I, P, M, F, W)) which is similar to motifs I, II and III of SF1 helicases 
(Koonin & Rudd 1996) (Figure 1.15). 
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Figure 1.15 Hidden Markov Model showing conserved motifs of PhoH proteins 
that are similar to SF1 helicases 
Based on a multiple sequence alignment the height of each letter defines the significance 
of the amino acid at that position within the PhoH family. The width of each letter 
defines the significance of this position in the identification of the PhoH family. The dark 
and light pink regions are where insertions have occurred. The black underlined regions 
mark the conserved tripartite sequence specific to PhoH from E. coli and M. leprae. The 
first and second (I and II) contain the Walker A and B motifs respectively (Koonin & 
Rudd 1996). Generated using PFam (Finn et al. 2010).  
 
Motif I Walker A, Motif II Walker B, and motif III in SF1 are involved with the 
coordination of the NTP and nucleic acid binding (Fairman-Williams et al. 
2010). This analysis suggests that PhoH proteins are missing the recognised 
helicase domain motifs V and VI of SF1 helicases, and led Koonin and Rudd 
(1996) to propose that a stand-alone PhoH protein is comparable to the 
N-terminal helicase domain of SF1 helicases. 
 
Upon closer examination of the PhoH protein HMM and comparisons with the 
sequence of the one PhoH structure (PDB 3B85), cg2513 from 
Corynebacterium glutamicum, it is apparent that there are a number of 
additional conserved residues, many of which are similar to conserved motifs 
of other helicase families (Figure 1.16 and Table 1.2).  
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Figure 1.16 Hidden Markov Model showing the conserved motifs of PhoH 
proteins  
Based on a sequence alignment the height of each letter defines the significance of the 
amino acid at that position within the PhoH family. The width of each letter defines the 
significance of this position in the identification of the PhoH family. The dark and light 
pink regions are where insertions have occurred. The black underlined regions mark the 
conserved tripartite sequence specific to PhoH from E. coli and M. leprae (Koonin & 
Rudd 1996). The boxed regions show sites of high amino acid conservation that are 
similar to that of other helicase families: Q motif (green), Walker A (yellow), R residue 
(light grey), RGRTL (dark green), Walker B (magenta), N residue (orange), R residue 
(red), motif III (black) and R residue (blue). Generated using PFam (Finn et al. 2010).  
 
Two of the nine motifs shown in Figure 1.16 appear to be unique to PhoH 
proteins, the arginine residue (Figure 1.16 light grey box) and the RGRTL 
sequence (Figure 1.16 dark green box). The remaining conserved regions can 
be matched to characteristic motifs of other helicase families (Table 1.2).  
 
 
 
 
 
 
 
 
Chapter One   22 
 
Table 1.2 Comparison of conserved amino acids in PhoH with other conserved 
helicase SF motifs 
 Motif Position in 
HMM 
Position in 
3B85 
Identified in SF Function 
Green Q motif 9 124 Some SF1/2 
SF2 DEAD box 
Adenine 
coordination 
Yellow Walker 
A 
 
26-33 
GxxGxGKT 
141-148 
GPAGSGKT 
All NTP 
coordination 
and hydrolysis 
Light 
grey 
R 
residue 
56 171 
SO4 binding 
Unique  
Dark 
green 
RGRTL 114-118 
RGRTL 
229-233 
SO4 binding 
Unique  
Magenta Walker 
B 
123-129 
hhhhDExQ 
237-244 
FVILDEAQ 
All NTP 
coordination 
and hydrolysis 
Orange N 
residue 
130 245 
Top of β4 
AAA+ SI 
Polar residue 
top of β4 
Water 
coordination 
with WB for 
nucleophilic 
attack on γ 
phosphate 
Red R 
residue 
142 257 
End of α5 
AAA SRH 
Arg finger end 
of α5 (between 
β4 and β5) 
Energy 
coupling 
Black Motif 
III 
150-157 
VVxGDxxQ 
265-272 SF1 Motif III Coordination 
of NTP and 
nucleic acid 
binding 
Blue R 
residue 
193 308 
Base of α7 
AAA+ SII 
Base of α7 
Interaction 
with γ 
phosphate 
Q motif (Singleton et al. 2007), WA and WB (Walker et al. 1982; Leipe et al. 2002; 
Marchler-Bauer et al. 2011), SI AAA+ (Erzberger & Berger 2006), SRH AAA (Lupas & 
Martin 2002), Motif III SF1 (Caruthers & McKay 2002), SII AAA+ (Erzberger & Berger 
2006). 
 
A topology diagram of the PhoH protein sequence from PDB 3B85 and the 3D 
structure of PhoH protein (cg2513) from C. glutamicum show the positions of 
the conserved residues and motifs identified in the HMM, and by SO4 ion 
binding in the structure of PDB 3B85 (Figure 1.17). Both show that PhoH 
adopts the traditional P-loop NTPase α/β protein structure of α-β units with 
centrally, most parallel β-sheets surrounded by α-helices (Leipe et al. 2002), 
and has SF1 helicase family β strand topology, 615423 (Figure 1.17a) 
(Fairman-Williams et al. 2010). It is apparent that PhoH has the SRH 
(arginine finger) positioned similar to that of AAA proteins between β4 and 
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β5 (amino acid 257 3B85) (Lupas & Martin 2002) (Figure 1.17). Figure 1.17c 
and d show the relative position of the conserved residues and motifs. 
 
Figure 1.17 PhoH protein topology and PhoH-like ATPase monomer protein 
structure 
a) Topology diagram of PhoH protein 3B85 showing SF1/2 β strand topology (615423) 
and the positions of the conserved residues and motifs identified in the HMM: Q motif 
(Q), Walker A (WA), arginine residue (R), RGRTL motif, Walker B (WB), Sensor I (N) (SI), 
arginine second region of homology (R) (SRH), Motif III (III), Sensor II (R) (SII). b) 
Monomeric PhoH protein from C. glutamicum (cg2513) showing the characteristic SF1/2 
family domain β strand topology, 615423 (yellow β1, green β2, red β3, magenta β4, 
orange β5 and blue β6) also shared by PhoH proteins (Fairman-Williams et al. 2010). c) 
Monomeric PhoH2 protein showing the positions of conserved residues/motifs Q 
(green), Walker A (yellow), R residue (light grey), RGRTL (dark green), Walker B 
(magenta), N residue (SI) (orange), R residue (SRH) (red), III (black) and R residue (SII) 
(blue). d) Monomeric PhoH2 protein turned 90 ° to show the positions of the conserved 
residues/motifs (coloured as in b). Images were generated using PDBsum 
(www.ebi.ac.uk/pdbsum/) and were made in PyMOL using PDB 3B85. 
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Based on the structure of PDB 3B85, it is likely that PhoH-like ATPases adopt 
a hexameric macromolecular conformation (Figure 1.18). Furthermore, this 
structure suggests that multiple hexamers may work together to perform 
mechanical work (Figure 1.18). 
 
 
Figure 1.18 PhoH-like ATPase hexamer and symmetry mate protein structures 
a) Hexamer of PhoH protein from C. glutamicum (cg2513) showing the positions of the 
conserved residues/motifs Q (green), Walker A (yellow), R residue (light grey), RGRTL 
(dark green), Walker B (magenta), N residue (SI) (orange), R residue (SRH) (red), III 
(black) and R residue (SII) (blue). b) Symmetry mates of hexamer conformation showing 
the possible interaction of multiple hexamers, the Walker A and B motifs are coloured 
yellow and magenta respectively. Images were made in PyMOL using PDB 3B85. 
 
Overall, PhoH proteins share a number of conserved motifs and residues with 
the other helicase families, as well as two motifs that are unique to PhoH: an 
arginine residue (position 56 in HMM and position 171 in 3B85) and 
conserved sequence RGRTL located between β3 and β4. Like SF1/2 helicases, 
PhoH has core β strand topology as well as a motif similar to motif III of SF1. 
They also have the defining features of AAA+ proteins (SI, SII) and the SRH in 
a position similar to AAA proteins. Furthermore, PhoH has a Q motif 
characteristic of DEAD box RNA helicases and many members of SF1/2. 
Based on these observations, it is likely that PhoH proteins will possess 
helicase activity.  
 
1.4.3.1 phoH from E. coli 
The gene for phoH in E. coli is identical to psiH, which has been identified as a 
phosphate starvation-inducible gene (Metcalf et al. 1990). In E.  coli, 
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promoters of Pho regulon genes share a consensus sequence known as the 
pho box: CTGTCATA (A/T) A (A/T)CTGT(C/A) A (C/T) (Kim et al. 1993). In 
E. coli, this sequence is located ~150 bp upstream of the translational start 
site. The phoH gene in E. coli has two reported transcriptional start sites: the 
first site includes a pho box, and PhoB, the transcriptional activator of the pho 
regulon in E. coli, was shown to bind to the pho box of the phoH gene under 
phosphate starvation conditions (Kim et al. 1993). Transcription from the 
second site was constitutive and was independent of phoB. Further, Kim et al. 
(1993) have also demonstrated experimentally ATP binding by PhoH from 
E. coli, suggesting PhoH has ATPase characteristics. Whether this activity was 
dependent on a secondary nucleic acid substrate remains to be determined. 
 
It has been speculated that PhoH-like ATPases are likely to play a role in RNA 
metabolism due to the addition of RNA binding PIN and KH domains to some 
PhoH family members. They may also demonstrate helicase function or be 
involved with ATP-dependent activities with uncharacterised 
ribonucleoprotein (RNP) complexes in bacteria (Anantharaman et al. 2002). 
It is also likely that PhoH proteins are involved in the cellular response to 
phosphate starvation. 
 
1.5 phoH2 from C. glutamicum and the phosphate starvation 
response in mycobacteria 
In C. glutamicum the NCgl0065 (phoH2) gene was identified as one of a subset 
of genes that shows elevated expression after a shift from 
phosphate-sufficient to phosphate-limiting conditions (Ishige et al. 2003). In 
a further study, none of these prominent phosphate starvation genes 
previously identified including cg0085 phoH1 (homologous to NCgl0065) 
were induced by a shift from phosphate-sufficient to phosphate-limiting 
conditions in a ΔphoRS knockout strain. This indicates that two-component 
regulatory system PhoRS controls transcriptional activation of these genes 
and that it is involved with the adaptation of C. glutamicum to phosphate 
starvation (Kocan et al. 2006). These findings raise the possibility that phoH2 
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genes in other organisms are under the control of PhoRS or other phosphate 
response systems. 
 
1.5.1 PhoPR in M. tuberculosis  
The PhoPR two-component system has been described as essential for 
virulence and pathogenesis of M. tuberculosis (Ryndak et al. 2008). In 
M. tuberculosis, the PhoPR two-component system has a variety of functions 
including involvement with lipid metabolism and secretion, and the initial 
and enduring hypoxic response (Gonzalo-Asensio et al. 2008; Ryndak et al. 
2008). Unlike PhoRS in C. glutamicaum, PhoPR has not been reported to be 
involved with the phosphate starvation response. When global gene 
expression was compared between wild type and a PhoP mutant strain 
grown in 7H9 medium, the phoH2 gene (Rv1095) did not show any 
differential expression, suggesting that it is not under the direct control of the 
PhoPR system in M. tuberculosis (Walters et al. 2006). A further study to 
confirm the regulation of DosR/DevR (dormancy survival regulon) by PhoP 
compared expression between a PhoP mutant strain and wild type, DosR 
expression was reduced in the mutant strain which was reversed when 
complemented with PhoP, to wild type expression levels (Gonzalo-Asensio et 
al. 2008). PhoP is suggested to be a link between early and enduring hypoxic 
responses of M. tuberculosis. 
 
Given the observations with PhoP, this raises questions as to the regulation of 
the phoH2 gene and protein in M. tuberculosis. 
 
1.5.2 Phosphate starvation response and SenX3-RegX3 in 
mycobacteria 
In M. tuberculosis, the two-component regulatory system SenX3-RegX3 
controls expression of the phosphate specific transport operon 
pstS3-pstC2-pstA1 which is induced under phosphate starvation (Rifat et al. 
2009). It has been identified that SenX3 contains a PAS-like domain. These 
domains are found in a number of prokaryotes and eukaryotes, and function 
as sensors of oxygen and redox state (Rickman et al. 2004). It was later found 
that SenX3-RegX3, in addition to being responsible for expression of 
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phosphate-dependent genes, has a role in modulating cydB and gltA1 genes 
involved with aerobic respiration (Parish et al. 2003b; Roberts et al. 2011). In 
relation to phoH2, Roberts et al. (2011) have shown that there is no 
difference in the levels of expression of phoH2 (Rv1095) with a RegX3 mutant 
compared with wild type expression under static and hypoxic growth 
conditions, where other genes showed differential expression. This suggests 
that phoH2 is not under the direct control of the SenX3-RegX3 
two-component system in its response to hypoxia in M. tuberculosis. 
Similarly, in the study of Rifat et al. (2009) which looked at phosphate 
dependent gene expression under phosphate limiting conditions using 
microarrays, phoH2 was not listed as having differentially regulated gene 
expression at 24 and 72 hours after phosphate starvation. The complete list 
of genes, up or down regulated under these growth conditions was not 
provided therefore these results do not rule out a role of phoH2 in the 
response to phosphate starvation in M. tuberculosis. 
 
In M. smegmatis, two systems are responsible for assimilation of phosphate 
under nutrient stress: the high affinity ABC-transport system pst (phosphate 
specific transporter) and phn system, both of which have a similar affinity for 
phosphate (Gebhard et al. 2006). Within the phn operon, an additional gene 
coding for a GntR-like transcriptional regulator, phnF, has been identified. 
This gene was found to act as a repressor of the phn operon but did not affect 
the expression of the pst system (Gebhard & Cook 2008). Additional 
expression analyses also showed that the phnF and phn operon are regulated 
by the SenX3-RegX3 regulon. In M. smegmatis, this two-component 
regulatory system is responsible for expression of phosphate-dependent 
genes (Glover et al. 2007). Berney and Cook (2010) also showed with 
microarray data that the SenX3-RegX3 two-component regulatory system is 
upregulated under hypoxic growth conditions. 
 
In summary, the precise role and regulation of PhoH2 proteins is unclear. It is 
plausible that they are involved in the response to phosphate starvation and 
may be linked with growth under hypoxic conditions. 
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1.6 Toxin-Antitoxin systems 
Toxin-antitoxin (TA) loci that contain PIN-domain proteins are found in a 
diverse range of prokaryotes (Gerdes & Wagner 2007). TA systems were first 
identified in E. coli where they were shown to be involved in plasmid 
maintenance post-segregation (Gerdes et al. 1986). TA systems have also 
been found on bacterial chromosomes, suggesting additional biological roles 
(Buts et al. 2005). These systems are reported to be involved with antibiotic 
resistance and tolerance, virulence, pathogenicity islands, bacterial 
persistence and pathogen trafficking (Gerdes 2000; Hayes & Sauer 2003; 
Hayes 2003; Mattison et al. 2006) 
 
TA systems are classified based on the nature of their antitoxin. In type I TA 
systems, the antitoxin is a small RNA (sRNA) that base pairs with the mRNA 
of the toxin gene. This base pairing prevents synthesis of the toxin protein 
(Fozo et al. 2010) (Figure 1.19a). In type II TA systems, the antitoxin is a 
protein which binds to the toxin protein forming a benign complex and in 
doing so offsets the toxic effects of the toxin protein (Fozo et al. 2010) (Figure 
1.19b). More recently, a third RNA-protein TA system has been reported, 
ToxIN, in which a 36 nucleotide motif found in the RNA antitoxin encoded by 
the toxI gene inhibits the toxic effect of the protein encoded by toxN 
post-protein expression (Fineran et al. 2009) (Figure 1.19c).  
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Figure 1.19 TA systems 
TA systems are organised in an operon where the antitoxin gene precedes the toxin 
gene. a) In type I TA systems the sRNA antitoxin base pairs with the mRNA of the toxin 
gene suppressing translation and causes the resulting duplex mRNA to be susceptible to 
degradation by cellular RNases. b) In type II TA systems the antitoxin protein binds to 
the toxin protein forming a benign protein complex which binds back to the promoter 
region in so regulating transcription of the operon. The antitoxin protein is susceptible 
to cellular proteases which cause release of the toxin. c) In type III TA systems the 
antitoxic RNA binds to the toxin protein forming a benign RNA-protein complex. A 
transcriptional terminator located between the two genes regulates the expression 
levels of toxI and toxN. To regulate transcription of the operon the complex binds to the 
promoter region. Unknown cellular factors promote the activation of the toxin through 
degradation of the antitoxin. Adapted from (Blower et al. 2011). 
 
Generally, type I toxin proteins are smaller and more hydrophobic than the 
toxin proteins of type II TA systems (Buts et al. 2005). Each toxin protein of 
the various TA systems has different biochemical activities; the MazF and 
VapC (PIN-domain) toxins, for example, are sequence specific RNases that 
have been shown to target mRNA and to inhibit translation (Inouye 2006; 
Robson et al. 2009; McKenzie et al. 2012b). 
 
1.6.1 VapBC TA systems 
The most widespread TA system in bacteria and archaea is the VapBC TA 
family. In many unrelated organisms there has been an expansion in the 
number of vapBC operons. For example, in the archaeon Pyrococcus 
kodakaraensis, there are 29 annotated vapBC operons and 42 are annotated 
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in Sinorhizobium meliloti (Sevin & Barloy-Hubler 2007; Makarova et al. 
2009). Within mycobacteria, the expansion of the VapBC family has occurred 
most considerably in species that are pathogenic to mammals (McKenzie et 
al. 2012b). Of the 48 PIN-domain proteins in M. tuberculosis, 47 are annotated 
as putative VapBC TA systems (Arcus et al. 2005; Ramage et al. 2009; Arcus 
et al. 2011).  
 
Several VapBC TA systems have been biochemically characterised including 
FitAB from Neisseria gonorrhoeae, NtrPR from S. meliloti and VapBCs from 
mycobacteria, Haemophilus influenzae, Leptospira interrogans, 
enterobacteria, S. solfataricus and two VapC proteins from P. aerophilum  
(Puskas et al. 2004; Zhang et al. 2004; Bodogai et al. 2006; Mattison et al. 
2006; Daines et al. 2007; Cooper et al. 2009; Robson et al. 2009; Winther & 
Gerdes 2009; McKenzie et al. 2012a; McKenzie et al. 2012b). Each VapC toxin 
belongs to the PIN-domain family and exerts its effect via RNase activity. 
NtrR is predicted to have RNase activity due to the conservation of the four 
acidic residues characteristic of PIN-domains for enzymatic activity (Arcus et 
al. 2011).  
 
VapC proteins have been implicated in the control of bacterial growth within 
intracellular environments (Hopper et al. 2000), growth inhibition of E. coli 
(Daines et al. 2007) and disruption of translation in M. smegmatis (Robson et 
al. 2009). Biochemically, VapC proteins target RNA, for example, VapC-1 from 
H. influenzae cleaves total RNA (Daines et al. 2007), and VapCs from Shigella 
flexneri 2a and Salmonella enterica cleave formylmethionine tRNA (tRNAfMET) 
(Winther & Gerdes 2011). VapC from M. smegmatis shows sequence specific 
endoribonuclease activity, cleaving the ssRNA sites AUAU and AUAA both 
in vitro and in vivo (McKenzie et al. 2012b). The VapC proteins VapCRv0065 and 
VapCRv0617 from M. tuberculosis, like VapC from M. smegmatis also cleave RNA 
at specific sites (Ahidjo et al. 2011). VapC protein from vapBC operon 
Rv0596c-Rv0595c specifically targets ssRNA at ACGC and AC(A/U)GC 
(McKenzie et al. 2012a; Sharp et al. 2012), and the VapC proteins VapCRv0065 
and VapCRv0617 target (G/C)G(G/C)(G/C/A) sequences (McKenzie et al. 2012a). 
Data suggest that within M. smegmatis, VapC plays a role in the rate of 
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glycerol utilisation, which is coupled to growth in order to match anabolic 
and catabolic demands of the cell. This allows for post-transcription tuning of 
catabolic metabolism (McKenzie et al. 2012b).  
 
It is evident that VapC PIN-domain proteins are involved in the regulation of 
cellular metabolism by virtue of their ribonuclease activity. Thus far, all 
characterised prokaryotic PIN-domain proteins have been part of TA 
systems, whereas the other classes of PIN-domain proteins remain 
unexamined.  
 
1.7 Aims and objectives 
At the beginning of this project, a bioinformatics survey (unpublished) 
indicated an association between VapBC TA systems in bacterial genomes 
and AAA+ ATPase proteins. A BLAST search for AAA+ ATPases or similar in 
M. tuberculosis at this time revealed PhoH2 (Rv1095). What was striking 
about PhoH2 was that it was an example of a PIN-domain protein fusion with 
a PhoH-domain, and this PIN-domain protein accounted for the one 
remaining PIN-domain in the M. tuberculosis genome not associated with a 
toxin-antitoxin operon. The biological function of PhoH2 from M. tuberculosis 
and M. smegmatis and of PhoH2 proteins in general at the start of this project 
was unknown.  
 
The overall aim of this research was to investigate the biological function of 
PhoH2 proteins by examining PhoH2 from M. tuberculosis. The 
characterisation of PhoH2 was carried out based on three main objectives as 
outlined below. 
 
Objective 1 – Investigate the transcriptional context of phoH2 genes from 
M. tuberculosis and M. smegmatis and the biological effect of PhoH2 protein 
expression. 
  
Objective 2 – Clone, express, purify, crystallise and solve the structure of 
PhoH2 proteins from M. tuberculosis and M. smegmatis. 
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Objective 3 – Determine the biochemical activity of PhoH2 proteins from 
M. tuberculosis and M. smegmatis. 
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2 Chapter Two: Materials and Methods 
Details of all media and bacterial strains used in this study can be found in 
Appendix A. 
 
2.1 DNA and RNA manipulations 
M. bovis BCG Pasteur 1173P2 was kindly provided by Dr Ray Cursons, and 
M. smegmatis mc2155 from Dr Joanna McKenzie for culture. 
 
2.1.1 M. bovis BCG and M. smegmatis Genomic DNA Extraction 
M. bovis BCG strain Pasteur 1173P2 and M. smegmatis mc2155 were cultured 
in LB Tween-80 broth (LBT) for a minimum 18-21 days or 2-3 days 
respectively. Cells were added with 1/10 the volume of 5 M guanidium 
isothiocynate (GITC) pH 7 (usually 1 ml cells and 100 µl 5 M GITC) to a 2 ml 
screw cap tube containing approximately 0.3 g of 0.1 mm and 2.5 mm 
zirconia beads. Cells were ruptured with three rounds of bead beating using a 
FastPrep cell disrupter (FP120 Thermo Savant) for 30 seconds (setting 6), 
left to cool for 1 minute and the process repeated twice more. Fifty µl of 2 M 
Na acetate pH 4, and an equal volume of phenol/chloroform (made fresh) 
was added and the samples were shaken well. For deproteinisation, samples 
were rotated for 10 minutes at RT. The samples were then centrifuged at 
13 000 rpm at RT for 1 minute to separate the phases. The top layer was 
transferred to a new tube, and an equal volume of isopropanol (IPA) was 
added. This was incubated for 10-20 minutes at RT. After incubation samples 
were centrifuged at 13 000 rpm at RT for 20 minutes, the supernatant was 
removed and discarded, and the pellet washed with 1 ml 70 % ethanol. All 
traces of ethanol were removed and the pellet was air dried at RT. Once dried 
the pellet was resuspended in 50 µl TE buffer (10 mM Tris HCl pH 8, 1 mM 
EDTA). 
 
2.1.2 E. coli Vector DNA Extraction 
E. coli vector DNA was extracted from 5 ml overnight cultures using the 
QIAprep Spin Miniprep Kit (Qiagen, Netherlands) according to 
manufacturer’s instructions. Vector DNA was eluted in 50 μl of elution buffer.  
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2.1.3 Agarose Gel Electrophoresis 
DNA fragments were separated using agarose gel electrophoresis. The 
percent of agarose used in the gel depended on the size of DNA; as a general 
rule samples <200 bp were run on a 2 % gel, 200-400 bp 1.5 %, 400-1000 bp 
1 % and >1000 bp 0.8 % agarose in 1x TAE buffer (40 mM Tris-acetate, 
20 mM EDTA). Samples were mixed with 5 x DNA loading dye (25 % glycerol, 
0.2 % bromophenol blue) prior to loading onto the gel. Agarose gels were 
either stained with 0.5 μg/ml ethidium bromide or 1 x SYBR SafeTM DNA gel 
stain (Invitrogen, USA). Gels were visualised by UV light (ethidium bromide) 
or on a blue light box (Invitrogen, USA) and images captured. Band sizes were 
determined by comparison with the 1kb-Plus DNA ladder (Invitrogen, USA). 
 
2.1.4 DNA Quantification 
DNA was quantified using a Nanodrop ND-1000 Spectrophotometer 
(Nanodrop Technologies, USA). This measures absorbance of DNA at 260 nm, 
quantifying the amount of DNA. 
 
2.1.5 Polymerase Chain Reaction (PCR) 
2.1.5.1 Primers 
All primers were a minimum of 16 bp in length. Primers used for ligase-based 
cloning were designed with 5’ and 3’ flanking restriction enzyme sites that 
included an extra 2-4 bases to allow for efficient cleavage (the number of 
bases included was dependent on the restriction enzymes used). Primers for 
Gateway cloning were designed as recommended in the manufacturer’s 
instructions. All primers were analysed using either Vector Nti (Invitrogen, 
USA) or Geneious Pro (Version 5.1.7) (BioMatters Ltd, NZ) to check for 
secondary structure such as primer dimers or hairpins. Primers were 
supplied by Invitrogen (USA), Sigma (USA) or IDT (USA) and were dissolved 
in 1 x TE buffer to a 100 μM concentration.  
 
2.1.5.2 PCR for RT-PCR and amplification of vector inserts   
The Taq or Platinum Pfx® DNA polymerase system (Invitrogen, USA) was 
used for RT-PCR and for the amplification of gene inserts. For each set of 
primers a gradient PCR was carried out to determine the optimal Tm for the 
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PCR reaction. Five °C above and below the calculated Tm of the primers was 
selected as the upper and lower limits of the gradient. A Tm that resulted in a 
product of the expected size was selected for use in PCR for amplification. 
The reactions were carried out in 15 or 25 μl volumes. The following 
concentrations and reaction conditions were used:  
 
Platinum Pfx® PCR Taq PCR 
1 x Pfx amplification buffer 1 x PCR buffer 
0.3 mM deoxynucleotide mix  
(dATP, dCTP, dTTP & dGTP) 
0.2 mM deoxynucleotide mix  
(dATP, dCTP, dTTP & dGTP) 
1 mM MgSO4 1.5 mM MgCl2 
1-2 U Platinum Pfx® DNA polymerase 2.5 U Taq DNA Polymerase 
0.2 μM each primer 0.2 μM each primer 
20-120 ng template DNA 20-120 ng template DNA 
  
Cycling conditions (min:sec) x29 cycles 
95 °C 2:00 (initial denaturation) 
95 °C 0:15 
95 °C 2:00 (initial denaturation) 
95 °C 0:15 
Tm* 0:30  Tm* 0:30  
68 °C 0:45**  72 °C 0:45**  
68 °C 7:00 (final extension) 72 °C 5:00 (final extension) 
 
*Initial denaturation was carried out for 2 minutes 
*Tm determined by gradient PCR  
**Elongation time dependent of the insert size, as a rule 1 kb = 1 minute  
 
PCR reactions were performed and visualised as in section 2.1.3. 
 
2.1.5.3 Colony PCR  
The Taq DNA polymerase system (Invitrogen, USA) was used to test positive 
transformants for the correct insertion of vector insert DNA. Positive 
transformant colonies were resuspended in a dilute antibiotic solution and 
used as DNA template for PCR using T7 or M13 F and R primers (Table 2.1) 
and the method described in section 2.1.5.3. For the T7 primers, a Tm of 
52.5 °C was used and for the M13 primers a Tm of 55 °C. 
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Table 2.1 Primers used for colony PCR 
Primer Primer Sequence 
F T7 TAATACGACTCACTATAGGG 
M13 TGTAAAACGACGGCCAGT 
R T7 TAGTTATTGCTCAGCGGTGG 
M13 CAGGAAACAGCTATGACC 
 
2.1.5.4 PCR for difficult templates 
For the amplification of difficult DNA templates the KAPA HiFiTM HotStart 
DNA polymerase was used using kit recommended reaction conditions and 
cycling parameters. 
 
KAPA HiFiTM HotStart PCR 
1 x KAPA HiFi GC buffer (contained 2 mM Mg2+) 
0.3 mM deoxynucleotide mix  
(dATP, dCTP, dTTP & dGTP) 
5 % DMSO 
0.5 U KAPA HiFi HotStart DNA polymerase 
0.3 μM each primer 
20-120 ng template DNA 
Cycling conditions (min:sec) x29 cycles 
95 °C 2:00 (initial denaturation) 
98 °C 0:20 
65 °C 0:15  
72 °C 0:45  
72 °C 5:00 (final extension) 
  
PCR reactions were performed and visualised as in section 2.1.3. 
 
2.1.6 Purification of PCR Products and other reactions from Solution 
PCR or enzymatic reactions were pooled and purified using a High Pure PCR 
Product Purification Kit (Roche Applied Science, Switzerland) or a Qiaquick 
PCR Product Purification Kit (Qiagen, Netherlands) according to 
manufacturer’s instructions. 
 
2.1.7 Purification of PCR Products from agarose gels 
PCR reactions of the desired size were excised and purified using a High Pure 
PCR Product Purification Kit (Roche Applied Science, Switzerland) or a 
Qiagen Gel Purification Kit (Qiagen, Netherlands) according to 
manufacturer’s instructions. 
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2.1.8 Restriction Enzyme Digest 
Restriction enzymes were purchased from Invitrogen (USA) and Roche 
Applied Science (Switzerland). Digestion of DNA with restriction enzymes 
was carried out according to manufacturer’s instructions. Buffers were 
chosen based on manufacturer’s recommendations to maximise the activity 
of the restriction enzyme and reactions were incubated for 1 to 4 hours at the 
appropriate temperature. Double digestions (two restriction enzymes in one 
reaction) were used if the reaction buffer for each enzyme was the same. If 
not, one reaction with one restriction enzyme was performed then the DNA 
purified according to method in section 2.1.6 and the second reaction with 
the other restriction enzyme performed. Digested DNA was purified from 
solution according to method in section 2.1.6. 
 
2.1.9  DNA Ligation 
DNA ligations were performed according to manufacturer’s 
recommendations using 5 U of T4 DNA Ligase (Invitrogen, USA) in 20 μl 
reactions and incubated for 6 hours at room temperature or at 18 °C 
overnight. 
 
2.1.10  DNA Transformation 
2.1.10.1 Preparation of Electrocompetent E. coli 
A glycerol stock of the desired strain of E. coli was streaked onto an LB agar 
plate and incubated at 37 °C overnight. A single colony was then used to start 
a 5 ml LB culture which was grown at 37 °C in a shaking incubator at 200 
rpm overnight. The overnight culture was used to seed a 500 ml LB culture, 
which was grown at 37 °C in a shaking incubator at 200 rpm until an OD600 of 
0.5-0.7 was reached. The cells were then chilled on ice for at least 20 minutes 
before being transferred to a pre-chilled sterile centrifuge bottle and 
centrifuged at 4000 g at 4 °C for 15 minutes. The supernatant was discarded 
and the cell pellet resuspended in 500 ml ice cold sterile 10 % glycerol. The 
cells were centrifuged again at 4000 g at 4 °C for 15 minutes and the 
supernatant discarded. The cell pellet was resuspended in 250 ml ice cold 
sterile 10 % glycerol and centrifuged at 4000 g at 4 °C for 15 minutes. The 
supernatant was discarded and the cell pellet resuspended in 20 ml ice cold 
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sterile 10 % glycerol and transferred to a pre-chilled 50 ml falcon tube and 
centrifuged at 4000 g at 4 °C for 15 minutes. The supernatant was discarded 
and the pellet resuspended in 1 to 2 ml ice cold sterile 10 % glycerol. Fifty μl 
aliquots of resuspended cells were then flash frozen in liquid nitrogen and 
stored at -80 °C. 
 
2.1.10.2 Electroporation of E. coli 
One - two μl of vector DNA or ligation reaction was added to 50 μl freshly 
thawed (on ice) electrocompetent E. coli cells of the desired strain. The 
mixture was placed in a 2 mm electroporation cuvette (BioRad Laboratories, 
USA), tapped to settle the mixture between the electrodes and electroporated 
with a Bio-Rad Gene PulserTM (Bio-Rad Laboratories, USA) at 2.5 kV, 25 μF 
capacitance and 200 Ω resistance. SOC medium (1 ml) was added 
immediately to the electroporated cells and incubated at 37 °C shaking at 300 
rpm for 30 minutes. An aliquot of the cells was plated on LB agar plates 
containing the appropriate antibiotic for selection and incubated at 37 °C 
overnight. Colonies from these agar plates were then used to start 5 ml LB 
broth cultures containing the appropriate antibiotic. These cultures were 
incubated at 37 °C shaking at 200 rpm overnight and used to isolate vector 
DNA according to the method in section 2.1.2.  
 
2.1.10.3 Preparation and transformation of chemically competent E. coli 
(Gateway®) 
One colony of DH5α cells cultured overnight was grown in 5 ml of LB 
medium at 37 °C at 200 rpm for 3.5 hours. After incubation 1.5 ml of cells 
were harvested by centrifuging at 13 000 rpm for 1 minute. The supernatant 
was removed and the cells were resuspended in 100 µl of 0.1 M CaCl2, 1% 
PEG 8000 solution and incubated on ice for 5 minutes. Ten µl of vector-insert 
was added and the suspension incubated further on ice for 20 minutes with 
periodic gentle mixing. The suspension was then heat shocked at 42 °C for 45 
seconds, 900 µl of LB medium was added and the heat shocked suspension 
was incubated at 37 °C for 1 hour. The cells were harvested by centrifuging at 
13 000 rpm for 1 minute. The supernatant was removed and the cells were 
resuspended in 100 µl of LB medium and spread onto an LB agar plate 
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supplemented with 50 µg/ml kanamycin (pDONR221) or 100 µg/ml ampicillin 
(pDEST17) for incubation at 37 °C overnight. 
 
2.1.10.4 Preparation of Electrocompetent M.  smegmatis 
A glycerol stock of the desired M.  smegmatis strain was streaked onto an LBT 
agar plate and incubated at 37 °C overnight. A single colony from this plate 
was used to start a 5 ml LBT culture which was grown overnight at 37 °C in a 
shaking incubator at 200 rpm until an OD600 of around 0.7 was reached. One 
ml of the overnight culture was used to seed 100 ml of 7H9/ADC + 0.05 % 
(v/v) Tween-80 medium. The 100 ml culture was grown at 37 °C in a shaking 
incubator at 200 rpm until an OD600 of 0.5-0.7 was reached. The cells were 
then chilled on ice for 1.5 hours before being transferred to a pre-chilled 
sterile centrifuge bottle and centrifuged at 4000 g at 4 °C for 20 minutes. The 
supernatant was discarded immediately as mycobacterial cell pellets are 
delicate and likely to break up. The cell pellet was resuspended in 100 ml ice 
cold sterile 10 % glycerol. The cells were centrifuged again at 4000 g at 4 °C 
for 20 minutes and most of the supernatant was discarded leaving a small 
volume of supernatant to resuspend the cells in. The cell pellet was 
resuspended in the remaining supernatant, transferred to a sterile 50 ml 
falcon tube and centrifuged at 4000 g at 4 °C for 20 minutes. The supernatant 
was discarded and the cell pellet resuspended in 0.2 ml ice cold sterile 10 % 
glycerol. Forty μl aliquots of resuspended cells were then flash frozen in 
liquid nitrogen and stored at -80 °C. 
 
2.1.10.5 Electroporation of M. smegmatis 
Electroporation of M. smegmatis required adjustment of transformation 
parameters. One μl of plasmid DNA or ligation reaction was added to 40 μl 
freshly thawed (on ice) electrocompetent M. smegmatis cells of the desired 
strain. The mixture was placed in a 2 mm electroporation cuvette (Bio-Rad 
Laboratories, USA), tapped to settle the mixture between the electrodes and 
electroporated with a Bio-Rad Gene PulserTM (Bio-Rad Laboratories, USA) at 
2.5 kV, 25 μF capacitance and 1000 Ω resistance. One ml of 7H9/ADC + 
0.05 % (v/v) Tween-80 medium was added immediately to the 
electroporated cells and incubated at 37 °C shaking at 200 rpm for 3 hours. 
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An aliquot of the cells was plated on 7H10/ADC + 0.05 % (v/v) Tween-80 
agar plates containing the appropriate antibiotic for selection and incubated 
at 37 °C for 3 days. 
 
2.1.10.6 Glycerol Stocks 
Glycerol stocks for the long term storage of transformed bacteria were made 
by the addition of 0.5 ml of overnight culture (LB (E. coli) or LBT 
(M. smegmatis) + appropriate antibiotic) to 0.5 ml of sterile 50 % glycerol. 
Glycerol stocks were stored at -80 °C. 
 
2.1.11 Isolation of Total RNA from M. bovis BCG and M. smegmatis  
Method developed by Ali Ruthe 
Proteins & Microbes Laboratory, University of Waikato 
For the preparation of total RNA, M. bovis BCG strain Pasteur 1173P2 and 
M. smegmatis mc2155 were cultured in LBT broth for a minimum of 21 days 
or 2-3 days at 37 °C respectively. Cells were immediately added to four times 
the volume of 5 M GITC pH 7 (usually 2 ml cells with 8 ml 5 M GITC) and 
pelleted by centrifugation. The supernatant was removed and cells 
resuspended in 0.5 ml of fresh 5 M GITC and transferred to a 2 ml screw cap 
tube containing approximately 0.3 g of 0.1 mm and 2.5 mm zirconia beads. 
The cells were ruptured with four rounds of bead beating in a Fast Prep cell 
disrupter (FP120 Thermo Savant) for 20 seconds (setting 6.5), left to cool for 
one minute and the process repeated for increasing periods (i.e. 20, 25, 30 
and 35 seconds). Samples were centrifuged briefly at 4 °C to remove foam. 
*One tenth of the volume (50 µl) of 2 M Na acetate pH 4 was added and mixed 
gently. An equal volume (0.5 ml) of water-saturated phenol was added, 
vortexed then rotated for 10 minutes at RT. One hundred μl of 1-bromo, 
3-chloro propanate was added, shaken for one minute and incubated on ice 
for 5 minutes. Samples were centrifuged to separate the phases and the top 
layer removed and the method repeated from the * above with volumes 
decreased accordingly. The top layer was removed and was added to an 
equal volume of isopropanol and chilled on ice for 30 minutes. The 
precipitated RNA was then centrifuged at 13 000 g at 4 °C  for 30 minutes, 1 
ml 70 % ethanol added, centrifuged at 13 000 g at 4 °C for 15 minutes, 
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supernatant removed, 1 ml 100 % ethanol added, centrifuged at 13 000 g at 
4 °C for 15 minutes, supernatant removed. The pellet was then centrifuged 
again briefly and any residual ethanol removed. The pellet was resuspended 
in 25 μl of 10 mM Tris-HCl pH 7, 0.5 mM MnCl2. RNA concentrations were 
determined using a Nanodrop ND-1000 spectrophotometer (Nanodrop 
Technologies, USA). 
 
2.2 Protein Purification and Manipulation 
2.2.1 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) Protein 
Analysis 
SDS-PAGE gels were cast in a Hoeffer gel casting system. SDS-PAGE gels were 
made up of a resolving gel (10, 12, 15 or 18 % acrylamide depending on 
protein size), that was overlaid with a stacking gel (5 % acrylamide). All 
SDS-PAGE gels were made up with 30 % acrylamide with an 
acrylamide:bisacrylamide ratio of 37:5:1 (Bio-Rad Laboratories, USA) and 
included 0.1 % (w/v) SDS, and were polymerised by the addition of 0.05 % 
(w/v) ammonium persulfate (APS) and 0.05 % (v/v) TEMED. 
 
Protein samples were mixed in a 3:1 ratio with 4 x SDS loading buffer 
(250 mM Tris HCl pH 6.8, 20 % glycerol, 4 % SDS, 10 % β-mercaptoethanol, 
0.025 % (w/v) bromophenol blue) and heated to 95 °C for 5 minutes before 
loading onto gel. Gels were run in 1 x SDS-PAGE running buffer (25 mM Tris, 
250 mM glycine, 0.1 % (w/v) SDS) at 70 V until the dye front entered the 
resolving gel and then at 150 V until the dye front reached the end of the gel. 
 
2.2.2 Native Polyacrylamide Gel Electrophoresis (Native-PAGE) Protein 
Analysis 
Native-PAGE gels were cast and run as for SDS-PAGE gels as in section 2.2.1, 
except without SDS in the gel, running buffer (25 mM Tris, 250 mM glycine) 
or loading dye (300 mM Tris HCl pH 6.8, 50 % glycerol, 0.05 % (w/v) 
bromophenol blue). 
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2.2.3 Coomassie Blue Staining for Protein Gel Electrophoresis 
Gels were stained using the quick coomassie blue staining method (Wong et 
al. 2000) unless otherwise stated. Gels were placed in a microwaveable box 
with 50 ml Fairbanks staining solution A (0.05 % (w/v) coomassie blue 
R-250, 25 % (v/v) isopropanol, 10 % (v/v) acetic acid), microwaved for 30 
seconds on full power, then cooled to RT with gentle shaking. The stain was 
then removed and Fairbanks staining solution B (0.005% (w/v) coomassie 
blue R-250, 10% (v/v) isopropanol, 10% (v/v) acetic acid) was added and 
microwaved as above. This was then repeated for Fairbanks staining 
solutions C & D (C – 0.002 % (w/v) coomassie blue, 10 % (v/v) acetic acid 
and D - 10 % (v/v) acetic acid), solution D being the destaining solution. 
Protein sizes were estimated by comparison with the protein sizes of the 
Precision Plus ProteinTM Unstained Standard (Bio-Rad Laboratories, USA). 
 
2.2.4 Measurement of Protein Concentration 
Protein concentration was measured using the Biorad Protein Assay (Biorad 
Technologies, USA), and/or Nanodrop ND-1000 spectrophotometer 
(Nanodrop Technologies, USA). The Biorad Protein Assay is based on the 
Bradford Assay and was performed according to manufacturer’s instructions. 
Comparison of samples with a standard curve provides a relative 
measurement of protein concentration. The Nanodrop ND-1000 measures 
absorbance at 280 nm and the accompanying software calculates protein 
concentration using the Beer-Lambert equation: A=ε.c.l  
A = absorbance at 280 nm 
ε = theoretical molar extinction coefficient (M-1cm-1) 
c = concentration (M) 
l = pathlength (cm) 
 
The theoretical molar extinction coefficients were calculated using the online 
tool ProtParam (http://web.expasy.org/protparam), by providing the amino 
acid sequence. 
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2.2.5 Concentration of Protein Samples 
Protein samples were concentrated using 20 ml, 2 ml or 500 μl Vivaspin 
concentrators (Sartorius AG, Germany) with molecular weight cut offs of 10 
kDa. Concentrators were pre-equilibrated with 0.05 % (v/v) Tween-80 and 
purification buffer. Protein samples were added to the upper reservoir of a 
pre-equilibrated concentrator and spun at 3 000 g (20 ml), 3 600 g (2 ml) or 
9 000 g (500 μl) at 4 °C until the desired volume or concentration was 
achieved. 
 
2.2.6 Dialysis of Protein Samples 
Protein samples were dialysed using Spectra Por® dialysis tubing of 6-8 kDa 
molecular weight cut off (Spectrum Laboratories, USA). The dialysis tubing 
was pre-wet with target buffer, the protein sample was then added to the 
tubing and the ends of the tubing sealed with dialysis clips. The protein 
sample was then left to dialyse against 1 L of target buffer with gentle stirring 
for 2-3 hours at 4 °C. The target buffer was then replaced with fresh buffer 
and the protein dialysed with gentle stirring overnight at 4 °C. 
 
2.2.7 Purification of His-tagged Proteins using IMAC  
The supernatant from lysed large scale expression cultures was filtered 
through 1.2, 0.45 and 0.2 μm Minisart filters (Sartorius AG, Germany). If the 
supernatant was very viscous as was generally the case with M. smegmatis 
expression cultures, it was filtered only through 1.2 and 0.45 μm Minisart 
filters. The filtered supernatant was then loaded onto an IMAC column, which 
was pre-equilibrated with the appropriate lysis buffer at a flow rate of 1-2 
ml/min. The column was then attached to either a ÄKTA PrimeTM, ÄKTA 
BasicTM or ÄKTA PurifierTM FPLC system. The column was washed with 15-25 
ml of lysis buffer, at a flow rate of 1 ml/min to remove unbound proteins. 
Bound proteins were removed by running a gradient of 0-50 % elution buffer 
(lysis buffer + 1 M imidazole) over 50 ml at a flow rate of 1 ml/min. Fractions 
containing the desired protein were then analysed by SDS-PAGE as in section 
2.2.1. 
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2.2.8 Size Exclusion Chromatography 
Size exclusion chromatography was used as required to further purify 
proteins. Size exclusion chromatography was performed using either a 
HiLoadTM 16/60 SuperdexTM or a 10/300 SuperdexTM column (analytical size 
exclusion column) (GE Healthcare, UK). Protein solutions were concentrated 
to between 1 and 5 ml and filtered with a Nanosep® MF 0.2 μm filter (Pall, 
USA) before loading onto a pre-equilibrated column. 
 
2.2.9 Calibration of the Size Exclusion Column S200 10/300  
High and low molecular weight gel filtration kits (GE Healthcare, UK) were 
used to calibrate the S200 10/300 analytical size exclusion column. Briefly, 
all proteins were reconstituted to the recommended concentration with 50 
mM phosphate buffer pH 7.4, 200 mM NaCl with the exception of carbonic 
anhydrase, which was resuspended in water as per kit instructions. Two 
protein mixes were made up: Protein Mix A contained ferritin, conalbumin, 
carbonic anhydrase and ribonuclease with final concentrations of 0.3 mg/ml 
for ferritin and 3 mg/ml for the remaining proteins; and Protein Mix B 
contained aldolase, ovalbumin, ribonuclease A and aprotinin with final 
concentrations of 4 mg/ml for aldolase and ovalbumin, and 3 mg/ml for 
ribonuclease A and aprotinin. Each protein mix was fractionated and the 
elution volume for each protein determined. The void volume of the column 
was determined by the elution volume of Blue Dextran 2000 (1 mg/ml).  
 
A calibration curve was then determined for the column by calculation of the 
Kav (gel phase distribution coefficient) values for the calibration kit proteins 
using the equation:  
 
Kav = (Ve - Vo) / (Vc - Vo)  
(Vo = column void volume, Ve = elution volume, Vc = geometric column 
volume).  
 
The calibration curve was made by plotting Kav against the log molecular 
weight and an equation determined to calculate the molecular weight of 
sample proteins. 
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2.3 Methods relating to Chapter 3 
2.3.1 RT-PCR  
For the preparation of total RNA from M. bovis BCG strain Pasteur 1173P2 
and M. smegmatis mc2155, RNA was extracted using the phenol-GITC method 
for the isolation of RNA as described in section 2.1.11.  
To prepare cDNA, 1 µg of RNA was treated with 1 U of RQ1 RNase-Free 
DNase (Promega, USA) in the presence of 10 mM Tris-HCl pH 7, 0.5 mM 
MnCl2 according to manufacturer’s instructions. Briefly reactions were 
incubated at 37 °C with shaking at 600 rpm for 30 minutes. The DNase 
reaction was stopped with of 1.1 μl EGTA stop solution and samples heated to 
65 °C for 10 minutes. Synthesis of cDNA was carried out using the 
Superscript III First-Strand Synthesis system (Invitrogen, USA) according to 
kit instructions with and without Superscript III to exclude DNA 
contamination (+/-RT). Random hexanucleotides (2 µl of 50 ng/µl) were 
added and incubated at 65 °C for 5 minutes then placed on ice immediately 
for 1 minute. Buffer 5x (4 µl), 0.1 M DTT (1 µl), 10 mM dNTP (1 µl) (-RT) and 
SSIII (0.75 µl of 200 U/µl) (+RT) were added and mixed gently. Reactions 
were incubated at 25 °C for 10 minutes then at 50 °C for 1 hour and 85 °C for 
10 minutes. cDNA was stored at -20 °C.  
 
M. bovis BCG and M. smegmatis cDNA (+ and – RT) were used as templates for 
PCR reactions with 6 primer combinations that spanned the upstream 
sequence of Rv1095 and MSMEG_5247, including observed possible 
alternative translational start sites upstream of phoH2. Figure 2.1 illustrates 
the location of each RT primer set. 
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Figure 2.1 Genomic position of primers used in RT-PCR 
Genomic location of each RT primer set for a) M. tuberculosis (M. bovis BCG) and b) 
M. smegmatis. RT F 1-6 primers were each used with RT R positioned within the phoH2 
gene (Rv1095/MSMEG_5247).  
 
Primers used for RT-PCR and the corresponding expected PCR product sizes 
are listed in Table 2.2. 
 
Table 2.2 Primers used for RT-PCR 
Organism Primer Primer sequence  Expected band size  
M. bovis BCG F RT 1  GCTACCGAGCCGAGAAGTACAC 724 bp 
RT 2 TTCTACGAGCGCTGCG 674 bp 
RT 3  CGGAGTAGGTCGCACTCGAT 275 bp 
RT 4  CACTCGATGGCTAGCGACATGCTC 263 bp 
RT 5  GCTAGCGACATGCTCTGCTGCCA 254 bp 
RT 6  TCATGACAAGGGCAGGACCGGC 204 bp 
R RT  CACCACCAACGGAACCACCACAT  
M. smegmatis F RT 1  GCTACCGCGCCGACCGCTTCA 880 bp 
RT 2  TTCTTCGAGCGCTCGC 830 bp 
RT 3  CTTCTCCAACCTCGTCAGCTA 714 bp 
RT 4  AGTGCGGGTTCGTGGCGC 471 bp 
RT 5  GTCGAAGTCGATGGCTAGCGAC 315 bp 
RT 6  GGGGCCGCATGAAGAGCG 205 bp 
R RT  GCCGCGCGAACCAGCCGA  
 
 
In addition to + and –RT templates, genomic DNA was tested to confirm the 
size of the PCR products. Initially gradient Taq polymerase PCR cycling 
parameters were screened from 52-62 °C as in section 2.1.5.2 and 58 °C was 
found to be a suitable annealing temperature for all primer sets. PCR 
products were analysed by agarose gel electrophoresis as described in 
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section 2.1.3. The experiment was repeated at least 3 times to confirm the 
presence or absence of +RT products. 
 
2.3.2 Conditional expression  
To create tetracycline inducible expression constructs of phoH2 and phoH2alt 
(phoH2 cloned from alternative start site 1 (Figure 3.6)) from M. tuberculosis 
and M. smegmatis, the genes for Rv1095, Rv1095alt and MSMEG_5247 were 
amplified from genomic DNA using primers listed in Table 2.3. The PCR 
products were digested and ligated between the BamHI/SpeI sites of the 
tetracycline-inducible vector pMIND and were transformed into E. coli TOP10 
cells for selection on low salt LB medium supplemented with 50 µg/ml 
hygromycin B. Sequencing confirmed the correct integration of the insert. 
Primers pTB F, pTBalt F, pMS F also introduced a synthetic RBS sequence 
upstream of the phoH2 gene to ensure translation.  
 
Table 2.3 Primers used for cloning into pMIND  
Primer Primer Sequence RE + RBS RE 
F pMS  AAATTTGGATCCGGAGGAATAATGGTGACTGAGCAAGCTGTCC
G 
BamHI 
pTB  AAATTTGGATCCGGAGGAATAATGGTGACCGATACCCGCACGT
A 
BamHI 
pTBalt  AAATTTGGATCCGGAGGAATAATGGCTAGCGACATGCTCTG BamHI 
R pMS  AAATTTACTAGTTCAGGGCAGGGCGCCGGGGC SpeI 
pTB  AAATTTACTAGTTCAGCGCGGCCCGGTGATCT SpeI 
RE – restriction site RBS – ribosome binding site 
 
Sequenced constructs were transformed into wild type M. smegmatis mc2155 
as described in section 2.1.10.5, as well as the intact empty pMIND vector 
(EV), to generate M. smegmatis mc2155 harbouring pMINDEV, 
pMINDMSMEG_5247, pMINDRv1095, and pMINDRv1095alt. 
 
For overexpression analysis, all M. smegmatis strains carrying vectors 
pMINDEV, pMINDMSMEG_5247, pMINDRv1095, and pMINDRv1095alt were grown to an 
OD600 between 0.2-0.4 in LBT supplemented with 50 µg/ml hygromycin B. 
Each LBT starter culture was used to seed a second starter culture in 
Hartman's-de Bont minimal medium (HdB) supplemented with 0.2 % 
glycerol, 50 mM MES, 0.05 % (v/v) Tween-80 and 50 µg/ml hygromycin B.  
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HdB cultures were grown to an OD600 between 0.1-0.2 and diluted to an 
OD600 of 0.0025 in 100 ml HdB medium in a 250 ml flask. The growth of all 
strains was monitored until an OD600 of between 0.1-0.15 was reached, and 
then protein expression was induced with 20 ng/ml tetracycline (Tc), which 
had been previously reported to be sufficient for induction from the 
tetracycline-inducible promoter with limited toxicity to the cells (Robson 
2010). Samples of culture were taken periodically to monitor the growth 
(OD600) of the culture and cell viability (CFUs). For cell viability, samples of 
culture were serially diluted 10-fold from 10-1 to 10-6 in 1x phosphate 
buffered saline (PBS) (0.02 M phosphate (0.0038 M NaH2PO4), 0.15 M NaCl, 
pH 7.4) and each dilution was spotted onto plates supplemented with 
hygromycin B and tetracycline (+Tc), and hygromycin B only (-Tc).  
 
2.4 Methods relating to Chapter 4 
2.4.1 Cloning into pYUB1049 
The annotated ORF containing the Rv1095 sequence was amplified from 
M. bovis BCG strain Pasteur 1173P2 genomic DNA (100 % identity to Rv1095 
from M. tuberculosis) using two different primer sets Rv1095C F and Rv1095C 
R; and Rv1095N F and Rv1095N R (Table 2.4) using the method described in 
section 2.1.5.2. The amplified PCR products were purified as in section 2.1.6 
and digested with NcoI/BamHI and NdeI/BamHI respectively, and then 
ligated into the pYUB1049 shuttle vector as in section 2.1.9, enabling 
expression of a C-terminal and N-terminal his-tag attached to PhoH2 
(Rv1095). 
 
Table 2.4 Primers used for cloning Rv1095 and Rv1095alt with a C- or 
N-terminal his-tag into pYUB1049  
Primer Primer Sequence RE RE 
F Rv1095C TAACTCCATGGGTGACCGATACCCGCAC NcoI 
Rv1095N TCTCGTACATATGGTGACCGATACCCG NdeI 
Rv1095altC TAACTCCATGGCTAGCGACATGCTCTGC NcoI 
Rv1095altN TCTCGTACATATGGCTAGCGACATGCTCTG NdeI 
R Rv1095C TACAGGATCCGCGCGCGGCCCGGTGATC BamHI 
Rv1095N TACAGGATCCTCAGCGCGCGGCCCGGTGATC BamHI 
RE – restriction enzyme 
 
Ligations were transformed into E. coli TOP10 cells as in section 2.1.10 and 
plated on low salt LB agar medium supplemented with 0.05 % (v/v) 
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Tween-80 and 50 µg/ml hygromycin B to select for positive transformants. 
To test for gene insertion, colony PCR was carried out using T7 F and R 
primers that flanked the insert site as in section 2.1.5.3. Positive clones were 
cultured overnight, their vector DNA was extracted as in section 2.1.2. and 
sequenced with T7 F and R primers prior to transformation into 
M. smegmatis mc24517 cells (section 2.1.10.5). Positive transformants of 
M. smegmatis mc24517 were selected by plating onto 7H10 agar medium 
supplemented with ADC, 0.05 % (v/v) Tween-80 and 50 µg/ml kanamycin 
and hygromycin B. Selected colonies were cultured in 5 ml of PA-0.5G 
medium supplemented with 0.05 % (v/v) Tween-80, 50 µg/ml kanamycin 
and hygromycin B with shaking at 200 rpm at 37 °C for 48 hours. These 
cultures were used to seed 5 ml ZYP-5052 autoinduction medium 
supplemented with 0.05 % (v/v) Tween-80 and 50 µg/ml kanamycin and 
hygromycin B, at a 1:100 dilution. Expression cultures were incubated at 
37 °C with shaking at 200 rpm for 96 hours.  
 
The same approaches were taken to clone and express Rv1095altC and 
Rv1095altN using Rv1095altC F and Rv1095C R, and Rv1095altN F and Rv1095N 
R (Table 2.4). 
 
2.4.2 Cloning into Gateway pDONR221, pDESTSMG, and pDEST17 
For cloning into Gateway vectors, the ORFs encoding Rv1095, Rv1095alt, the 
PIN-domain of Rv1095 and the PhoH-domain of Rv1095 sequences were 
amplified from M. bovis BCG strain Pasteur 1173P2 genomic DNA using 
flanking gene specific primers listed in (Table 2.5) and RT 5 F (Table 2.2), 
using the method described in section 2.1.5.2. The amplified PCR products 
were purified as in section 2.1.6 and used as template for a second round of 
PCR using gene specific recombination primers to gain attB-flanked PCR 
products.  
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Table 2.5 Primers used for Gateway flanking and recombination reactions 
Flanking Primer Primer Sequence  
F Flank 1 CGGAGTAGGTCGCACTCGAT 
PhoH FLGW  GGGTCAATGCGCATAAACGTGTT 
R Rv1095 FLGW  GCGCAGTGCGATTCTGTGTC 
PIN FLGW  TCCTGCGCGTGGTACTCGTCG 
Recombination Primer Primer Sequence 
F 
Rv1095GWR   
GGGGACAAGTTTGTACAAAAAAGCA 
GGCTTCGTGACCGATACCCGCACGTA 
 
Rv1095altGWR   
GGGGACAAGTTTGTACAAAAAAGCA 
GGCTTCATGGCTAGCGACATGCTCTG 
PhoHGWR  
GGGGACAAGTTTGTACAAAAAAGCA 
GGCTTCGAGGCGTTCGGTCTGCGTG 
R 
Rv1095GWR  
GGGGACCACTTTGTACAAGAAAGCTG 
GGTCTCAGCGCGGCCCGGTGATCTCC 
PINGWR  
GGGGACCACTTTGTACAAGAAAGC 
TGGGTCCTAAACGCAGCGGAATG 
 
The recombination PCR products were purified as in section 2.1.6 and 
inserted into pDONR221 via the Gateway BP reaction. Briefly, 100 femtomoles 
of attB-PCR product was incubated with 2 µl of pDONR221 (150 ng/µl) and 
4 µl of BP clonaseTM in a 20 µl reaction made up with TE buffer pH 8 for 1 
hour at 25 °C. The reactions were stopped by incubating at 37 °C for 10 
minutes with the addition of 2 µl of Proteinase K. These reactions were 
transformed into chemically competent DH5α cells (section 2.1.10.3) and 
plated onto LB agar medium containing 50 µg/ml kanamycin. Colony PCR 
was carried out using M13 F and R primers that flanked the insertion site to 
check for the insert as in section 2.1.5.3. Successful clones were cultured 
overnight and vectors extracted as in section 2.1.2. 
 
For expression of constructs in M. smegmatis, these were inserted into 
pDESTSMG via the Gateway LR reaction. Briefly, 100 ng of pDONRRv1095, 
pDONRRv1095alt, pDONRPIN and pDONRPhoH were incubated with 2 µl (300 ng) 
of destination vector (pDESTSMG) and 4 µl of LR clonaseTM in a 20 µl reaction 
made up with TE buffer pH 8 for 1 hour at 25 °C. The reactions were stopped 
as before with Proteinase K. To verify that the recombination with pDESTSMG 
had been successful, the expression constructs were transformed into E. coli 
TOP10 cells as in section 2.1.10.2 and plated on low salt LB agar medium 
supplemented with 50 µg/ml hygromycin B. Colonies were tested for the 
presence of insert via colony PCR using T7 F and R primers as in section 
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2.1.5.3. Successful clones were cultured overnight and vector DNA extracted 
as in section 2.1.2. These constructs were sequenced with T7 F and R primers 
prior to transformation into M. smegmatis mc24517 cells as described in 
section 2.4.1. 
 
For expression of pDONR221 constructs in E. coli, a second Gateway LR 
reaction was performed with pDEST17. The same LR reaction was performed 
as before, and to verify that recombination with pDEST17 had been successful 
the expression constructs were transformed into electrocompetent, or 
chemically competent DH5α cells and plated onto LB agar medium containing 
100 µg/ml ampicillin. Colonies were tested for the presence of the insert via 
colony PCR and successful clones were cultured overnight and vector DNA 
extracted as in section 2.1.2. These were sequenced prior to transformation 
into E. coli BL21 (DE3) cells (section 2.1.10.2). Positive E. coli transformants 
were selected by plating onto LB agar medium containing 100 µg/ml 
ampicillin. Colonies were cultured in 5 ml of LB medium supplemented with 
100 µg/ml ampicillin with shaking at 200 rpm at 37 °C for 24 hours, these 
cultures were used to seed 5 ml LB broth at a 1:100 dilution. Overexpression 
cultures were incubated at 37 °C with shaking at 200 rpm until an OD600 
0.4-0.6 was reached. They were induced with 1 mM IPTG (final 
concentration) and were incubated at 37 °C with shaking at 200 rpm 
overnight. 
 
All of these constructs enabled expression of an N-terminal his-tag attached 
to each of the proteins.  
 
2.4.3 Cloning into pYUB28b 
The ORFs containing Rv1095, the PIN-domain of Rv1095, PhoH-domain of 
Rv1095, and PINalt-domain of Rv1095 were amplified from M. bovis BCG strain 
Pasteur 1173P2 genomic DNA or previously cloned constructs using the 
primers listed in Table 2.6 as in section 2.1.5.2.  
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Table 2.6 Primers used for cloning Rv1095, PIN, PhoH, and PINalt domains with 
a C-terminal his-tag  into pYUB28b  
Primer Primer Sequence RE RE 
F Rv1095/PIN28b  TAACTCCATGGTGACCGATACCCGC NcoI 
PhoH28b  TAACTCCATGGAGGCGTTCGGTCTGCG NcoI 
PINalt28b  TAACTCCATGGCTAGCGACATGCTCT  NcoI 
R Rv1095/PhoH28b  TAACTAAGCTTGCGCGGCCCGGTGATC HindIII 
PIN28b  TAACTAAGCTTAACGCGCAGCGGAAT HindIII 
RE – restriction enzyme 
 
In addition, the ORFs containing MSMEG_5247, MSMEG_5247alt (cloned from 
alternative start site 1 (Figure 3.6)) the PIN-domain of MSMEG_5247, PhoH+1 
and PhoH+2-domains of MSMEG_5247 were amplified from M. smegmatis 
mc2155 genomic DNA using the primers listed in Table 2.7 as in section 
2.1.5.2.  
 
Table 2.7 Primers used for cloning MSMEG_5247, MSMEG_5247alt, PIN, PhoH+1 
and PhoH+2 domains with a C-terminal his-tag into pYUB28b  
Primer Primer Sequence RE RE 
F MS524728b F TAACTCCATGGTGACTGAGCAAGCTGTC NcoI 
MS5247alt28b F TAACTCCATGGCTAGCGACCTGCT NcoI 
PhoHMS128b F TAACTCCATGGAAGTGTTCGGCCTC NcoI 
PhoHMS228b F TAACTCCATGGATCGCGAAGTGTTC NcoI 
R MS524728b R  TAACTAAGCTTGGGCAGGGCGCCGGG HindIII 
PINMS28b R TAACTAAGCTTGACGCGCAGCGGGAT HindIII 
RE – restriction enzyme 
 
The amplified products were purified as in section 2.1.2 and digested with 
NcoI/HindIII, then ligated into the pYUB28b shuttle vector enabling 
expression of a C-terminal his-tag attached to each of the proteins. The 
successful clones were transformed into E. coli TOP10 cells as in section 2.4.1 
and screened by colony PCR as in section 2.1.5.3 using T7 F and R primers. 
Positive clones were sequenced with T7 F and R primers prior to 
transformation into M. smegmatis mc24517 cells (section 2.1.10.5).  
 
2.4.4 Cloning into pET28b-PstI 
The amino acid sequence of TBIS_3092 was submitted to GeneArt® (Life 
Technologies) for gene synthesis with codon optimisation for protein 
expression in E. coli. The resulting lyophilised plasmid DNA was resuspended 
in MQ as per manufacturers’ instructions. The gene was amplified from the 
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GeneArt® plasmid using primers TBIS F and R (Table 2.8) as described in 
section 2.1.5.2. 
 
Table 2.8 Primers used for cloning GeneArt synthesised TBIS_3092 with a 
C-terminal his-tag into pET28b-PstI  
Primer Primer Sequence RE RE 
F TBIS AACTGCAGATGGTTGCAGTTAGCAGCA PstI 
R TBIS CCCAAGCTTGATGGTAATATCTTGCAGC HindIII 
RE – restriction enzyme 
 
The amplified products were purified as in section 2.1.2 and digested with 
PstI/HindIII, then ligated (section 2.1.9) into the pET28b-PstI expression 
vector enabling expression of a C-terminal his-tag attached to the TBIS_3092. 
Ligations were transformed into DH5α cells as in section 2.1.10.2 and plated 
on LB agar medium supplemented with 50 µg/ml kanamycin to select for 
positive transformants. These were screened by colony PCR using the above 
gene specific primers and sequenced prior to transformation into E. coli BL21 
(DE3) cells (section 2.1.10.2). Positive clones were selected by plating onto 
LB agar medium supplemented with 50 µg/ml kanamycin. These colonies 
were cultured in 5 ml LB broth supplemented with 50 µg/ml kanamycin and 
were incubated with shaking at 200 rpm at 37 °C for 24 hours. These cultures 
were used to seed 5 ml LB broth overexpression cultures and were grown 
and induced as in section 2.4.2 for protein expression in E. coli.  
 
2.4.4.1 Small scale expression testing and purification from 
M. smegmatis and E. coli 
After successful protein expression strains were obtained in either 
M. smegmatis or E. coli, Ni2+-sepharose beads were used to test for the 
expression and his-tag binding affinity of the proteins. A sample of 2.5 ml of 
each 5 ml overexpression culture was spun down in an Eppendorf tube at 
13 000 rpm. The cells were resuspended in 200 µl of 50 mM Na-phosphate 
buffer pH 7.4, 200 mM NaCl, 20 mM imidazole (lysis buffer A), and sonicated 
on ice using an Ultra sonic processor XL 2020 sonicator (Misonix 
incorporation, USA) (micro tip, setting 3, 4 x 15 seconds). The sonicated cell 
lysate was then centrifuged at 13 000 rpm at 4 °C for 20 minutes in order to 
separate the insoluble and soluble fractions. The Ni2+-sepharose beads were 
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washed with 1 ml of lysis buffer A, left to settle, and were centrifuged at 3000 
rpm at room temperature (RT) for 30 seconds. The wash buffer was then 
removed and replaced with the supernatant from the centrifuged cell lysate. 
Samples were incubated with shaking (1000 rpm) at RT for 15 minutes. After 
incubation, Ni2+-sepharose beads were left to settle and were then 
centrifuged at 3000 rpm at RT for 30 seconds. The supernatant was removed 
and kept, and the beads were washed a total of three times with 1 ml lysis 
buffer A as before. Typically, the expression culture, the initial supernatant, 
the supernatant from the Ni2+-sepharose beads after incubation, wash one 
and the Ni2+-sepharose beads were analysed on a 15 % SDS-PAGE gel.  
 
2.4.5 Large scale protein expression and purification from 
M. smegmatis 
Autoinduction medium (ZYP-5052) supplemented with 0.05 % (v/v) 
Tween-80 and 50 μg/ml kanamycin and hygromycin B was used for protein 
expression. As described in section 2.4.1 a single transformed colony was 
selected and used to inoculate a PA-0.5G seeder culture. This culture was 
grown for 48 hours at 37 °C with shaking at 200 rpm and was used at a 1:100 
dilution to inoculate a ZYP-5052 expression culture which was grown for 96 
hours at 37 °C with shaking at 200 rpm. 
 
The cells from large scale expression cultures were harvested by centrifuging 
at 4600 rpm at 4 °C for 20 minutes. Cell pellets were resuspended in 50 mM 
Na-phosphate buffer pH 7.4, 200 mM NaCl, and centrifuged again. For 
purification, cells were resuspended in an appropriate lysis buffer (generally 
50 mM Na-phosphate buffer pH 7.4, 200 mM NaCl, 20 mM imidazole (lysis 
buffer A)) and sonicated and harvested as in section 2.4.4.1 using the large 
tip, with setting 5-7, for 30 second bursts for a total of 4-5 minutes. The 
soluble fraction containing his-tagged PhoH2alt MTB, PhoH2alt MSMEG, or 
PhoH2MSMEG was loaded onto a HisTrap HP column (GE Healthcare Life 
Sciences) and purified as in section 2.2.7. The fractions containing purified 
protein were concentrated as in section 2.2.5 and if required, purified further 
by size exclusion chromatography using either a HiLoadTM 16/60 SuperdexTM 
or a 10/300 SuperdexTM column (analytical size exclusion column) (GE 
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Healthcare, UK) as in section 2.2.8., typically equilibrated with the same lysis 
buffer minus imidazole (50 mM Na-phosphate buffer pH 7.4, 200 mM NaCl). 
 
2.4.6 Large scale protein expression and purification from E. coli 
LB broth supplemented with 50 μg/ml kanamycin was used for protein 
expression. As described in section 2.4.4 a single transformed colony was 
selected and used to inoculate a 5 ml LB seeder culture. This culture was 
grown for 24 hours at 37 °C with shaking at 200 rpm and was used at a 1:100 
dilution to inoculate 1 L of LB medium supplemented with 50 μg/ml 
kanamycin. Overexpression cultures were incubated at 37 °C with shaking at 
200 rpm until an OD600 0.4-0.6 was reached. Cultures were induced with a 
final concentration of 1 mM IPTG and were incubated at 37 °C with shaking at 
200 rpm overnight. 
 
The cells from large scale expression cultures were harvested and purified as 
in section 2.4.5 using 50 mM Tris or Na-Hepes buffer pH 7.4, 200 mM NaCl, 
buffers.  
 
2.4.6.1 Lysis buffer screens 
Lysis buffer screens were performed to test for protein solubility. 
Overexpression cultures were tested similarly as described in section 2.4.4.1. 
Briefly, aliquots of overexpression culture were resuspended in 200 µl of 
buffer listed in Table 2.9. Cells were sonicated then centrifuged, and samples 
of the supernatant and cell pellet were analysed on a 15 % SDS-PAGE gel. 
 
Table 2.9 Lysis buffers used in lysis buffer screen 
Buffer pH NaCl 
50 mM Na-Acetate 5.0 150 mM 
50 mM Na-Acetate 5.0 500 mM 
50 mM Na-Hepes 7.0 150 mM 
50 mM Na-Hepes 7.0 500 mM 
50 mM Na-Phosphate 7.4 200 mM 
50 mM Tris 8.0 150 mM 
50 mM Tris 8.0 500 mM 
50 mM Na-bis-tris propane 9.0 150 mM 
50 mM Na-bis-tris propane 9.0 500 mM 
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2.4.6.2 Growth temperature screen for protein expression 
Growth temperature screens were trialled in an attempt to remedy poor 
protein expression with cultures grown at 37 °C. For protein expression in 
M. smegmatis, the temperature for incubation of autoinduction cultures was 
reduced to 30 °C. For protein expression in E. coli cultures were incubated at 
28 °C, 22 °C or 18 °C post-induction with 1 mM final IPTG.  
 
2.4.7 Denaturing purification of PIN and PhoH-domains from E. coli 
Large scale protein expression of the PIN and PhoH-domain from Rv1095 that 
had been cloned into pDEST17 was carried out in LB medium. One litre of LB 
broth supplemented with 100 µg/ml ampicillin cultures were seeded with 
1:100 dilution of seeder culture, induced with IPTG as before at an OD600 
0.4-0.6 and incubated at 37 °C overnight. Cells from overexpression cultures 
were harvested as above for the purification from M. smegmatis and E. coli. 
Cell pellets were resuspended in 50 mM Tris buffer pH 7.5, 200 mM NaCl, 8 M 
urea and sonicated on ice as in section 2.4.5 for a total of 2-3 minutes. The 
cell lysate was centrifuged at 13 000 rpm at 4 °C for 20 minutes, and the 
insoluble fraction was resuspended in 50 mM Tris buffer pH 7.5, 200 mM 
NaCl, 8 M urea and incubated on ice with gentle shaking for 1 hour.  The 
resuspended pellet was then centrifuged at 10 000 rpm for 10 minutes, the 
supernatant removed and loaded onto a HisTrap HP column (GE Healthcare 
Life Sciences) and the protein purified as in section 2.2.7. 
 
2.4.8 Protein refolding  
An adapted version of the Hampton refolding screen (Hampton Research, 
USA) of 16 solutions was used to test for protein refolding (Appendix A). The 
solutions screened the effect of: divalent cations (Mg2+/Ca2+ and EDTA), 
buffer pH and composition (MES/Tris-HCl), salt concentration (NaCl/KCl), 
PEG; detergent (Triton X), polar (arginine) or non polar (sucrose) additives, 
chaotropes (guanidine-HCl), and oxidising/reducing agents (GSH/GSSG or 
DTT) on refolding. 
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2.4.8.1 Small scale refolding screen 
The PIN and PhoH-domain proteins were purified as in section 2.2.7 under 
denaturing conditions (section 2.4.7). These proteins were dialysed in 20 μl 
dialysis buttons sealed with 6-8 MWCO dialysis membrane against 2 ml of the 
refolding screen (Appendix A) solutions at 4 °C for 1-2 days as in section 
2.2.6. The dialysed protein was examined for precipitate and analysed by 
Native-PAGE (section 2.2.2). Positive protein refolding was determined by 
the absence of precipitate after dialysis and by being able to successfully run 
into native polyacrylamide gel.  
 
2.4.8.2 Large scale refolding 
Protein refolding conditions that showed the most promise in the small scale 
refolding screen were scaled up in 10 fold steps from 20 µl to 20 ml. 
Denatured protein was dialysed in 1000x the protein volume of appropriate 
refolding buffer at 4 °C  for 1-2 days. The dialysed protein was then dialysed 
at 4 °C overnight into storage buffer (refolding buffer base plus 200 mM 
NaCl) and analysed by size exclusion chromatography as in section 2.2.8. 
 
2.4.9 Solubilisation trials of PIN and PhoH-domains from E. coli 
2.4.9.1 Small scale solubilisation trials 
Small scale expression cultures were set up as in section 2.4.2. For 
solubilisation testing, 3 mL of culture was spun down and resuspended 
initially in 250 µl 50 mM Na-phosphate buffer pH 7.4, 200 mM NaCl, 1.5 % 
(w/v) N-lauroylsarcosine or 50 mM Tris buffer pH 7.5, 200 mM NaCl, 20 mM 
imidazole, 1.5 % (w/v) N-lauroylsarcosine. Buffer without 
N-lauroylsarcosine or triton X-100 was used as a control. The suspension was 
sonicated and centrifuged at 13 000 rpm at 4 °C for 20 minutes. The 
supernatant was removed from the cell pellet and was mixed with 1 %, 2 % 
or 3 % triton X-100. Small scale purification trials were performed as in 
section 2.4.4.1. For elution of the protein from the Ni resin, 100 µl 50 mM Tris 
buffer pH 7.5, 200 mM NaCl, 500 mM imidazole was added to the resin and 
pipetted to mix for 2 minutes. The resin was left to settle and the supernatant 
was removed and kept. Both the supernatant and the beads were analysed by 
SDS-PAGE and Native-PAGE. 
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2.4.9.2 Large scale solubilisation trials 
For large scale solubilisation trials, 1 L expression cultures were set up as in 
section 2.4.6 supplemented with 100 µg/ml ampicillin. The cells were 
harvested as described in section 2.4.5 and resuspended in 20 mL 50 mM 
Tris buffer pH 7.5, 200 mM NaCl, 20 mM imidazole. Once resuspended, 1.5 % 
final (w/v) N-lauroylsarcosine was added and mixed by inversion. The 
suspension was sonicated and harvested as in section 2.4.6. The supernatant 
was removed and mixed with 1 % final concentration of triton X-100. The 
suspension was analysed by IMAC purification as in section 2.2.7.  
 
2.4.10 Initial crystallisation screens 
Initial crystallisation trials for PhoH2alt MTB protein purified in 50 mM 
Na-phosphate buffer pH 7.4, 200 mM NaCl were set up using a 
medium-throughput robotic system (Moreland et al. 2005) at the School of 
Biological Sciences at the University of Auckland. This trial consisted of five 
in-house screens with a total of 480 conditions from various screens 
(Moreland et al. 2005) in five 96 well Intelli-plates (Hampton Research, USA). 
A Multiprobe® II HTEX dispensing robot (Perkin-Elmer, USA) was used to 
dispense 75 μl of each condition into the reservoir wells of the Intelli-plate. A 
Honeybee Sitting Drop crystallisation robot (CartesianTM Dispensing Systems, 
USA) was used to dispense protein and reservoir solutions (100 nl each) into 
the crystallisation well and the plate was then sealed with ClearsealTM film 
(Hampton Research, USA). 
 
Crystallisation trials were carried out with PhoH2MSMEG purified in 50 mM 
Na-phosphate buffer pH 7.4, 200 mM NaCl and 50 mM Na-Hepes buffer pH 
7.4, 200 mM NaCl using the following Hampton Research crystallisation 
screens (Hampton Research, USA): Crystal (HR2-130), PEG Rx (HR2-086), 
Salt Rx (HR2-136) and Index (HR2-134). One hundred microlitres of each 
screen condition were pipetted into four 96-well Intelli-plates (Hampton 
Research, USA). A Mosquito® crystallisation robot (TTP LabTech Ltd, UK) 
was used to dispense protein and reservoir solutions (100 nl each) into the 
crystallisation well, and the plates were sealed with ClearsealTM film 
(Hampton Research, USA).  
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Screens were also performed for PhoH2TBIS purified in 50 mM Tris buffer pH 
8, 200 mM NaCl and 50 mM Na-Hepes buffer pH 7.5, 200 mM NaCl in the 
presence of 1 mM adenylyl-imidodiphospahte (AMP-PNP), and after a limited 
proteolytic digest of PhoH2TBIS with trypsin at a 1:100 ratio for 30 minutes at 
RT using the procedure described for PhoH2MSMEG. 
   
2.4.11 Optimisation of crystallisation conditions 
When promising crystallisation conditions were identified from the robot 
screen, fine screens were performed to optimise the condition for protein 
crystal growth.  
 
2.4.11.1 Fine screening - Hanging drop vapour diffusion  
For hanging drops, the tops of the wells of a Crystalquick 24-well plate 
(Greiner Bio-one, Germany) were greased with glisseal grease and 500 μl of 
each fine screen condition was added to the wells. One microlitre of protein 
was mixed 1:1 with the reservoir solution and pipetted onto a 22 mm cover 
slip (siliconised glass, square) (Hampton Research, USA). The cover slip was 
then inverted and placed over the reservoir solution and pressed down 
gently to seal.  
 
2.4.11.2 Additive screening 
For additive screening a selection of 14 additives were incorporated into the 
precipitant solution. Drops were set up as in section 2.4.11.1. 
Table 2.10 Additives used in additive screen 
Additive Final concentration 
Co(II)Cl2.6H2O 0.01 M 
MgCl2.6H2O 0.01 M 
Ni (II) Cl2.6H2O 0.01 M 
CsCl2 0.1 M 
Glycine 0.1 M 
EDTA 0.01 M 
Glucose 3 % 
Sucrose 3 % 
Glycerol 3 % 
PEG 400 5 % 
Ethanol 3 % 
Methanol 3 % 
Acetonitrile 4 % 
Butanol 0.7 % 
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2.4.11.3 Seeding 
For macro and streak seeding, hanging crystallisation drops were set up as in 
section 2.4.11.1 and left to equilibrate for 2-3 hours before seeding. For 
macro seeding, an already formed crystal from a source drop was removed to 
the new pre-equilibrated drop. For streak seeding, a dry cat’s whisker 
cleaned with 70 % ethanol was streaked through a source drop containing 
crystals and then brushed through the new pre-equlibrated drop. For batch 
seeding, a source drop containing crystals was added to 18 µl of 
crystallisation condition and vortexed. This seed stock was diluted 1:10, 
1:100 and 1:1000 in crystallisation condition, mixed 1:1 with protein and 
placed over the reservoir crystallisation solution. 
 
2.4.11.4 Testing of Crystals by X-Ray Diffraction  
Prior to testing for diffraction, crystals were looped out of their drop and 
moved into a cryo protectant solution which was made up of the 
crystallisation solution plus 5-20 % glycerol, before being snap frozen in 
liquid nitrogen. X-ray diffraction testing was performed at the Home-Source 
at the School of Biological Sciences, University of Auckland using CuKα 
radiation (λ=1.5418 Å). X-rays were generated by a MicroMaxTM -007HF 
generator (Rigaku, Japan) operated at 50 kV and 100 mA with a rotating 
copper anode and Osmic VariMaz optics. The cryo-loop was mounted onto 
the goniometer using a MAR345dtb goniometer setup with an EasymountTM 
automatic sample mounting system (MAR Research, Germany). Crystals were 
kept at 110-113 K with a cold stream of nitrogen gas produced by a Cobra 
cryosystem (Oxford Cryosystems, UK). 
 
Crystals were tested and X-ray diffraction data collected at the Australian 
synchrotron on beamline MX1, equipped with a ADSC Quantum 210r 
detector (Area Detector Systems Corporation, USA) with λ=0.9537 Å. 
 
2.4.11.5 Data processing 
Data were analysed using iMOSFLM for indexing, cell refinement and 
integration. The resulting mtz file was scaled using Scala or Aimless, and the 
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Matthews coefficient and self rotation function analysed using Matthews and 
MOLREP in the CCP4i suite.  
 
2.4.12 Transmission electron microscopy (TEM) of PhoH2TBIS 
Size exclusion purified PhoH2TBIS protein was prepared at 0.1, 0.03 mg/ml for 
analysis by TEM in 50 mM Tris buffer pH 8, 200 mM NaCl. Protein samples 
were negatively stained onto grids with 2 % uranyl acetate. Electron 
microscope grids were examined using BIRU Technai G2 electron microscope 
and low dose images were taken. 
 
2.4.13 Cloning of alt peptide into pYUB28b 
The alt peptide sequence from M. tuberculosis was amplified from pYUB1049 
habouring the Rv1095alt gene sequence using primers ALT F and R (Table 
2.11) and was cloned into pYUB28b as in section 2.4.3 and transformed into 
M. smegmatis 4517 cells as in section 2.1.10.5. 
 
Table 2.11 pYUB28b M. tuberculosis alt cloning primers 
Primer Primer Sequence RE RE 
F ALT TAACTCCATGGCTAGCGACATGCTCT  NcoI 
R ALT28b TAACTAAGCTTCGGAGCGCTCCTCGAGCT HindIII 
RE – restriction enzyme 
 
Small scale expression tests were carried out as in section 2.4.4.1 to observe 
protein expression and his-tag binding affinity. 
 
2.4.14 MALDI-TOF Mass Spectrometry (University of Waikato) 
2.4.14.1 Preparation of tryptic digest and whole protein samples 
Tryptic digest samples for analysis by MALDI-TOF MS were prepared as 
follows. Purified protein was separated on a 12 % SDS-PAGE gel and the 
protein band of the correct size was excised. The gel piece containing protein 
was destained overnight in 1:1 acetonitrile (ACN):25 mM NH4HCO3 and then 
washed with fresh 1:1 ACN:25 mM NH4HCO3. The supernatant was discarded 
and the gel piece was dehydrated with ACN for 15 minutes. The supernatant 
was removed again and the sample was dried under vacuum. One µl of 1 
µg/µl trypsin was resuspended in 199 µl of 25 mM NH4HCO3 and was used to 
rehydrate the gel piece at 4 °C for 1 hour. Excess trypsin solution was 
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removed and the gel piece was incubated at 37 °C for 4-5 hours. A solution of 
20 % ACN:0.1 % trifluoroacetic acid (TFA) (15 µl) was added to the sample 
and left to incubate overnight at RT. Samples were sonicated in a waterbath 
sonicator (Elma, Germany) at RT for 10 minutes prior to mixing 1:1 (0.5 
µl:0.5 µl) with matrix and spotted onto an AnchorChipTM MALDI-TOF target 
plate (Bruker Daltonics, USA) and left to air dry. Whole protein samples for 
analysis by MALDI-TOF MS were prepared by dialysis into MQ overnight and 
then mixed 1:1 with matrix. 
 
2.4.14.2 Preparation of matrix 
A 9:1 mixture of 2, 5-dihydrozybenzoic acid and 
2-hydroxy-5-methoxybenzoic acid (Super-DHB) was used as matrix for 
whole protein samples and α-Cyano-4-hydroxycinnamic acid (HCCA) as 
matrix for peptides. Solid matrix (10 mg) was added to 30 μl of 2:1 0.1 % TFA 
or ACN: 0.1 % TFA respectively and mixed well before sonicating in a 
waterbath sonicator (Elma, Germany) at RT for 10 minutes. The matrix 
solution was centrifuged at 13 000 rpm for 10 minutes and briefly 
centrifuged again before mixing with calibrant (peptide calibration standard 
or the whole protein calibration standard II (Bruker Daltonics, USA) or 
sample, and spotting onto the anchor chip. 
 
2.4.14.3 MALDI-TOF Set Up  
An AutoflexTM II MALDI-TOF mass spectrometer (Bruker Daltonics, USA) was 
used to analyse samples. Samples were analysed in linear mode, with the 
mass range selector set to “medium range”, pulsed ion extraction of 450 ns, 
gain to 2500 V, acceleration voltage to 20 kV and a range of 5-60 kDa 
collected depending on application. Laser power was typically around 
60-80 %. Spectra for the peptide calibration standard or the whole protein 
calibration standard II (Bruker Daltonics, USA) were collected first and the 
spectrometer calibrated with an automatic polynomial correction. All spectra 
were searched against the SWISS-PROT amino acid sequence database using 
the Mascot search engine (http://www.matrixscience.com). The search was 
set up for full tryptic peptides with a maximum of four missed cleavage sites. 
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2.4.15 N-terminal sequencing  
For the method performed by CPR, University of Otago, freshly IMAC purified 
PhoH2alt MTB and PhoH2alt MSMEG were couriered immediately after purification 
for N-terminal sequencing analysis.  
 
The samples were prepared for analysis on a PVDF membrane. For 
sequencing the N-terminus half, the samples on the membrane were 
subjected to guanidination and sulfonation with 4-sulfophenyl isothiocyanate 
(SPITC) according to the method developed by Chen et al. (2004). All samples 
(modified and unmodified) were digested on-membrane with trypsin 
(Shevchenko et al. 1996) and the eluted peptides collected and dried. 
Samples were resuspended in 30 % ACN:0.1 % TFA and were mixed with 
α-cyano-4-hydroxycinnamic acid (HCCA) matrix before spotting onto an 
Opti-TOF 384 well plate (Applied Biosystems, MA) for analysis using an 4800 
MALDI tandem time-of-flight mass spectrometer (MALDI TOF/TOF, Applied 
Biosystems, MA).  
 
For analysis by LTQ-Orbitrap the same sample preparation was undertaken, 
however the trypsin digested samples were fractionated by nano-flow 
reverse phase liquid chromatography and injected directly via an emitter tip 
into the ion source of a LTQ-Orbitrap hybrid mass spectrometer for analysis. 
  
All MS spectra with MALDI TOF/TOF were gained in positive-ion mode with 
800 laser pulses per sample spot. The 15-20 strongest precursor ions of each 
sample spot were selected for MS/MS collision-induced dissociation (CID) 
analysis. CID spectra were gained with 5000 laser pulses per selected 
precursor using the 2 kV mode and air as the collision gas at a pressure of 
1x10-6 torr.  
 
All MS/MS spectra (from either mass spectrometer) of modified peptides that 
had reasonable peak intensities were manually interpreted. Unambiguous 
sequence tags were used for homology searches using the BLAST program at 
NCBI (http://www.ncbi.nlm.nih.gov/BLAST/). Further, all MS/MS spectra 
were searched against the SWISS-PROT amino acid sequence database using 
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the Mascot search engine (http://www.matrixscience.com). The search was 
set up for full tryptic peptides with a maximum of four missed cleavage sites. 
Carboxyamidomethyl cysteine, oxidized methionine, pyroglutamate (E, Q), 
guanidination (K) and SPITC-sulfonation (N-terminus) were included as 
variable modifications. The precursor mass tolerance threshold was 75 ppm 
and the maximum fragment mass error was 0.4 Da. The peptide score 
distribution ions score was -10log(P), where P is the probability that the 
observed match is a random event. Individual ions scores > 32 indicate 
identity or extensive homology where p < 0.05. 
 
Samples were also screened for their intact protein mass by MALDI 
TOF/TOF. Proteins in solution were diluted 1/27, mixed with matrix and 
spotted onto the anchor chip. 
 
2.5 Methods relating to Chapter 5 
2.5.1 ATPase Methods 
KH2PO4 phosphate standards were prepared by diluting a 10 mM KH2PO4 
stock to a 100 µM (phosphate) working stock. The working stock was then 
serially diluted 1:1 in assay buffer (20 mM Na-Hepes buffer pH 7.4, 20 mM 
NaCl) from 50 µM to 1.56 µM.  
 
Pilot trials with PhoH2alt MTB showed that 1.25 µg of protein in a 100 µl 
reaction (0.25 µM) was suitable for sufficient colour development using 
substrate concentrations from 0-6 µM ATP. 
 
All reactions contained a final concentration of 1 mM MgCl2 and 0-6 µM ATP, 
and were made up to a total volume of 100 µl with assay buffer. Control 
EDTA reactions contained a final concentration of 2 mM EDTA. Each reaction 
was pre-equilibrated at 37 °C prior to the addition of protein. Reactions were 
incubated at 37 °C for 10 minutes before being stopped with 30 µl stop 
solution (1.5 % ammonium molybdate, 0.18 % (v/v) Tween-80, 0.1 % 
malachite green and 14 % sulphuric acid). Colour development was 
measured at 620 nm after incubation at RT for 10 minutes. 
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For assays performed in the presence of RNA, reactions included 0.0025 µM 
total M. smegmatis RNA or 5’3 RNA (Table 2.12). For time course assays, 1 µM 
ATP was used for all reactions and reactions were incubated for 0-8 minutes 
before being stopped with stop solution. 
 
All assays were performed in triplicate and standardised against a blank 
reaction containing no protein. The molar concentration of phosphate in the 
reactions was calculated by comparing with the phosphate (KH2PO4) 
standard (0-100 µM). 
 
2.5.2 Unwinding and ribonuclease Methods  
Self-annealing RNA and DNA oligonucleotides were ordered from Sigma and 
IDT (Custom Science). The RNA-oligonucleotides were made up to a working 
concentration (2 µM) in diethylpyrocarbonate (DEPC) or nuclease free water. 
The oligonucleotides were radio-labelled with adenosine 5’-triphosphate γ-
33P (SciMed) using T4 polynucleotide kinase according to kit instructions and 
then diluted 1:1 in hybridisation buffer (20 mM Tris-HCl pH 7.5, 500 mM 
NaCl, 1 mM EDTA). These were incubated at 95 °C for 10 minutes then left to 
hybridise overnight to RT. DNA-oligonucleotides were made up to a working 
concentration (12.5 µM) and were radio-labelled as above then diluted 4:1 in 
annealing buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM EDTA). Samples 
were incubated at 95 °C for 5 minutes and left to anneal for 45 minutes to RT.  
 
Purified PhoH2 (1 µM, 10 pmol) was incubated with 10 fmol (0.01 µM) of 
RNA/DNA oligonucleotide (Table 2.12) in a reaction containing 1 mM ATP 
made up to 10 µl with assay buffer (50 mM Na-phosphate pH 7.4, 20 mM 
NaCl, 10 mM MgCl2). Control reactions to test for ATP-dependent activity 
(-ATP), cofactor-dependent activity (+EDTA), and the requirement for ATP 
hydrolysis (AMP-PNP used in place of ATP), and test reactions were 
incubated at 37 °C for 30 minutes and then stopped with an equal volume (10 
µl) of stop solution (20 % glycerol (w/v), 0.2 % SDS, 4 mM EDTA, 0.1 % 
(w/v) bromophenol blue) or with 2x formamide stop solution (80 % 
formamide (v/v), 5 mM EDTA, 0.1 % (w/v) bromophenol blue, 0.1 % (w/v) 
xylene cyanol FF). The control for positive unwinding (oligonucleotide with 
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assay buffer) was boiled at 95 °C for 10 minutes prior to being stopped with 
stop solution. All reactions were analysed directly by electrophoresis on 
either a native 1xTBE-10 % polyacrylamide sequencing gel or a 1xTBE-10 % 
minigel. Gels were run in 1x TBE (0.089 M Tris HCl, 0.089 M boric acid, 
20 mM EDTA). The results were visualised by autoradiography. The gels 
were dried and reactions were exposed to film (Amersham HyperfilmTM MP) 
for 2-24 hours. Films were developed for at least 2 minutes in Kodak 
Developer and replenisher (Sigma Aldrich), and fixed with Kodak Fixer and 
replenisher (Sigma Aldrich) for at least 30 seconds in the dark. 
 
Table 2.12 RNA and DNA oligonucleotides 
Oligonucleotide Sequence 5’-3 (duplex) Predicted ΔG 
(kcal/mol-1) 
RNA 5’ GAAUGUACAUCAGAGUGCGCACUC -4.33 
3’ GAGUGCGCACUCGAAUGUACAUCA -4.74 
ss  GAAUGUACAUCAGAAUGUACAUCA -7.82 
Blunt GAAUGUACAUCAUGAUGUACAUUC -11.06 
3’AU GAGUGCGCACUCGAAUGUACAU -4.34 
3’UA GAGUGCGCACUCGAAUGUA -4.07 
5’AC ACAUGUACAUCAGAGUGCGCACUC -4.12 
3’AC GAGUGCGCACUCACUACAUGUACA -4.31 
5’AC blunt ACAUGUACAUCAUGAUGUACAUGU -11.74 
5’ACAA ACAACAACAUCAGAGUGCGCACUC -2.60 
5’1 UCAUGUACAUCAGAGUGCGCACUC -4.12 
5’2 AGAUGUACAUCAGAGUGCGCACUC -4.46 
5’3 ACUUGUACAUCAGAGUGCGCACUC -4.08 
5’4 ACAAGUACAUCAGAGUGCGCACUC -3.86 
5’5 ACAUCUACAUCAGAGUGCGCACUC -2.63 
DNA 5’ GAATGTACATCAGAGTGCGCACTC  
3’ GAGTGCGCACTCGAATGTACATCA  
Blunt  GAATGTACATCATGATGTACATTC  
ss  GAATGTACATCAGAATGTACATCA  
5’AC ACATGTACATCAGAGTGCGCACTC  
5’ or 3’ indicates position of the ss tail with respect to the duplex.  
The predicted ΔG value of each RNA oligonucleotide was calculated using 
http://www.basic.northwestern.edu/biotools/oligocalc.html.  
 
2.5.3 UTR assays  
Upstream substrates MTBalt and MSMEGalt were amplified from M. bovis BCG 
strain Pasteur 1173P2 and M. smegmatis mc2155 genomic DNA using MTBalt 
F with MTBalt R, and MSMEGalt F with MSMEGalt R. The PCR products were 
purified as in section 2.1.6 and were used as template for further PCR 
amplification with MTBaltT7 with MTBalt R, and MSMEGaltT7 F with MSMEGalt 
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R (Table 2.13) to generate MTBaltT7 and MSMEGaltT7. These products were 
used as template for transcription of RNA using the MEGAscript transcription 
reaction kit (Ambion) according to the kit instructions. The resulting RNA 
was dephosphorylated using shrimp alkaline phosphatase (SAP) (Roche) 
according to the kit instructions and was radio labelled with γ-33P as in 
section 2.5.2. 
 
Table 2.13 Primers for MTB and MSMEG alt substrates 
Primer Primer Sequence  T7 promoter sequence 
F MTBalt ATGGCTAGCGACATGCTCTGCTGCC 
MSMEGalt ATGGCTAGCGACCTGCTCTGCTGTC 
MTBaltT7 TAATACGACTCACTATAGGGATGGCTAGCGACATGCTCTG 
MSMEGaltT7 TAATACGACTCACTATAGGGATGGCTAGCGACCTGCTCTG 
R MTBalt R CGGAGCGCTCCTCGAGCTAACG 
MSalt SMEG R GTCACGTGGCGCTCCTAGGGGA 
 
For activity assays, 0.01 µM of RNA was incubated with 1 µM protein in a 
reaction containing 1 mM ATP made up to 10 µl with assay buffer (50 mM 
Na-phosphate pH 7.4, 20 mM NaCl, 10 mM MgCl2) for 15 minutes at 37 °C.  All 
reactions were incubated at 95 °C for 5 minutes then incubated on ice 
immediately for at least 1 minute prior to being analysed directly by 
electrophoresis on a native 1xTBE-10% polyacrylamide gel and visualised by 
autoradiography. 
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3 Chapter Three: Bioinformatics and 
transcriptional context of phoH2 
3.1 Bioinformatics 
3.1.1 phoH2 genes in M. tuberculosis and M. smegmatis 
The genomes of M. tuberculosis and M. smegmatis each contain a single copy 
of a phoH2 gene (Rv1095 and MSMEG_5247). The proteins encoded by these 
genes are 90.2 % identical, where most differences are conservative, single 
amino acid changes. Both amino acid sequences are of similar lengths (433 aa 
for PhoH2 from M. tuberculosis and 437 aa for PhoH2 from M. smegmatis) and 
share the conserved acidic residues characteristic of PIN-domain proteins at 
positions ~10-12, ~47, ~102 and ~127, and each of the conserved motifs 
identified for PhoH proteins in section 1.4.3 (Figure 3.1).  
 
Figure 3.1 Alignment between PhoH2 protein sequences from M. tuberculosis 
(Rv1095) and M. smegmatis (MSMEG_5247)  
The four N-terminal black boxed regions indicate the positions of the four conserved 
acidic residues within the PIN-domain of PhoH2. The latter boxes show the conserved 
residues and motifs of PhoH proteins: Q (green), Walker A (WA, yellow), R residue (R, 
light grey) RGRSL (RGR seq, dark green), Walker B (WB, magenta), N residue (SI, 
orange), R residue (SRH, red), III (black), R residue (SII, blue). Alignment was generated 
in GeneiousPro (V 5.1.7) using ClustalW. 
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3.1.2 Genomic context  
The genomic context between M. tuberculosis and M. smegmatis is very 
similar (Figure 3.2). 
 
Figure 3.2 Genomic context of Rv1095 and MSMEG_5247 
Genomic context of phoH2 genes from a) M. tuberculosis (Rv1095) and b) M. smegmatis 
(MSMEG_5247). Red arrow indicates position of phoH2 gene. Adapted from Xbase 
(http://www.xbase.ac.uk/) and BLAST (NCBI). 
 
For both genomic contexts, the genes coaA and glyA encode for a 
pantothenate kinase and serine hydroxymethyltransferase, respectively. The 
remaining genes surrounding Rv1095 encode a putative acyl-desaturase 
(desA2), a glycosyl hydrolase (Rv1096) and putative membrane glycine and 
proline rich proteins (Rv1097c). Most of these proteins are involved with 
fatty acid biosynthesis and metabolism (Nagai & Bloch 1968; Jaworski & 
Stumpf 1974; Stover & Schirch 1990; Appaji et al. 2003). The genes coaA and 
glyA are found in a similar position in M. smegmatis. There is, however an 
additional gene inserted between them (MSMEG_5250). This gene is listed as 
CalR9, which when analysed by PSI-BLAST is annotated as a hypothetical 
protein of unknown function. The gene MSMEG_5246 is listed as a 
hypothetical protein and does not align with Rv1096. PSI-BLAST analysis 
annotates MSMEG_5246 as a nitroreductase. MSMEG_5245 is a universal 
stress protein (USP-like) and MSMEG_5244 (not shown) encodes the 
transcriptional regulator DevR. DevR in M. smegmatis is involved with the 
adaptation to oxygen starvation and heat stress during stationary phase 
(O’Toole et al. 2002). MSMEG_5241 (not shown) harbours DevS, the histidine 
kinase associated with DevR. DevRS (Rv3132, Rv3133c) in M. tuberculosis is 
found at a remote region of the genome from phoH2 gene (O’Toole et al. 
2002).  
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In M. smegmatis, microarray data revealed an upregulation of several genes 
including the gene cluster MSMEG_5241 through MSMEG_5246 when cultured 
under slow growth conditions and 0.6 % air (Berney & Cook 2010). Upon 
closer examination of these microarray data, MSMEG_5247 was also found to 
be upregulated >2 fold under these growth conditions, suggesting the 
possible involvement of phoH2 in the response to oxidative stress. 
 
The STRING database (http://string-db.org) provides information on 
protein-protein interactions, each of which is provided with a confidence 
score and accessory information (Szklarczyk et al. 2011). The STRING 
database in the case of Rv1095 and MSMEG_5247 lists 10 predicted functional 
partners for both phoH2 genes (Table 3.1). The first six functional partners of 
phoH2 in Table 3.1 are shared by both M. tuberculosis and M. smegmatis. The 
latter genes are unique to each organism. 
 
Table 3.1 Predicted functional partners of phoH2 
Partner Type of partner  Annotation 
Rv3419c gcp 
MSMEG_1580 gcp 
Neighbourhood Putative DNA binding/iron metalloprotein/ 
AP endonuclease 
Rv1094 desA2 
MSMEG_5248 
Neighbourhood 
Coexpression 
Acyl-[acyl-carrier protein] desaturase 
Rv1863c 
MSMEG_3612 
Neighbourhood Integral membrane protein 
Rv2883c pyrH 
MSMEG_2540 
pyrH 
Neighbourhood Uridylate kinase – pyrimidine metabolism 
Rv0807 
MSMEG_5817 
Cooccurrence Hypothetical 
Rv1010 rsmA 
MSMEG_5438 
ksgA 
Neighbourhood Dimethyladenosine transferase  
Rv0430 Cooccurrence Hypothetical 
Rv1096 Neighbourhood Glycosyl hydrolase 
Rv0476 Cooccurrence Transmembrane protein 
Rv3416 whiB3 Cooccurrence Transcriptional regulatory protein 
MSMEG_5246 Neighbourhood Hypothetical protein 
MSMEG_5245 Neighbourhood Universal stress protein 
MSMEG_5244 Neighbourhood Two-component transcriptional regulator 
DevR 
MSMEG_4173 Neighbourhood MaoC family protein 
AP – Apurinic/apyrimidinic, Rv – M. tuberculosis, MSMEG – M. smegmatis 
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WhiB3 in M. tuberculosis is regulated by DosR/S/T (DevRS), and controls the 
differential production of virulence associated lipids in reponse to 
fluctuations in the intracellular redox environment (Singh et al. 2009). This 
modulates the response of macrophages to infection and maintains 
intracellular redox homeostasis (Singh et al. 2009). In M. smegmatis WhiB3 
shows a slight increase in expression under slow growth conditions and 
0.6 % air (Berney & Cook 2010), however not to the same degree as the 
cluster around MSMEG_5247. Predicted functional partner MSMEG_1580 
(putative DNA binding/metalloprotein/AP endonuclease) is upregulated 
under these growth conditions (Berney & Cook 2010) further suggesting the 
plausibility of phoH2 involvement in the oxidative stress response.  
 
3.1.3 Predicted transcriptional regulators and regulatory sites 
The Tuberculosis Database (TBDB) has predicted four transcriptional 
regulator binding sites responsible for the expression of Rv1095 (Figure 3.3). 
 
Figure 3.3 Genomic positions of predicted transcription factor binding sites 
Arrows indicate the position of the four predicted transcription factor binding sites. The 
red arrow indicates the position of the PhoH2 gene. Adapted from TBDB 
(http://www.tbdb.org/). 
  
Rv0494 is a transcriptional regulator that belongs to the GntR family and is 
predicted to target Rv1093-Rv1095 at -755 and +204 relative to the start of 
Rv1095. Rv1990c is a transcriptional regulator of unknown function and is 
predicted to target Rv1094 and Rv1095 at position -95 and Rv3133c encodes 
DevR which is predicted to target Rv1095-Rv1097c at position +1935. In 
M. smegmatis DevR is found two genes away from phoH2 (MSMEG_5244). 
Likely homologues of Rv0494 (MSMEG_0179) and Rv3133c (MSMEG_5244) in 
M. smegmatis show an elevated level of expression when cultured under slow 
growth conditions and 0.6 % air (Berney & Cook 2010). No homologue was 
found to Rv1990c in M. smegmatis. In a SenX3-RegX3 mutant strain of 
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M. tuberculosis, global expression data have shown that Rv1990c expression 
was increased compared with levels in the wild type, suggesting control of 
this transcriptional regulator by Sen3-RegX3 (Parish et al. 2003a).  
 
Based on these observations and those made in sections 1.5.1, 1.5.2 and 3.1.2, 
it is plausible that phoH2 may be involved in the response of the cell to 
hypoxic growth conditions and may play a role in virulence associated lipid 
biosynthesis. This may be achieved in M. tuberculosis through indirect 
regulation by: 1) PhoP, through its control of the Dos/Dev regulon (section 
1.5.1) 2) WhiB3, that is under control of Dos/Dev (3.1.2) 3) SenX3-RegX3, 
through its control of Rv1990c (section 3.1.3) or 4) Rv0494, which is 
implicated in the hypoxic response (section 3.1.3). In M. smegmatis, through: 
1) Dos/Dev and 2) SenX3-RegX3, both which showed elevated expression 
under hypoxic growth conditions along with phoH2. 
 
In relation to these potential regulators, Kazakov et al. (2003), using an 
iterative signal PSI-SITE search predicted potential regulatory sites upstream 
of orthologous BS-YlaK genes. In the genomes of M. tuberculosis and M. bovis 
BCG the conserved 18 bp candidate site was predicted to be a 
pseudopalindrome (AGGACCGGCCCCGGTCCT) and located at position -87 
(Figure 3.4a). The same sequence is found upstream of MSMEG_5247 in 
M. smegmatis at position -86 (Figure 3.4b).  
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Figure 3.4 Relative position of candidate regulatory site upstream of Rv1095 
and MSMEG_5247 
Positions of candidate regulatory sites upstream of a) M. tuberculosis/M. bovis BCG and 
b) M. smegmatis (Kazakov et al. 2003). Annotated sequence was made using 
GeneiousPro (V 5.1.7). 
 
Overall, there are a number of candidate transcriptional regulator sites and 
potential regulatory sequences within the 5’UTR for the regulation of phoH2. 
It is striking that there exists strict conservation at -87 and -86 in 
M. tuberculosis and M. smegmatis. 
 
3.1.4 Candidate alternative start sites upstream of phoH2 
As PIN-domains, when they are found as single domain proteins are 
coexpressed with an upstream transcription factor (Arcus et al. 2011) and 
given the position of the PIN-domain at the N-terminus of PhoH2 it is 
possible that with phoH2 there may exist an analogous transcriptional 
arrangement to that of vapBC. In the case of vapBC, there is a coding region 
upstream of vapC (PIN-domain), vapB (antitoxin) that is out of frame of and 
overlaps the translational start of the VapC protein. Figure 3.5 illustrates the 
possible arrangement of a coding region upstream of phoH2.  
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Figure 3.5 PhoH2 protein schematic with possible antitoxin upstream 
PhoH2 protein schematic illustrating the possible position of an antitoxin protein 
upstream, analogous to vapB of vapBC. 
 
Upon closer examination of the sequences upstream of the phoH2 gene in 
M. tuberculosis and M. smegmatis, a number of possible alternative start sites 
for short potentially coding ORFs were identified that are out of frame of 
Rv1095 and MSMEG_5247 (Figure 3.6), analogous to VapB. 
  
 
Figure 3.6 Position of possible alternative start sites upstream of Rv1095  and 
MSMEG_5247 
Locations of possible alternative start sites for short potentially coding ORFs upstream 
of a) Rv1095 and b) MSMEG_5247.  
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This raised the possibility of a coding region that is not currently annotated 
in either genome, and the possibility of a gene that may code for a protein of 
similar nature to an antitoxin protein. A BLAST search of the non-redundant 
protein sequence database revealed that the sequence taken from the 
farthest alternative start site (1) in M. tuberculosis is highly conserved in 
closely related mycobacterial species (Figure 3.7).  
 
 
Figure 3.7 Amino acid sequence alignment of mycobacterial sequences from 
alternative start site (1) 
Amino acid alignment from the alternative start site to the stop site 1-2 amino acids in 
from the annotated PhoH2 start site from Mycobacterium africanum, M. bovis, 
Mycobacterium canetti and M. tuberculosis. Alignment was generated in GeneiousPro (V 
5.1.7) using ClustalW. 
 
Across other mycobacterial species, sequence homology from this alternative 
start site in M. tuberculosis is observed for Mycobacterium marinum and 
Mycobacterium ulcerans 80 %, M. leprae 72 %, and Mycobacterium avium 
77 % sequence identity. This further suggests the likelihood of a protein 
coding transcript. This sequence conservation was limited to the 
mycobacterium family. In some genomes this ORF is annotated as protein 
coding, such as for M. marinum (MMAR_4372) (Figure 3.8).  
 
 
Figure 3.8 Genomic context of MMAR_4342  
Solid black arrow indicates the position of annotated MMAR_4373 ORF and the red 
arrow indicates the position of the phoH2 gene. Adapted from Xbase 
(http://www.xbase.ac.uk/). 
 
The sequence directly upstream of MSMEG_5247 from M. smegmatis is 69 % 
similar to the equivalent sequence in M. tuberculosis (Figure 3.9). This may be 
a reflection of the genetic differences between M. tuberculosis and 
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M. smegmatis which is likely due to pathogenic differences between these 
two organisms. 
 
Figure 3.9 Amino acid sequence alignment of M. tuberculosis and M. smegmatis 
upstream sequences 
Amino acid alignment from the alternative start site to the stop site 1-2 amino acids in 
from the annotated PhoH2 start site from M. tuberculosis and M. smegmatis. 
 
These observations prompted the analysis of transcription of phoH2 genes 
from M. tuberculosis and M. smegmatis.  
 
3.2 Transcriptional context of phoH2 
3.2.1 Introduction 
PIN-domain proteins are commonly expressed as part of an operon with an 
antitoxin gene located upstream of the gene for the PIN-domain. In these 
systems, expression and translation of the antitoxin protein is required to 
offset the potentially toxic activity of the PIN-domain protein (Arcus et al. 
2011). In the case of PIN-domain proteins expressed as part of a domain 
fusion, it is unknown whether there is a requirement for a preceding 
antitoxin-like element for successful protein expression, translation or 
regulation, and whether the domain fusion is enough to compensate for the 
potentially toxic activity of the PIN-domain.  
 
The remainder of this chapter will focus on the investigation of transcription 
of Rv1095 and MSMEG_5247, and the effect of conditional PhoH2 protein 
expression on M. smegmatis mc2155 cell growth and viability.  
 
RT-PCR and 5’RACE are two methods that can be used to study mRNA 
transcripts. RT-PCR is a method used to amplify cDNA copies of RNA 
(Sambrook & Russell 2001). The use of random hexanucleotides in the 
amplification of cDNA leads to the production of fragments of the entire 
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population of RNA and ensures a uniform representation of all the RNA 
sequences. These products can then be analysed using specific primers in 
order to map mRNA transcripts.  
 
Once the approximate mRNA transcript length has been obtained, to 
determine the exact transcriptional start site of an mRNA transcript, 5’RACE 
can be used. By tailing cDNA that has been generated using a gene specific 
primer with dATP, and subsequent PCR amplification and cloning with a dT 
oligo plus a second gene specific primer, the 5’ terminal sequence can be 
identified. 
 
To study the effect of protein expression on wild type growth and viability 
conditional expression experiments can be performed. Conditional 
expression vectors allow for lower levels of protein expression under the 
control of an inducible promoter.   
 
The conditional overexpression of PIN-domain proteins, such as VapC from 
M. smegmatis has been shown to result in reduced cell growth and viability 
(Robson et al. 2009). To determine whether PhoH2 from M. tuberculosis and 
M. smegmatis had a similar effect when overexpressed in wild type 
M. smegmatis mc2155, inducible expression constructs were made that 
contained the phoH2 gene from M. smegmatis and M. tuberculosis under the 
control of a tetracycline-inducible promoter using the pMIND vector. In order 
to investigate any effects of cloning from the alternative start site, for the 
short ORF upstream of phoH2, the Rv1095alt (phoH2alt) sequence from 
M. tuberculosis was also cloned into pMIND. 
 
3.2.2 Results  
3.2.2.1 RT-PCR  
RT-PCR was used map the mRNA transcripts associated with Rv1095 and 
MSMEG_5247 from M. tuberculosis and M. smegmatis. Using 6 primer 
combinations that spanned the upstream region of each phoH2 gene (Figure 
2.1) both Rv1095 and MSMEG_5247 were shown to be transcribed as part of a 
longer mRNA transcript (Figure 3.10 and Figure 3.11). With Rv1095, each 
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primer combination that covered the possible alternative start sites (Figure 
3.6) and extended into the preceding gene, with the exception of primer 
combination (1) gave a positive result for an mRNA transcript (Figure 3.10a 
and c) suggesting a leader length of approximately 569 bases (Figure 3.10b). 
With MSMEG_5247, each primer combination with the exception of (1) and 
(2) gave a positive +RT result (Figure 3.11a and c). These results suggested a 
leader length of approximately 548 bases (Figure 3.11b) for M. smegmatis. 
 
Figure 3.10 Length of Rv1095 leader 
a) RT-PCR results with each of the 6 RT primer combinations (1-6). (+RT) cDNA, (gDNA) 
genomic DNA and (–RT) absence of RT during cDNA synthesis, used as template for PCR 
reactions (gDNA to confirm PCR product sizes and –RT to exclude DNA contamination 
during cDNA synthesis). b) Schematic of primer positions that yielded a positive (2) and 
negative (1) result for an mRNA transcript. c) Repeat test of primer sets 1 and 2 
confirming absence of +RT product with primer combination 1. 
 
The +RT PCR product with primer combination 2 may represent partial 
primer binding due to limited overlap between the primer and the cDNA 
template. This may be caused by the lack of cDNA template available for the 
5’ end of the primer to bind to as the 5’ end of the mRNA transcript may fall 
within the primer sequence, this ultimately leading to a weak PCR product.  
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Figure 3.11 Length of MSMEG_5247 leader 
a) RT-PCR results with each of the 6 RT primer combinations (1-6). (+RT) cDNA, (gDNA) 
genomic DNA and (–RT) absence of RT during cDNA synthesis, used as template for PCR 
reactions (gDNA to confirm PCR product sizes and –RT to exclude DNA contamination 
during cDNA synthesis). b) Schematic of primer positions that yield a positive (3) and 
negative (2) result for an mRNA transcript. c) Repeat test of primer sets 2 and 3 
confirming absence of +RT product with primer combination 2. 
  
Given the positive result for a long mRNA transcript associated with both 
phoH2 genes, a closer examination of the mRNA transcripts (+RT products) 
was undertaken to identify any distinguishing transcriptional elements.   
 
In prokaryotes it is common for a hexameric sequence to be located around 
the -10 region upstream of the transcriptional start point (TSP). This 
promoter element is known as a Pribnow box. In mycobacteria it has been 
identified that these promoter sequences are dissimilar from those found in 
E. coli (Bashyam et al. 1996). It was found by Bashyam (1996) that 
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mycobacterial Pribnow boxes contain conserved nucleotides at specific 
positions, for M. tuberculosis the sequence T 80 %, A 90 %, Y 60 %, G 40 %, A 
60 % and T 100 %, and for M. smegmatis T 100 %, A 93 %, T 50 %, A 57 %, A 
43 % and T 71 % was derived by aligning mycobacterial promoter sequences 
on the basis of their TSP, where Y is a pyrimidine. It is evident that most 
conservation lies with positions 1, 2, and 6, the other positions are thought to 
be more variable due to the high GC content of mycobacterial DNA (Bashyam 
et al. 1996). It is further reported that no single -35 sequence in mycobacteria 
is identical suggesting that mycobacteria can tolerate a greater variety of 
sequences at this position compared with E. coli (Bashyam et al. 1996). The -
35 sequences in mycobacteria were investigated by (Agarwal & Tyagi 2006), 
here it was found that a specific -35 sequence increased RNAP activity 
(TTGCGA) and that 18 nucleotides between the -10 and -35 sites was more 
optimal for promoter activity than 17 nucleotides which is favoured by E. coli.  
 
Figure 3.12 outlines the hypothetical -10 and -35 sites of both phoH2 and alt 
genes from M. tuberculosis and M. smegmatis. The -10 and -35 sites upstream 
of the phoH2 TSP are dissimilar between M. tuberculosis and M. smegmatis. 
However, there is conservation of a GGAG Shine Delgarno sequence at the -10 
position. In contrast, the -10 sites upstream of the alt gene TSP are identical 
and located in the exact same position in these two organisms, 8 nucleotides 
from the TSP. Further, these -10 sites fulfil the consensus 1st, 2nd and 6th 
positions (T, A and T) identified by Bashyam et al. (1996). The -35 sites do 
not match the sequence found to increase promoter activity, and these sites 
are dissimilar between these two organisms. 
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Figure 3.12 Putative promoter elements of phoH2 from M. tuberculosis and 
M. smegmatis  
mRNA transcripts found to be associated with phoH2 from a) M. tuberculosis and b) 
M. smegmatis (+RT product) were analysed for distinguishing putative promoter 
elements. The underlined nucleotides at the beginning and end of each sequence 
represent the sites of the RT primers that yielded the +RT product with RT-PCR. The 
further underlined nucleotides represent putative promoter elements (-10 and -35) and 
the site of the pseudopalindromic sequence identified by Kazakov (2003). The TSP is 
indicated (+1, bold) for both the phoH2 and alt genes.  
 
These mRNA transcripts were also analysed for consensus sigma factor 
sequences (Rodrigue et al. 2006). None were identified in either sequence. 
 
Chapter Three  82 
 
 
3.2.2.2 5’RACE  
Many attempts were made to use 5’RACE as an approach to determine the 
actual transcriptional start site of phoH2 from both M. tuberculosis and 
M. smegmatis. Efforts with Roche 5’RACE kit as per kit instructions and with 
the steps optimised as required were exhaustive but unsuccessful likely due 
to the extensive secondary structure within the GC rich upstream region. 
RNA secondary structure has been shown to cause strong hindrance of 
reverse transcription and result in the build up of spurious products or 
inhibition of reverse transcriptase activity (Tuerk et al. 1992; Olsen et al. 
1994).  
 
3.2.2.3 Conditional protein expression  
To determine the biological effect of PhoH2 protein expression in 
M. smegmatis, conditional expression constructs that contained phoH2 genes 
from M. tuberculosis and M. smegmatis (pMINDRv1095, pMINDRv1095alt and 
pMINDMSMEG_5247) were cloned into tetracycline inducible pMIND 
conditional expression vector and transformed into M. smegmatis mc2155. 
This enabled the effect of PhoH2 and PhoH2alt protein expression on the 
growth and viability of M. smegmatis mc2155 to be examined by monitoring 
OD600 and CFUs respectively.  
 
The conditional overexpression of pMINDMSMEG_5247 (PhoH2 from 
M. smegmatis) had no effect on the growth or viability of M. smegmatis 
(Figure 3.13). The expression of pMINDRv1095 (PhoH2 from M. tuberculosis) 
however caused less growth and reduced cell viability, which was reversed 
by the presence of the alt peptide (pMINDRv1095alt/PhoH2alt). This suggests a 
negative effect of protein expression by pMINDRv1095 (PhoH2) that is 
alleviated by the alt peptide. 
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Figure 3.13 The effect of conditional expression from pMINDEV, 
pMINDMSMEG_5247, pMINDRv1095, and pMINDRv1095alt on cell growth and viability of 
M. smegmatis mc2155 
Cellular growth and the effect of protein expression were examined for M. smegmatis 
mc2155 strains harbouring pMIND constructs pMINDEV (empty vector), pMINDMSMEG_5247, 
pMINDRv1095, and pMINDRv1095alt by monitoring optical density a) OD600 and cell viability 
b) CFU ml-1 in the presence of Tc. During early exponential phase (OD600 of ~0.1-0.2) 
protein expression was induced in all strains by the addition of tetracycline (indicated 
by black arrow). Graphs are shown from data from one experiment of three cultures for 
each strain. For OD600 the results are shown as the mean and +/-SD of the three cultures. 
The viability was determined by CFUs from point of induction of expression by the 
addition of tetracycline for 96 hours, the results are shown as the mean and +/-SD of 
three technical replicates taken at each time point from each of the three cultures.  
 
Culture samples that had been induced with tetracycline were also spotted 
onto LBT plates supplemented with hygromycin B only (-Tc) to look for 
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differences between colonies grown on plates containing tetracycline and 
those without tetracycline. If there is an effect of protein expression on 
growth and colony formation it should be apparent on those plates 
containing tetracycline as PhoH2 protein expression should be maintained. If 
PhoH2 protein expression is bactericidal, growth on the plates that do not 
contain tetracycline should be similar to the growth on plates that contain 
tetracycline. If PhoH2 protein expression is bacteriostatic (reversible) then 
culture samples grown on plates that do not contain tetracycline should 
adopt ‘normal’ colony size. Figure 3.14 shows that immediately after 
induction of the cultures with tetracycline no differences are observed 
between those colonies grown in the presence (+Tc) or absence (-Tc) of 
tetracycline (0 hours panel). For M. smegmatis mc2155 strain expressing 
pMINDRv1095, culture samples plated out after 72 hours of growth in the 
presence of tetracycline, onto agar plates supplemented with tetracycline 
(+Tc) showed smaller pinpoint-sized colonies compared with the normal 
colony growth observed for the same samples grown on plates in the absence 
(-Tc) of tetracycline (Figure 3.14c (72 hours panel)). Slight differences were 
observed for this strain at earlier time points, however not to the degree seen 
at 72 hours.  
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Figure 3.14 Colony morphology of M. smegmatis mc2155 strains 
harbouring pMINDEV, pMINDMSMEG_5247, pMINDRv1095, and pMINDRv1095alt 
Colony growth on agar plates of M. smegmatis mc2155 harbouring pMIND constructs a) 
pMINDEV (empty vector) b) pMINDMSMEG_5247 c) pMINDRv1095 and d) pMINDRv1095alt in the 
presence (+Tc) and absence (-Tc) of tetracycline at 0 and 72 hours post-culture 
induction with tetracycline. Spots are representative of the 10-4 dilution of each culture 
sample.  
 
The difference in colony morphology observed for M. smegmatis mc2155 
pMINDRv1095 supports the negative effect of pMINDRv1095 protein expression 
on the viability (CFUs) of M. smegmatis.  
 
3.2.3 Discussion 
The genes and genomic contexts of phoH2 in M. tuberculosis and 
M. smegmatis are similar. In addition, the predicted functional partners and 
transcriptional regulators implicate phoH2 in the cells response to phosphate 
and oxidative stress as well as with virulence associated lipid biogenesis in 
response to redox environments. Both share a pseudopalindrome sequence 
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at nearly identical positions upstream and alternative start sites possibly a 
protein coding sequence out of frame of the phoH2 gene.  
 
The results of the RT experiments that aimed to map the mRNA transcript 
associated with phoH2 from M. tuberculosis and M. smegmatis show that the 
mRNA transcript length of phoH2 is similar between these two organisms. 
These results suggest the possibility of an upstream gene due to positive RT 
(+RT) products obtained for each primer set that spanned the possible 
alternative start sites. Further, the putative -10 sites upstream of both 
possible alt genes in M. tuberculosis and M. smegmatis are the conserved and 
share the consensus nucleotides identified for mycobacterial -10 sites, this 
was not the case for the -10 site upstream of the phoH2 gene. The -35 sites 
were dissimilar in both positions which is not surprising given previous 
observations that no two mycobacterial -35 regions are the same (Bashyam 
et al. 1996).  
 
It is possible that these results may also suggest regulation by transcription 
factors that are predicted to control the expression of Rv1094 and 
MSMEG_5248, such as the predicted transcriptional regulator Rv0494 (section 
3.1.3). This regulator is thought to target Rv1094 and Rv1095 at positions 
-755 from the annotated start site of Rv1095 and at +204 within the Rv1095 
gene. The predicted binding site at -755 is 185 nucleotides upstream of the 5’ 
end of the +RT PCR product.   
 
For genes that do not have a leader sequence, the AUG site is the only site 
recognised by the ribosome in vivo for translation (Kozak 2005). Long 5’ 
leaders can adopt a number of possible roles including presentation of 
structural elements that confer structural stability to the overall transcript, 
and sequence and structural components that guide intracellular mRNA 
localisation. Irnov (2010) states that the average length of long 5’ leaders 
which contain cis-acting elements is around 360 nucleotides in B. subtilis. The 
reported average shorter leader length of 35 nucleotides does not possess 
regulatory elements. It is further suggested that where 5’ leader regions 
occur they contain specialised functions within them (Irnov et al. 2010). In 
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addition to cis-acting elements, small ORF’s located near the 5’ of the mRNA 
can down regulate expression of the mRNA transcript. These can be 
overcome by changes in mRNA structure (Kozak 2005). Certain RNase 
enzymes have been shown to interact with their 5’ leader and in so doing, 
autoregulating their own expression (Schuck et al. 2009). It is possible that 
PhoH2 acts on its 5’ leader region and that short alternative 5’ ORF’s are 
involved with protein expression. These hypotheses are further investigated 
in Chapter 4 and 5. 
 
Conditional expression experiments which examined the biological effect of 
PhoH2 protein expression in M. smegmatis showed a negative effect of 
Rv1095 protein expression that was alleviated by the presence of the alt 
peptide and reversed in the absence of tetracycline (-Tc) indicating the effect 
was bacteriostatic in nature. With the M. smegmatis mc2155 strain expressing 
the Rv1095alt construct from M. tuberculosis (phoH2 cloned from alternative 
start site 1), no effect on growth or viability was observed. This may suggest 
that this construct includes transcriptional and/or translational regulatory 
factors within the sequence upstream of the annotated start site of the phoH2 
gene that are responsible for ‘normal’ protein expression and translation. 
Conversely, there may be an inhibitory role of a possible protein or transcript 
encoded in this region that is offsetting the activity of the PhoH2 protein 
analogous to the toxin-antitoxins. It is apparent that the fusion between the 
PIN and PhoH-domain does not play a compensatory role with regard to its 
toxic activity. 
 
For M. smegmatis mc2155 strain containing pMINDMSMEG_5247 growth and 
viability were similar to wild type M. smegmatis containing pMINDEV (empty 
vector). Protein expression did not have a negative effect as seen for Rv1095, 
despite the similarity between the two proteins from these two 
mycobacterial organisms. It is likely that MSMEG_5247 may have its toxicity 
masked by compensation by endogenous levels of MSMEG_5247 antitoxin 
(equivalent upstream sequence to that of phoH2alt), due to expression in 
M. smegmatis mc2155. Alternatively, these two proteins may differ in their 
modes of regulation. 
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3.2.4 Conclusions 
This investigation of the transcriptional context of phoH2 from 
M. tuberculosis and M. smegmatis has revealed both similarities and 
differences between these two organisms. My results have shown that both 
genes are transcribed as part of a long, extensively structured mRNA 
transcript which is likely to contain regulatory elements or short 5’ORFs 
involved in successful expression, regulation and translation of the PhoH2 
protein. In addition Rv1095 protein expression had a negative effect on the 
growth of M. smegmatis mc2155 which is bacteriostatic in nature as in the 
absence of inducer (tetracycline) ‘normal’ colony growth was resumed. This 
negative effect was alleviated by the presence of the alt peptide as it was not 
observed with the expression of Rv1095alt (phoH2alt) or MSMEG_5247 from 
M. smegmatis, which raises the possible role of elements present in the short 
sequence directly upstream of Rv1095 that may be involved with protein 
expression, translation or mRNA transcript regulation. 
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4 Chapter Four: Protein cloning, expression, 
purification & crystallisation  
 
4.1 Introduction 
4.1.1 Protein expression in M. smegmatis 
Expression of mycobacterial proteins in E. coli can be challenging due to the 
formation of insoluble protein often found in inclusion bodies. Previous work 
in our lab showed that often mycobacterial proteins express insolubly in 
E. coli. One approach to overcome the expression of insoluble protein is to 
express the protein in its host or in a host that is more closely related to the 
organism from which the protein is derived. M. smegmatis is a 
non-pathogenic mycobacterial species which is relatively fast growing 
compared with M. tuberculosis, with a doubling time of ~3 hours (Snapper et 
al. 1990). The M. smegmatis overexpression strain mc24517, in combination 
with the traditional mycobacterial expression vector pYUB1049, can yield 7 
mg of soluble protein per litre of culture (Bashiri et al. 2007). This strain of 
M. smegmatis can be grown in autoinduction medium using methods 
established for E. coli, which negates the need to monitor optical density for 
induction and also reduces the cost of culture by eliminating the need for 
albumin dextrose catalase supplement (ADC) enrichment traditionally used 
for mycobacterial culture growth (Bashiri et al. 2007).  
 
4.1.2 Protein expression using Gateway® 
A cloning system which can help to overcome the obstacles associated with 
recombinant E. coli protein expression is Gateway. The expression vector 
pDESTSMG is adapted from the mycobacterial shuttle vector pYUB1049 
(Goldstone et al. 2008) and allows for ease of cloning associated with the 
Gateway system. It also makes use of protein expression in the M. smegmatis 
mc24517 expression strain. In this system BP clonase is used to catalyse the 
recombination of the gene insert amplified with flanking attB sites and the 
donor vector which inserts the gene into the attP recombination sites. The 
gene can then be transferred to the destination vector using LR clonase 
which recombines and inserts the gene into the attR recombination sites. 
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With the cloning of genes initially into pDONR221 and subsequently into a 
destination vector, proteins can be tested for expression in an alternative 
host which can be useful for further applications. 
 
4.1.3 Protein refolding 
If the issue of insoluble protein expression cannot be solved through the use 
of different expression constructs one approach to recover insoluble protein 
is through denaturation and renaturation. Chaotropic agents such as urea or 
guanidine HCl, thiocyanate salts or detergents like SDS can be used to 
denature proteins (De Bernardez 1998). Generally, 6-8 M urea or 6-7 M 
guanidine HCl is necessary to unfold and solubilise proteins (Tsumoto et al. 
2003). A number of methods are available to promote protein refolding 
including one-step dialysis, step-wise dialysis, gel filtration, dilution, mixing 
and solid phase refolding (De Bernardez 1998 ; Tsumoto et al. 2003). With 
one-step dialysis, denatured protein samples are dialysed against a refolding 
buffer. Over the course of dialysis the concentration of denaturant decreases, 
promoting the folding of the protein into intermediate and native structures 
(Tsumoto et al. 2003). Renaturation buffers need to promote the correct 
formation of disulphide bonds. Reagents such as glutathione (GSH), 
glutathione disulphide (GSSG) and dithiothreitol (DTT) are commonly used 
as oxidising and reducing agents to encourage disulphide bonds to break and 
reform.   
 
4.1.4 Protein solubilisation with detergents 
As well as being used to fully denature proteins prior to refolding, detergents 
can also be used to disrupt protein complexes for solubilisation from 
inclusion bodies, and can leave the disrupted protein in a more ordered state 
(Tsumoto et al. 2003). It has been reported that detergent N-lauroylsarcosine 
in combination with triton X-100 can solubilise E. coli expressed GST-fusion 
proteins, vascular endothelial growth factor and GST-pyruvate kinase muscle 
2, without the need for further renaturation (Zou et al. 2009; Park et al. 
2011). It is possible that other protein constructs may be able to be 
solubilised in this manner.  
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4.1.5 Protein crystallisation and Electron Microscopy 
Once soluble protein has been obtained the determination of the 
three-dimensional (3D) structure of a protein can provide insights into the 
molecular organisation and conformation. Nuclear magnetic resonance 
spectroscopy (NMR) and X-ray crystallography are two approaches used to 
gain high resolution protein structures. NMR is limited to smaller protein 
complexes in solution (<30 kDa), whereas X-ray crystallography is not 
limited by protein size but does rely on the growth of single protein crystals 
suitable for diffraction. Electron microscopy (EM) is a tool that can be used 
to, at low resolution, gain visualisation of the conformation and oligomeric 
state of proteins. EM generally relies on a uniform protein sample in solution.  
 
4.1.6 Mass spectrometry for protein analysis 
Mass spectrometry (MS) is a comprehensive and versatile tool for the study 
of proteins. The development of soft ionisation techniques, such as 
electrospray ionisation (ESI) and matrix-assisted laser desorption/ionisation 
(MALDI) enabling the ionisation of both proteins and peptides, has 
revolutionised the use of MS in proteomics (Han et al. 2008). The MALDI-TOF 
MS at the University of Waikato is generally used for protein identification 
after an in-gel proteolytic digestion. The MALDI TOF/TOF MS is used for this 
application as well and further allows for identification of sequence tags by 
collision induced dissociation (CID) MS/MS (CPR, University of Otago). 
LTQ-Orbitrap MS makes use of either MALDI or ESI as an ionisation source, 
has a higher mass accuracy and is generally used in top down proteomics and 
for protein identification from complex peptide mixtures (CPR, University of 
Otago) (Han et al. 2008).  
 
This chapter will focus on the cloning, expression, purification and 
investigation of PhoH2 proteins from M. tuberculosis, M. smegmatis and 
thermophilic homologue from Thermobispora bispora for crystallisation, 
characterisation and functional studies. A thermophilic PhoH2 protein was 
chosen as due to its thermophilic origins, it should have increased stability 
and may be able to be expressed and purified in higher yields than 
mycobacterial proteins.  
Chapter Four  92 
 
 
4.2 Results 
For functional and crystallographic studies, soluble PhoH2 protein needed to 
be obtained. To gain soluble protein a number of PhoH2 protein constructs 
were made to try to gain PhoH2 as a whole, and as two separate domains 
(PIN-domain and PhoH-domain) from both M. tuberculosis and M. smegmatis.  
 
4.2.1 Cloning into pYUB1049, pDONR221, pDESTSMG/17, pYUB28b, and 
pET28b-PstI 
Each phoH2 gene or sequence variant was successfully cloned into its 
respective vector for protein expression as listed in Table 4. 1. 
 
Table 4. 1 Genes cloned for protein expression and predicted protein MW 
Vector His-tag position Gene Expected MW 
 (Da) 
pYUB1049 C Rv1095 49274.0 
Rv1095alt 54445.9 
N Rv1095 49176.0 
Rv1095alt 54216.6 
pDONR221 
pDESTSMG 
N Rv1095 49432.3 
Rv1095alt 54604.2 
PIN-domain 17203.4 
PhoH-domain 25957.8 
pDONR221 
pDEST17 
N Rv1095 49574.5 
PIN-domain  17345.6 
PhoH-domain  26100.0 
pYUB28b C Rv1095 48532.4 
PIN-domain 16303.5 
PhoH-domain 25057.9 
PIN-domainalt 21344.1 
MSMEG_5247 48657.5 
MSMEG_5247alt 53728.2 
PIN-domain 16554.8 
PhoH-domain+1 25116.9 
PhoH-domain+2 25388.2 
pET28b-PstI C TBIS_3092 49285.5 
MW was calculated using ProtParam (http://web.expasy.org/protparam/). 
 
For mycobacterial protein expression using pYUB1049 or pYUB28b and 
restriction based cloning, the ligation reactions were first transformed into 
electrocompetent E. coli TOP10 cells as this strain allowed for selection of 
transformants with hygromycin B and ease of vector purification for 
sequencing prior to transformation into M. smegmatis mc24517 cells. 
Purification of vector DNA is challenging with mycobacterial strains due to 
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the nature of their cell wall which is rich in mycolic acids and is generally 
thicker than the cell wall of other bacteria (Bhamidi 2009). 
 
Successful insertion of genes cloned with each cloning system was confirmed 
by sequencing vector DNA from positive E. coli transformants with T7 or M13 
forward and reverse primers that flanked the multiple cloning site. This 
provided sequences in both the forward and reverse direction.  
 
4.2.2 Small scale expression tests 
Small scale expression tests were used to evaluate protein expression and 
his-tag binding affinity. Protein expression of PhoH2 and sequence variants 
in M. smegmatis had mixed success summarised in Table 4.2.   
 
Table 4.2 Summary of small scale expression tests and his-tag binding  
Vector His-tag Gene Protein None Insol Sol 
pYUB1049 C Rv1095 PhoH2MTB X   
Rv1095alt PhoH2alt MTB   X 
N Rv1095 PhoH2 MTB X   
Rv1095alt PhoH2alt MTB X   
pDONR221 
pDESTSMG 
N Rv1095 PhoH2 MTB X   
Rv1095alt PhoH2alt MTB X   
PIN-domain PINMTB X   
PhoH-domain PhoHMTB  X  
pDONR221 
pDEST17 
N Rv1095 PhoH2MTB X   
PIN-domain  PINMTB  X  
PhoH-domain  PhoHMTB  X  
pYUB28b C Rv1095 PhoH2MTB X   
PIN-domain PINMTB  X  
PhoH-domain PhoHMTB X   
PIN-domainalt PINalt MTB X   
MSMEG_5247 PhoH2MSMEG   X 
MSMEG_5247alt PhoH2alt MSMEG   X 
PIN-domain PINMSMEG  X  
PhoH-domain+1 PhoH+1 MSMEG  X  
PhoH-domain+2 PhoH+2 MSMEG  X  
pET28b-PstI C TBIS_3092 PhoH2TBIS   X 
Abbreviations: No protein expression (None), Insoluble protein expression (Insol) 
Soluble protein expression (Sol). 
 
Figure 4.1 shows that the cloning of Rv1095 (PhoH2MTB) from its annotated 
start site into pYUB1049 for expression in M. smegmatis with either a C- or 
N-terminal his-tag resulted in no clear protein expression neither soluble or 
insoluble (Figure 4.1a and b). This absence of expression prompted full 
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evaluation of the sequence upstream of phoH2 for possible alternative start 
sites for a short ORF given the length of the leader sequence identified by 
RT-PCR (Figure 3.10) and the analysis for putative transcriptional elements 
in the +RT products of both M. tuberculosis and M. smegmatis. It was 
hypothesised that the leader sequence may encode regulatory elements such 
as a short 5’ORF which may be involved in protein expression, and that if the 
ORF was acting as an antitoxin protein of PhoH2, soluble protein expression 
should be obtained as the possible negative effects of protein expression on 
growth of the culture should be overcome. The sequence from alternative 
start site 1 (Figure 3.6), Rv1095alt, was cloned into pYUB1049 for expression 
with a C- or N-terminal his-tag. Clear soluble protein expression was gained 
with cloning of Rv1095alt (PhoH2alt MTB) with a C-terminal his-tag (Figure 
4.1c) but not with an N-terminal his-tag (Figure 4.1d).   
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Figure 4.1 Small scale expression screen of PhoH2MTB and PhoH2alt MTB 
(pYUB1049 constructs) in M. smegmatis 
Expression and his-tag binding of a)PhoH2C MTB b) PhoH2N MTB c)PhoH2altC MTB and d) 
PhoH2altN MTB. White boxes indicate expected band size. Labels: whole cell fraction (WC), 
insoluble fraction (Insol), soluble fraction loaded onto Ni resin (Load), flow through 
(FT), wash one (W1), Ni resin with protein bound after wash steps (Resin). 
 
PhoH2alt MTB was subjected to a lysis buffer screen (section 2.4.6.1) that tested 
for protein solubility in a range of lysis buffers with different pH and NaCl 
concentrations, and PhoH2alt MTB was found to be soluble in each of the 
buffers screened (not shown).  
 
To confirm the requirement of cloning from the alternative start site and 
determine whether cloning with another system would yield further soluble 
protein, Rv1095, the PIN and PhoH-domain from Rv1095 were cloned into 
Gateway pDONR221 then into pDESTSMG and pDEST17 for expression testing in 
Chapter Four  96 
 
 
M. smegmatis and E. coli respectively. The Rv1095alt sequence was also cloned 
into pDESTSMG for expression trials in M. smegmatis. No clear protein 
expression was observed with the pDESTSMG constructs except with the 
PhoH-domain which was insoluble (Figure 4.2c). In this system, inclusion of 
the upstream segment did not give soluble expression. The PIN and 
PhoH-domain expressed insolubly in E. coli (Figure 4.2a and b). 
 
 
Figure 4.2 Small scale expression screen of PINMTB and PhoHMTB domains 
(pDEST17 constructs) in E. coli and PhoHMTB domain (pDESTSMG) in 
M. smegmatis 
Expression and his-tag binding of a) PINN MTB b)PhoHN MTB in E. coli and c)PhoHN MTB in 
M. smegmatis. White boxes indicate expected band size. Labels: whole cell fraction (WC), 
insoluble fraction (Insol), soluble fraction loaded onto Ni resin (Load), flow through 
(FT), wash one (W1), Ni resin with protein bound after wash steps (Resin). 
 
The insoluble PIN and PhoH-domains (Figure 4.2) were subjected to a lysis 
buffer screen (section 2.4.6.1) and reduced incubation temperatures for 
protein expression (section 2.4.6.2) as an attempt to improve solubility. 
These did not remedy insoluble protein expression. 
 
After receiving the new modified pYUB1049 vector, pYUB28b, which had the 
sparse MCS replaced with the MCS from pET28b, Rv1095, PIN, PINalt 
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(PIN-domain cloned from the alternative start site upstream of Rv1095) and 
PhoH-domain from M. tuberculosis were cloned into pYUB28b and tested for 
protein expression. No expression was observed with PhoH2 (Rv1095) and a 
similar observation was made for PINalt MTB and the PhoH-domain. The 
PIN-domain expressed insolubly (Figure 4.3). 
 
 
Figure 4.3 Small scale expression screen of PINMTB (pYUB28b construct) in 
M. smegmatis 
Expression and his-tag binding of PIN C MTB. White box indicates expected band size. 
Labels: insoluble fraction (Insol), soluble fraction loaded onto Ni resin (Load), flow 
through (FT), wash one (W1), Ni resin with protein bound after wash steps (Resin). 
 
Given the difficulties with expressing PhoH2 from M. tuberculosis it was 
hypothesised that the gene for PhoH2 from M. smegmatis (MSMEG_5247) may 
be more suited for protein expression, given that the protein is to be 
expressed in the organism from which it is derived. Genes for MSMEG_5247 
and MSMEG_5247alt from M. smegmatis, and the PIN and PhoH-domain 
(PhoH +1/+2) from MSMEG_5247 were cloned into pYUB28b. PhoH +1/+2 were 
extended sequences of the PhoH-domain that contained 1 or 2 additional 
amino acids at the N-terminus obtained from the linker region between the 
PIN and PhoH-domain. These were cloned from M. smegmatis to try to 
improve protein solubility. Figure 4.4 shows that both PhoH2MSMEG 
(MSMEG_5247) and PhoH2alt MSMEG (MSMEG_5247alt) from M. smegmatis 
expressed solubly. The extension of the PhoH-domain sequence did not 
remedy insoluble protein expression (Figure 4.4d and e). The PIN-domain 
also expressed insolubly (Figure 4.4c). 
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Figure 4.4 Small scale expression screen of PhoH2MSMEG, PhoH2alt MSMEG, 
PINMSMEG, PhoH+1 MSMEG and PhoH+2 MSMEG (pYUB28b constructs) in M. smegmatis 
Expression and his-tag binding of a) PhoH2C MSMEG b) PhoH2altC MSMEG c) PINC MSMEG d) 
PhoH+1C MSMEG e) PhoH+2C MSMEG. White boxes indicate expected band size. Labels: 
insoluble fraction (Insol), soluble fraction loaded onto Ni resin (Load), flow through 
(FT), wash one (W1), Ni resin with protein bound after wash steps (Resin). 
 
Despite gaining soluble expression of PhoH2MSMEG and PhoH2alt MTB/MSMEG, 
these proteins proved difficult to work with (inconsistent expression and low 
protein yield). Therefore to help overcome challenges met working with 
PhoH2 and PhoH2alt from M. tuberculosis and M. smegmatis, the nucleotide 
sequence that coded for the amino acid sequence of a thermophilic 
homologue of PhoH2 in the actinobacterium T. bispora (TBIS_3092) (75.5 % 
Chapter Four  99 
 
 
identical to PhoH2 from M. tuberculosis) was obtained from GeneArt® 
optimised for protein expression in E. coli. This gene was cloned into 
pET28b-PstI and produced soluble protein expression in E. coli (Figure 4.5). 
 
Figure 4.5 Small scale expression screen PhoH2TBIS 
(pET28b-PstI construct) 
Expression and his-tag binding of PhoH2TBIS. White box 
indicates expected band size. Labels: insoluble fraction 
(Insol), soluble fraction loaded onto Ni resin (Load), flow 
through (FT), wash one (W1), Ni resin with protein bound 
after wash steps (Resin). 
 
 
 
 
 
4.2.3 Large scale expression and protein purification from 
M. smegmatis and E. coli 
Following evidence of soluble protein expression of PhoH2alt MTB, 
PhoH2alt MSMEG, PhoH2MSMEG and PhoH2TBIS in small scale screens (Figure 4.1, 
Figure 4.4 and Figure 4.5), protein expression cultures were scaled up as in 
section 2.4.5 for M. smegmatis and 2.4.6 for E. coli, and each protein was 
purified by IMAC. The chromatograms and corresponding SDS-PAGE gels in 
Figure 4.6 depict the purification, column load and flow through fractions. 
With the purification of proteins expressed in M. smegmatis, non-specific 
proteins eluted early off the column at a low concentration of imidazole, 
whereas PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG eluted later in the 
gradient with a greater concentration of imidazole (~200-250 mM). 
Purification of PhoH2TBIS expressed in E. coli eluted early (~120-180 mM 
imidazole) and as a single peak.  
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Figure 4.6 IMAC purification and corresponding 12 % SDS-PAGE gels 
IMAC purified a) PhoH2alt MTB b) PhoH2alt MSMEG c) PhoH2MSMEG d) PhoH2TBIS 
The chromatogram depicts the UV absorbance (blue) and elution profile of each protein 
as the concentration of elution buffer increases (orange). The corresponding SDS-PAGE 
gels depict the insoluble fraction (Insol), soluble fraction loaded onto the column (Load), 
and flow through (FT). Fractions and their elution position are shown by the red bar. 
 
 
Each protein was further purified by size exclusion chromatography. Each 
protein eluted as a single peak on an analytical size exclusion column (Figure 
4.7). 
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Figure 4.7 Size exclusion chromatography and corresponding 12 % SDS-PAGE 
gels 
Size exclusion purified a) PhoH2alt MTB b) PhoH2alt MSMEG c) PhoH2MSMEG d) PhoH2TBIS. The 
chromatogram depicts the UV absorbance profile. The SDS-PAGE gel depicts the 
fractions, and their elution position is shown by the red bar. 
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An equation to determine the molecular weight (MW) of a protein using the 
SuperdexTM S200 10/300 size exclusion column was derived from the 
calibration of the column, using high and low molecular weight Gel Filtration 
Calibration kits (GE Healthcare, UK). The kit proteins were passed through 
the column and the elution profiles were used to calculate Kav values for each. 
These values were plotted against the log molecular weight to generate an 
equation that can be used to calculate the MW of sample proteins. 
 
For sample proteins the Kav (gel phase distribution coefficient) for each 
protein was determined using the following equation:   
Kav = (Ve - Vo) / (Vc – Vo)  
Where 
Ve = elution volume  
Vo = column void volume = 8.11 ml 
Vc = geometric column volume = 24 ml 
 
The Kav value for the protein was then substituted into the equation derived 
from the curve below (Figure 4.8) to determine the MW of the protein.  
 
Figure 4.8 Calibration Curve for S200 10/300 size exclusion column 
Kav values of kit proteins plotted against the log molecular weight. 
 
The equation from the calibration curve (y = -0.115x + 1.6833) was 
rearranged to calculate the molecular weight of each PhoH2 protein as 
below:  
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Kav = -0.115 logMW + 1.6833 
logMW= (Kav-1.6833)/-0.115 
MW = e [(Kav – 1.6833) / -0.115)] 
 
Table 4.3 denotes the elution volume of each PhoH2 protein and its 
corresponding MW calculated using this equation.  
 
Table 4.3 Calculated MW of PhoH2 proteins 
Protein Elution volume 
(ml) 
Kav MW 
(kDa) 
Predicted 
MW (kDa) 
MW/Pred 
PhoH2alt MTB 11.23 0.1965 411.7 54.5 7.5 
PhoH2alt MSMEG 10.80 0.1655 539.3 53.7 10.0 
PhoH2MSMEG 10.74 0.1693 521.9 48.7 10.7 
PhoH2TBIS 11.46 0.2108 363.7 49.3 7.4 
Predicted MWs were calculated using ProtParam (http://web.expasy.org/cgi-
bin/protparam/protparam). 
 
These results suggest a large protein complex that may be hexameric, 
heptameric or octomeric. The sizes obtained for PhoH2alt MTB and PhoH2TBIS 
are similar. The predicted MW of PhoH protein (cg2513 PDB 3B85) using 
ProtParam is 37.6 kDa, which when in a hexameric conformation would have 
a MW of ~225.8 kDa (37.6 x 6). With the addition of the PIN-domain and 
linker region (~23.5 kDa) to the PhoH protein a combined MW of ~366.8 kDa 
can be expected (23.5 x 6 = 141 kDa + 225.8 kDa = 366.8 kDa) which is very 
similar to the MW of PhoH2TBIS and PhoH2alt MTB suggesting these PhoH2 
proteins may be hexameric. The sizes obtained for PhoH2alt MSMEG and 
PhoH2MSMEG may reflect a larger “heptameric” or “octameric” oligomer. 
 
Samples of PhoH2alt MTB, PhoH2alt MSMEG, PhoH2MSMEG and PhoH2TBIS were 
analysed by Native-PAGE as in section 2.2.2.  
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Figure 4.9 Native-PAGE gels of PhoH2alt MTB, PhoH2alt MSMEG, PhoH2MSMEG and 
PhoH2TBIS 
IMAC purified PhoH2alt MTB, PhoH2alt MSMEG, PhoH2MSMEG and PhoH2TBIS protein samples 
were loaded and run on a 10 % Native-PAGE gel as described in section 2.2.2.  
 
PhoH2alt MTB and PhoH2alt MSMEG have distinct banding patterns which are not 
present with PhoH2MSMEG or PhoH2TBIS. This banding may suggest an effect on 
native protein conformation with the cloning and expression of PhoH2 from 
the alternative start site compared with the cloning and expression from 
their annotated start site. 
 
4.2.4 Effect of PhoH2MTB expression on growth of M. smegmatis 
mc24517 
In order to investigate whether the lack of protein expression of PhoH2MTB 
from M. tuberculosis in M. smegmatis was due to a potential toxic effect, 
growth of the M. smegmatis mc24517 strains harbouring the pYUB28b 
(empty vector), pYUBRv1095 (PhoH2MTB), pYUBRv1095alt (PhoH2alt MTB), 
pYUBMS5247 (PhoH2MSMEG) and pYUBMS5247alt (PhoH2alt MSMEG) constructs 
were compared during overexpression in ZYP-5052 autoinduction medium. 
Cultures were set up in triplicate and OD600 readings were taken 
periodically over a 96 hour period (Figure 4.10). 
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Figure 4.10 Growth of M. smegmatis mc24517 expression strains over a 96 
hour period 
Results are the mean of three technical replicates taken at each time point from each 
culture, the error bars represent +/-SD. 
 
There was no difference in growth between the strains harbouring 
PhoH2MTB/MSMEG and PhoH2alt MTB/MSMEG from M. tuberculosis or M. smegmatis, 
and the control (empty vector). The strain harbouring the pYUBRv1095 
(PhoH2MTB) construct that does not express PhoH2 shows no difference in 
growth compared to the other strains above. A similar observation was made 
for VapC from M. smegmatis which did not express and did not appear to 
have an effect on growth of an overexpression culture. In this case, a 2 bp 
insertion in the vapC gene was identified that led to a frame shift and 
insertion of a premature stop codon downstream (McKenzie 2011). The 
difference observed between these results and the results of conditional 
expression (Figure 3.13) may be due to the low level of protein expression 
with pMIND compared with the high levels of protein expression associated 
with overexpression strains. A negative effect on cell viability with 
conditional expression was also observed for VapC from M. smegmatis 
(Robson 2010).  
 
PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG were expressed at high levels 
with no obvious effect on the growth of the cells (Figure 4.10). 
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4.2.5 Small and large scale solubilisation trials 
The combination of N-lauroylsarcosine and triton X-100 was used to try to 
solubilise the PIN and PhoH-domains of PhoH2MTB that had been cloned into 
Gateway vector pDEST17 and expressed insolubly in E. coli (Figure 4.11). 
During screening, 1.5 % (w/v) N-lauroylsarcosine was added during cell lysis 
and 1-3 % triton X-100 was mixed with the cell lysate prior to screening for 
solubilisation. Figure 4.11a and b show that the PhoH-domain was solubilised 
under these conditions compared with the buffer only control. Figure 4.11c 
shows that the PIN-domain was also solubilised by the addition of 
N-lauroylsarcosine and triton X-100. 
 
 
Figure 4.11 Small scale solubilisation trial with the PhoH and PIN-domain  
a) PhoH-domain purified with N-lauroylsarcosine and 1 % and 2 % triton X-100. b) 
PhoH-domain purified with N-lauroylsarcosine and 3 % triton X-100, and buffer only 
control. c) PIN-domain purified with 1.5 % N-lauroylsarcosine + 1 % triton X-100. White 
boxes indicate where solubilisation has occurred. Labels: whole cell fraction (WC), 
insoluble fraction (Insol), flow through (FT), wash one (W1), Ni resin with protein 
bound after wash steps (Resin).  
 
After evidence of protein solubilisation on a small scale, larger cultures were 
tested for solubilisation using the same concentration of N-lauroylsarcosine 
and triton X-100 that led to soluble protein in the small scale tests (Figure 
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4.11) using the method described in section 2.4.9.2. These proteins were 
analysed for protein solubilisation by IMAC purification. No protein was 
observed on the chromatogram for either the PIN or PhoH-domain after 
treatment with both detergents (not shown). Therefore, small scale protein 
elution tests were performed to test for elution of the protein from the Ni 
resin as described in section 2.4.9.1. Figure 4.12 shows that in this trial most 
of the protein remained insoluble with little to no protein binding to the Ni 
resin, and neither protein eluted after treatment with imidazole. It is 
unknown why with the scaling up and repeats of this experiment that protein 
solubilisation was lost. 
 
Figure 4.12 Small scale solubilisation and purification of the PhoH and 
PIN-domain 
a) PhoH-domain and b) PIN-domain purified with 1.5 % N-lauroylsarcosine and 1 % 
triton X-100. White boxes indicate the expected band size. Labels: insoluble fraction 
(Insol), flow through from Ni resin (FT), wash one (W1), elution treatment from Ni resin 
(Elution), Ni resin after elution treatment (Resin).  
 
4.2.6 Denaturing purification of PIN and PhoH-domains 
Expression of the PIN and PhoH-domains from M. tuberculosis in E. coli 
resulted in insoluble protein. As no soluble expression had been gained for 
these two domains from either M. tuberculosis or M. smegmatis with further 
cloning using pYUB28b, a denaturing purification of the PIN and 
PhoH-domain (pDEST17 constructs) was performed as in section 2.4.7 by 
adding 8 M urea to lysis and elution buffers. The PIN and PhoH-domain were 
purified by IMAC as in section 2.2.7 under denaturing purification conditions.  
The chromatogram and corresponding SDS-PAGE gel (Figure 4.13) show that 
the PIN-domain eluted late in the elution gradient at ~ 40-50 % elution 
buffer corresponding to 400-500 mM imidazole, whereas the PhoH-domain 
eluted earlier, around ~ 20-35 % elution buffer (~200 mM imidazole). 
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Figure 4.13 Denaturing IMAC purification of the PIN and PhoH-domains 
expressed in E. coli and corresponding 15 % SDS-PAGE gels 
The chromatogram depicts the UV absorbance (blue) and elution profile (orange) of the 
a) PIN and b) PhoH-domains under denaturing conditions. The SDS-PAGE gel depicts the 
insoluble fraction (Insol), the soluble fraction (Load) and the flow through (FT). 
Fractions and their elution positions are shown by the red bar. 
 
4.2.7 Small and large scale refolding 
Once purified under denaturing conditions, the PIN and PhoH-domains were 
tested for refolding in a protein refolding screen (section 2.4.8.1). Small scale 
refolding screens of the PIN-domain yielded promising results for refolding 
solution sixteen (Figure 4.14b) (50 mM Tris pH 8.2, 250 mM NaCl, 2 mM 
MgCl2, 2 mM CaCl2, 0.05 % PEG 3350 (w/v), 0.3 mM dodecyl maltoside, 
500 mM guanidine HCl, 200 mM sucrose, 200 mM L-arginine, 1 mM GSH, 0.1 
mM GSSG).  
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Figure 4.14 Small scale refolding screen analysis by 10 % Native-PAGE  
PIN-domain refolding with refolding conditions a) 1-8 and b) 9-16, and PhoH-domain 
refolding with refolding conditions c) 1-8 and d) 9-16.  
 
The successful refolding treatment of the PIN-domain was scaled up to a 
200 μl dialysis button and further in 10 fold increments from 2 ml to 20 ml. 
The refolded protein was then dialysed into a storage buffer for analysis with 
size exclusion chromatography. No refolded PIN-domain protein was 
observed on a native-PAGE gel with scaling up from 20 µl, and no protein was 
eluted following size exclusion chromatography.  
 
No further cloning and expression trials were continued at this time. 
 
4.2.8 Initial crystallisation screens 
An initial crystallisation screen was carried out at the University of Auckland 
for PhoH2alt MTB that had been purified by IMAC and size exclusion in 50 mM 
Na-phosphate buffer pH 7.4, 200 mM NaCl and concentrated to 1.96 mg/ml. 
This trial yielded no distinctive crystals, however, there were a few 
conditions where flecks or edges were apparent and these conditions were 
followed up with fine screens. Crystals did not successfully grow in these fine 
screens and in some of the negative drops (reservoir crystallisation solution 
mixed with buffer only), small flecks of a crystalline nature appeared, 
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suggesting the formation of salt crystals. A second screen was performed 
with PhoH2alt MTB purified in 50 mM Na-Hepes buffer pH 7.4, 200 mM NaCl 
~ 100 mM imidazole with the aim of reducing the likelihood of salt crystals 
forming. One condition resulted in needle formation and a fine screen was set 
up to optimise this growth condition. However, these crystals were deemed 
likely imidazole salt crystals due to the formation of the same crystals in the 
negative drops (buffer only). 
 
Due to the relatively low protein concentration obtained for crystallisation of 
PhoH2alt MTB, PhoH2MSMEG was trialled in crystallisation screens at the 
University of Waikato, once purified in 50 mM phosphate buffer pH 7.4, 200 
mM NaCl and secondly purified 50 mM Na-Hepes pH 7.4, 200 mM NaCl.  No 
real crystal growth was observed for PhoH2MSMEG purified in phosphate 
buffer, and fine screens around conditions in which flecks were observed did 
not gain any crystals. Two conditions were further screened for PhoH2MSMEG 
purified in 50 mM Na-Hepes buffer pH 7.4, 200 mM NaCl and one condition 
(0.1 M CaCl2 0.2 M Bis-Tris pH 6.5 45 % MPD) led to crystal growth in only 
the protein drop and not in the negative drop (buffer only). This crystal was 
tested for diffraction at the Home-Source at the University of Auckland but 
was found to be salt. 
 
It was evident with the low protein concentrations obtained for 
mycobacterial PhoH2 proteins despite efforts to scale up to obtain greater 
protein yield, and the lack of promising conditions in robot screens, that a 
related thermophilic homologue of PhoH2 may be a better option for 
crystallisation trials. 
 
PhoH2TBIS was purified by IMAC and size exclusion chromatography in 
50 mM Tris buffer pH 8, 200 mM NaCl and concentrated to 9.9 mg/ml and 
trialled in crystallisation screens. Fine screens were set up around promising 
conditions, however better crystal growth than observed previously was not 
obtained. The initial screen was re-checked after 6 weeks and ‘true’ crystals 
(non-fleck or edge only) had grown in the crystallisation condition (0.1 M 
imidazole pH 7, 25 % PEG 550 mono methyl ether (MME)). A fine screen was 
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performed around this condition and one drop (0.15 M imidazole pH 7, 
18.75 % PEG 550 MME), gave small crystals in the protein drop and none in 
the negative drop (buffer only). This condition was re-screened with protein 
concentrated to 5 mg/ml and yielded crystals suitable for X-ray diffraction 
testing (Figure 4.15 c and d). An additive screen was also laid down to try to 
improve crystal growth, however no crystals grew in the presence of 
additives. 
 
Crystals grown from repeats of this fine screen condition (0.15 M imidazole 
pH 7, 18.75 % PEG 550 MME) were tested for X-ray diffraction at the 
Australian Synchrotron which confirmed that they were protein crystals 
(Figure 4.15 e).  
 
 
Figure 4.15 PhoH2TBIS protein crystals  
a) Robot screen drop 0.1 M imidazole pH 7, 25 % PEG 550 MME. b) Crystals grown in 
fine screen in 0.15 M imidazole pH 7, 18.75 % PEG 550 MME. c) and d) repeat condition 
of b) with 5 mg/ml protein. e) X-ray diffraction obtained from Australian synchrotron 
showing protein diffraction spots to ~ 8 Å. 
 
Further crystallisation screens were trialled for PhoH2TBIS; PhoH2TBIS + 1 mM 
final AMP-PNP (concentrated to 16.94 mg/ml prior to addition of AMP-PNP), 
and PhoH2TBIS was subjected to a limited proteolytic digest with trypsin 
(1:100) prior to laying down screens. No significant crystal growth was 
observed in these trials. 
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4.2.9 Protein crystal growth optimisation 
For optimisation of PhoH2TBIS protein crystals, seeding methods were 
adopted with the aim of improving crystal quality. Macro, streak and batch 
seeding were trialled for PhoH2TBIS concentrated to 15 and 29 mg/ml as 
described in section 2.4.11.3. Batch seeding led to the most favourable crystal 
growth (Figure 4.16).  
 
Figure 4.16 PhoH2TBIS protein crystals optimised using seeding 
Examples of the types of crystals obtained with seeding a) Streak seeding (15 mg/ml) b) 
Batch seeding 1:100 (15 mg/ml) c) Batch seeding 1:1000 (15 mg/ml) d) Batch seeding 
1:100 (29 mg/ml) and e) Batch seeding 1:1000 (29 mg/ml).  
 
A range of crystals from batch seeding drops 1:1000 (Figure 4.16c and e) 
were tested for X-ray diffraction at the Australian Synchrotron. Data to 7.5 Å 
(Figure 4.17) were collected for one crystal taken from batch seeding drop 
1:1000 (15 mg/ml) (Figure 4.16c). Frames from 1 – 360 ° were taken with 
0 % attenuation at 1 ° oscillations and 2 second exposures.  
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Figure 4.17 PhoH2TBIS Crystal and X-ray diffraction to 7.5 Å  
a) PhoH2TBIS batch seeding crystal used to gain improved X-ray diffraction b) X-ray 
diffraction of one frame obtained during data collection at the Australian Synchrotron 
(plate resolution 4.51 Å).     
 
4.2.10 Preliminary data processing 
Data analyses in iMOSFLM and CCP4i provided the following data. 
Table 4.4 Crystallographic data  
 Data set  1 Data set 2 
Space group C2 I222 
Unit cell dimensions   
a 186.45 181.91 
b 297.22 205.21 
c 174.25 208.67 
α 90.0 90.0 
β 121.84 90.0 
γ 90.0 90.0 
Matthews coefficient 2.33 3.23/2.15 
Number of molecules/asymmetric unit 18 6/9 
Solvent content % 47.17 61.9/42.86 
Resolution range (overall) Å 93.82-7.5 48.78-8.34 
Number of observations 341055 27070 
Number of unique reflections 45970 3829 
Completeness 99.7 98.2 
Multiplicity (overall) 7.4 7.1 
 
The maximum resolution obtained for the first data set that indexed in space 
group C2 was ~ 7.5 Å. The second data set to 8.3 Å were collected from a 
further batch seeding drop (1:100).  
 
These data were analysed in MOLREP using the self rotation function which 
provides information as to the contents and organisation of the asymmetric 
unit. This analysis is suggestive of hexameric symmetry (Figure 4.18).  
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Figure 4.18 Self rotation function map of PhoH2TBIS 
Self rotation function maps of PhoH2 data set 2 in space group I222 at different 
rotations (Chi). Peaks mark the positions where rotational symmetry axes enter and exit 
the sphere. The orientations of the axes in the sphere indicate the orientation of the 
n-fold symmetry axes in the crystal. Six axes of symmetry are observed together with 
the symmetry gained from the I222 crystallographic space group for PhoH2. Maps were 
generated using MOLREP Self Rotation Function using data set 2. 
 
The number of molecules in the asymmetric unit (Matthews probability) is 
likely to be 6 or 9 depending on the solvent content of the crystals. This is 
consistent with the probable hexameric symmetry revealed with the 
rotational symmetry (Figure 4.18) and the MW obtained for PhoH2TBIS (Table 
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4.3) which is very similar to the MW of PhoH protein (3B85) which shows a 
hexamer. PhoH2 probably adopts a hexameric oligomer. 
 
4.2.11 Electron microscopy investigation of PhoH2TBIS  
EM was used to further investigate the oligomerisation state of PhoH2 
proteins. PhoH2TBIS was purified by IMAC and size exclusion chromatography 
and diluted to 0.1 mg/ml and 0.03 mg/ml for analysis at the University of 
Auckland. The first image taken at the higher protein concentration revealed 
both circular assemblies and aggregates in solution (Figure 4.19).  
 
Figure 4.19 PhoH2TBIS visualised by TEM (0.1 mg/ml) 
White circles identify some of the circular assemblies observed. 
 
The second image taken of PhoH2TBIS, at the lower concentration allowed for 
better visualisation of specific assemblies. This image revealed a variety of 
oligomeric states (Figure 4.20).  
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Figure 4.20 PhoH2TBIS visualised by TEM (0.03 mg/ml) 
The white circles identify a) some of the circular ring-like assemblies, b) a helical 
assembly and c) spiral assemblies of PhoH2TBIS protein in solution. 
 
Taken together, PhoH2TBIS adopts both circular ring-like oligomers composed 
of 4, 5 or 6 subunits, and larger helical and spiral assemblies. 
 
4.2.12 Translational investigation of PhoH2alt proteins 
To gain soluble protein expression of PhoH2 from M. tuberculosis, cloning 
from an alternative start site located upstream and out of frame with the 
annotated translational start site was required. It was unclear throughout 
much of this research whether this short sequence was being translated. 
Therefore whether translation was occurring from the alternative or 
annotated translational start site or both sites, with PhoH2alt MTB and 
PhoH2alt MSMEG, which were both cloned from the alternative start site was 
unknown. When each of the PhoH2 proteins is run on a SDS-PAGE gel they 
b 
a 
a 
a 
c 
c 
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are fairly similar in size (Figure 4.6 and Figure 4.7). It is apparent, when these 
proteins are analysed by Native-PAGE, that there is an effect on native 
protein conformation with the cloning and expression of PhoH2 from the 
alternative start site, compared with the cloning and expression from their 
annotated start site (Figure 4.9). These results may reflect differences in 
protein translation or effects of regulatory factors within the additional 
transcript. 
 
To investigate the translational context of PhoH2alt MTB and PhoH2alt MSMEG, 
protein expression and mass spectrometry (MS) based analyses were carried 
out at the University of Waikato and at the Centre for Protein Research (CPR) 
at the University of Otago, who specialise in mass spectrometry based 
protein identification techniques.   
 
4.2.12.1 Cloning and expression testing of the alt sequence in 
pYUB28b/M. smegmatis 
The alt peptide sequence from M. tuberculosis (altMTB) was successfully 
amplified and cloned into pYUB28b, and transformed into M. smegmatis 
mc24517 cells. Small scale expression tests revealed a lack of peptide protein 
expression as shown by the absence of enrichment at the expected molecular 
weight (6.7 kDa) (Figure 4.21). It was possible that the peptide was too small 
to detect. 
 
Figure 4.21 Small scale expression screen of alt peptide from M. tuberculosis 
Expression and his-tag binding of altMTB. White box indicates expected band size. Labels: 
Insoluble fraction (Insol), Soluble fraction loaded onto Ni resin (Load), flow through 
(FT), wash one (W1), Ni resin with protein bound after wash steps (Resin). 
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4.2.12.2 Mass spectrometry – University of Waikato 
MALDI-TOF MS was used to analyse trypsin digested and whole protein 
samples of PhoH2alt MTB to confirm the cloning, expression, and translation of 
the full length construct. The resulting peptides were mapped to the 
PhoH2alt MTB amino acid sequence. Figure 4.22 shows the moderate sequence 
coverage of the matched tryptic peptides. 
 
 
Figure 4.22 Sequence coverage of PhoH2alt MTB 
Pink bars indicate sequence coverage of PhoH2alt MTB (37 %). Arrow indicates the 
position of the annotated translational start site. 
 
PhoH2 from M. tuberculosis was identified with 37 % sequence coverage. No 
peptides were found that matched the sequence between the alternative and 
annotated start site.  
 
PhoH2MTB was also analysed as a whole, Figure 4.23 shows that a mass of 
49207.2 Da was gained for PhoH2MTB by this method at the University of 
Waikato.   
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Figure 4.23 Whole protein MALDI-TOF MS of PhoH2alt MTB 
PhoH2alt MTB as a whole was analysed by MALDI-TOF MS. A mass of 49207.2 Da was 
gained. 
 
This mass may correspond to PhoH2 translation from its annotated start site 
or loss of the peptide during MALDI-TOF testing. The expected MW of 
PhoH2alt MTB was 54445.9 Da and the expected MW of the alt peptide is 
5189.8 Da, (54445.9 Da– 5189.8 Da = 49256.1 Da).   
 
These analyses were also attempted for PhoH2alt MSMEG and PhoH2MSMEG but 
either no signal was obtained or the intensity was too weak to distinguish 
from background signal. 
 
4.2.12.3 N-terminal sequencing – University of Otago 
Due to the inconclusive results gained with MS at Waikato, PhoH2alt MTB and 
PhoH2alt MSMEG were tested at the Centre of Protein Research (CPR) at the 
University of Otago, who specialise in N-terminal sequencing of tryptic 
protein peptides. 
 
For this purpose, freshly purified protein samples of PhoH2alt MTB and 
PhoH2alt MSMEG were couriered for analysis. For N-terminal sequencing, 
protein samples were chemically modified by guanidination and sulfonation 
prior to digestion with trypsin. Both modifications aimed to increase the 
efficiency and selective detection of peptide masses. Samples were analysed 
by MALDI TOF/TOF and by LTQ-Orbitrap MS. 
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The aim of these analyses was to identify the N-terminus and gain sequence 
coverage upstream of the annotated translational start site for both 
PhoH2alt MTB and PhoH2alt MSMEG if indeed, an antitoxin-like peptide was being 
translated. Figure 4.24 shows the combined sequence coverage of 
PhoH2alt MTB gained with MALDI TOF/TOF and LTQ-Orbitrap analysis of 
peptides. LTQ-Orbitrap MS revealed a peptide mass that mapped within the 
upstream sequence ahead of the annotated translational start site (ions score 
45, individual ions scores >32 indicate identity or extensive homology p < 
0.05) suggesting that translation can take place from the alternative start site 
which is positioned out of frame of the annotated translational start site. 
 
 
 
Figure 4.24 Sequence coverage of PhoH2alt MTB 
Sequence coverage of PhoH2alt MTB. Yellow bars indicate MALDI peptide analysis (53 % 
coverage), grey bars Orbitrap peptide analysis (83.8 % coverage), pink bars MALDI 
peptide analysis (University of Waikato). Arrow indicates the position of the annotated 
translational start site. 
 
Two other peptides towards the N-terminus were also detected by 
LTQ-Orbitrap MS (ion scores of 101 and 65 respectively) (Figure 4.25).   
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Figure 4.25 Position of the three most N-terminal matched peptides  
PhoH2alt MTB sequence with the positions of the three most N-terminal peptides. Grey bar 
most N-terminal peptide (ion score 45), green bar second most N-terminal peptide (ion 
score 101) and blue bar third most N-terminal peptide (ion score 65) detected 
significantly. Arrow indicates the position of the annotated translational start site. 
 
Neither of the two most N-terminal peptides mapped to PhoH2alt MTB were 
identified with their N-terminal modification (SPITC) perhaps due to full 
tryptic cleavage of the modification resulting in small fragments that were 
unable to be detected. The third most N-terminal peptide in contrast was 
identified with the modification.  
 
MALDI TOF/TOF and LTQ-Orbitrap MS analyses were also performed with 
PhoH2alt MSMEG. 
  
Figure 4.26 shows the combined sequence coverage of PhoH2alt MSMEG which 
confirms that translation of PhoH2alt MSMEG also does take place from the 
alternative start site. 
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Figure 4.26 Sequence coverage of PhoH2alt MSMEG 
Sequence coverage of PhoH2alt MSMEG. Yellow bars indicate MALDI peptide analysis (59 % 
coverage) and grey bars indicate LTQ-Orbitrap analysis (86.75 %). The two most 
N-terminal peptides had ions scores of 42 and 45 respectively. Arrow indicates the 
position of the annotated translational start site. 
 
Intact protein measurements were also made using MALDI TOF/TOF. Figure 
4.27 shows a number of intact masses for PhoH2alt MTB despite the presence of 
only one protein band on a SDS-PAGE gel. The largest reported mass was 
(49162.99 Da) which is comparable to the whole protein mass gained 
previously 49207. 2 Da (Figure 4.23). PhoH2alt MSMEG too gave a range of intact 
mass measurements (Figure 4.28), the largest being 54817.07 Da which is 
similar to the theoretical MW of the full length construct (full translation 
alternative start site) of 53728.2 Da.     
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Figure 4.27 Intact mass measurements of PhoH2alt MTB 
Whole protein mass spectra of PhoH2alt MTB (Spectra obtained from CPR, University of 
Otago). A range of masses were observed, the largest mass being 49162.99 Da. Lines 
above the masses indicate area shown in the enlargement. 
 
 
 
Figure 4.28 Intact mass measurements of PhoH2alt MSMEG 
Whole protein mass spectra of PhoH2alt MSMEG (Spectra obtained from CPR, University of 
Otago). A range of masses were observed, the largest mass being 54817.07 Da. Lines 
above the masses indicate area shown in the enlargement. 
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Taken together the MALDI TOF/TOF peptide analysis and LTQ-Orbitrap 
results reflect a pool of the same protein but of different lengths, and suggest 
that translation can occur from the alternative start site. 
 
A summary of all analyses and their main results are listed in Table 4.5. 
 
Table 4.5 Summary of all analyses 
Protein Analysis Main results 
PhoH2alt MTB MALDI TOF MS – tryptic digest 37 % sequence coverage 
MALDI TOF MS – whole protein Intact mass of 49207.2 Da  
MALDI TOF/TOF MS – SPITC  53 % sequence coverage 
LTQ-Orbitrap MS 83.8 % sequence coverage 
MALDI TOF/TOF MS – whole protein Intact mass of 49162.99 Da 
PhoH2alt MSMEG MALDI TOF/TOF MS – SPITC 59 % sequence coverage 
MALDI TOF/TOF MS – whole protein Intact mass of 54817.07 Da 
LTQ-Orbitrap MS 86.75 % sequence coverage 
 
4.3 Discussion  
Structure-function studies of PhoH2, and the domains that make up PhoH2, 
from M. tuberculosis and M. smegmatis would enable a greater understanding 
of the role of these proteins in mycobacteria. Obtaining soluble protein 
expression is the first step in achieving this. 
 
4.3.1 Cloning and expression using pYUB1049 
The traditional mycobacterial shuttle vector used for cloning mycobacterial 
proteins into M. smegmatis via E. coli is pYUB1049. This vector was the first 
cloning vector used for protein expression of PhoH2 from M. tuberculosis 
with a C- or N-terminal his-tag in M. smegmatis mc24517 cells. Soluble 
expression of PhoH2 was gained only with the cloning of the Rv1095alt gene 
sequence with a C-terminal his-tag, which included a short segment of 
sequence upstream of Rv1095 deemed a possible alternative translational 
start site by RT-PCR and promoter analysis. PhoH2alt MTB was tested in a lysis 
buffer which indicated that the protein was soluble in each of the buffers 
screened (data not shown), however, 50 mM Na-phosphate buffer pH 7.4, 
200 mM NaCl was later found to be the only buffer suitable for concentrating 
protein, other buffers prevented the successful concentrating of PhoH2alt MTB. 
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It was assumed that there was no expression of PhoH2MTB from its annotated 
start site due to its potential toxicity to the cells or vector, as when expressed 
with a possible regulatory or inhibitory sequence, expression was observed. 
This is analogous to PIN-domain (VapC) from M. smegmatis which does not 
express in the absence of its antitoxin (VapB) (McKenzie 2011).  
 
4.3.2 Cloning and expression using pDONR221 and pDESTSMG/17 
The Gateway cloning system for expression of proteins was the second 
cloning system used for protein expression of PhoH2MTB, and the PIN and 
PhoH-domains of PhoH2 from M. tuberculosis, and to test the requirement for 
cloning from the alternative start site for PhoH2MTB by cloning PhoH2alt MTB.  
Two destination vectors were used; pDESTSMG designed for the 
overexpression of mycobacterial proteins in M. smegmatis mc24517, and 
pDEST17 for the overexpression of proteins in E. coli.  
 
No protein expression was observed for PhoH2MTB, PhoH2alt MTB, or the 
PIN-domain, and insoluble protein expression was observed with 
overexpression of the PhoH-domain in M. smegmatis. Those protein 
constructs that did not show any signs of expression were re-transformed 
into M. smegmatis mc24517 cells, and the PhoH-domain which had insoluble 
protein expression was subject to a lysis buffer screen (section 2.4.6.1) and 
reduced incubation temperature for overexpression culture (section 2.4.6.2). 
PhoH2MTB, PhoH2alt MTB and the PIN-domain proteins did not express despite 
the second round of transformation, and the PhoH-domain remained 
insoluble.  
 
PhoH2MTB, the PIN-domain and PhoH-domain from M. tuberculosis were also 
cloned into pDEST17 for overexpression in E. coli. PhoH2MTB did not express, 
however, there was evidence of enrichment around the expected band size 
present on the Ni resin. This band was observed with each of the pDEST17 
E. coli small scale expression trials. PhoH2MTB, and both the PIN and 
PhoH-domain proteins that expressed insolubly, were subjected to reduced 
incubation temperatures for protein expression, and a lysis buffer screen. 
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These approaches did not remedy the lack of protein expression or insoluble 
protein expression.  
 
It is possible given the lack of protein expression of PhoH2MTB and 
PhoH2alt MTB when cloned with a N-terminal his-tag in pYUB1049 that the 
position of the his-tag at the N-terminus of the protein was responsible for 
difficulties with protein expression. The length of the linker sequence 
between the N-terminal his-tag and the start of the protein sequence may 
have also contributed to the poor expression and insolubility of these 
proteins (Woestenenk et al. 2004; Kurz et al. 2006). 
 
4.3.3 Cloning and expression using pYUB28b 
One of the difficulties with using the mycobacterial shuttle vector pYUB1049 
is the restriction based removal of a ~1000 bp segment from the multiple 
cloning site which is replaced with the gene of interest. This requires gel 
purification of the digested vector away from the ~1000 bp piece, which is 
generally inefficient, to ensure re-ligation of the vector with the ~1000 bp 
segment does not occur. In order to recover enough vector for ligations, large 
quantities of vector needed to be digested and gel purified. The 
mycobacterial shuttle vector pYUB28b overcomes the need to digest away 
the large ~1000 bp segment. Vector pYUB28b is a modified pYUB1049 vector 
which has had the original fragmented multiple cloning site replaced with the 
multiple cloning site from pET28b (Bashiri et al. 2010). This replacement has 
eliminated the need to gel purify digested vector away from the large ~1000 
bp segment prior to ligation and allows ease of C-terminal his-tag expression, 
compared with pYUB1049 which required inclusion of additional bases in the 
forward primer to ensure the gene would be in frame for subsequent protein 
expression. 
 
The pYUB28b vector was the third cloning vector used to try to express 
PhoH2 from M. tuberculosis with a C-terminal his-tag in M. smegmatis 
mc24517 cells. This vector was also used to express PhoH2 and PhoH2alt from 
M. smegmatis which were soluble. The solubility observed with PhoH2 from 
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M. smegmatis is likely due to endogenous levels of the alt peptide present, 
due to expression of this protein in the organism from which it is derived.  
 
This vector additionally was used to try to solubly express the PIN, PhoH, and 
PINalt domains of PhoH2 from M. tuberculosis, and the PIN, PhoH+1 and 
PhoH+2 domains that were cloned with additional amino acids at the 
N-terminus from M. smegmatis. This aimed to increase the likelihood of 
solubilisation given the insolubility observed earlier with cloning of the 
PhoH-domain from M. tuberculosis. This approach was unsuccessful and no 
further proteins were gained using this system. 
 
4.3.4 Large scale protein expression and purification 
Large scale expression of PhoH2alt from M. tuberculosis, and PhoH2 and 
PhoH2alt from M. smegmatis expressed in M. smegmatis mc24517 cells using 
autoinduction medium had mixed success with regard to consistent 
successful expression and subsequent purification. In general, when 
expression and IMAC purification were successful the protein yield was 
relatively poor (0.1-0.5 mg/ml), and to concentrate the proteins, the proteins 
required purification in Na-phosphate buffer and the concentrator had to be 
blocked with 0.05 % (v/v) Tween-80. The highest concentration obtained for 
these proteins following concentration was 1-2 mg/ml. For further 
purification, the smaller SuperdexTM S200 10/300 size exclusion column was 
used in place of the SuperdexTM S200 16/60 size exclusion column to try to 
recover as much protein as possible.  
 
In light of the low yields for PhoH2 from mycobacteria, a thermophilic 
homologue was used from T. bispora. This organism is classified in the 
actinobacteria, and is an obligate aerobe with an optimal temperature range 
of 50-65 °C (Liolios et al. 2010). It was hypothesised that expression and 
purification of a thermophilic PhoH2 protein would have increased stablity 
due to the thermophilic origins of this protein, and that expression would 
gain high protein yields owing to the optimisation of the amino acid sequence 
for expression in E. coli. This idea has subsequently been extended to the 
recently characterised Mycobacterium thermoresistibile a thermophile from 
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mycobacteria (Edwards et al. 2012 ). With large scale expression of PhoH2TBIS 
in E. coli using IPTG induction, expression and subsequent purification were 
successful. This protein was able to be purified and concentrated in a range 
of buffers and the highest protein concentration obtained was greater than 
25 mg/ml. This protein was stored at RT as precipitation was observed with 
storage at 4 °C.  
 
4.3.5 Small and large scale solubilisation trials and refolding 
It has been reported that N-lauroylsarcosine in combination with triton 
X-100 can solubilise previously insoluble proteins without the need for 
further refolding or renaturation efforts (Zou et al. 2009; Park et al. 2011).  
The use of these detergents in the solubilisation and purification of the PIN 
and PhoH-domains of PhoH2 from M. tuberculosis that were cloned into 
pDEST17 and expressed in E. coli initially looked promising, however, further 
experimentation and up scaling was unsuccessful and soluble protein was 
not obtained. The results suggested the possibility that with the initial 
promising treatment of the PIN and PhoH-domains with detergents had 
caused soluble aggregation of the proteins and therefore unsuccessful 
solubilisation. 
 
The refolding of the PIN and PhoH-domain of PhoH2 from M. tuberculosis was 
unsuccessful. In this case, the correct conditions for correct refolding were 
not met upon scaling up. 
 
4.3.6 Protein crystallisation and Electron microscopy 
Initial crystallisation trials with mycobacterial PhoH2 proteins were 
challenging due to the low yield and buffer requirements of these proteins. 
Crystallisation screens using the thermophilic homologue PhoH2TBIS, 
however, were more favourable due to the ease of purification in a range of 
buffers and with concentrating leading to a far greater protein concentration 
than with mycobacterial PhoH2 proteins. After fine screening around one 
promising condition obtained from the crystallisation screen, protein crystals 
were identified and optimisation attempts were successful to a point for data 
collection. A maximum resolution of ~7.5 Å was obtained. Preliminary data 
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analyses performed on the two sets of diffraction data led to the 
identification of possible space groups and with the self rotation function 
analysis, probable hexameric non-crystallographic symmetry, together with 
the calculated molecular weights gained from size exclusion 
chromatography. Electron microscopy revealed a variety of oligomeric 
assemblies. The symmetry mate structure of PhoH protein (3B85) shows an 
array of hexamers (Figure 1.18) suggesting the possibility of multiple 
oligomeric states. These oligomeric states may be similar to the assemblies 
revealed by EM of PhoH2TBIS. The heterogeneity of PhoH2TBIS purified by size 
exclusion chromatography determined by EM, can further account for the 
resolution limitations met with protein crystallisation. 
 
4.3.7 Investigation of PhoH2alt proteins 
Initial analysis using mass spectrometry of PhoH2alt MTB at the early stages of 
this research identified that PhoH2 from M. tuberculosis had been 
successfully cloned and expressed in M. smegmatis mc24517 cells. It was 
unclear, however whether translation was occurring from the alternative 
start site. With VapC PIN-domain proteins that are cloned and expressed as a 
VapBC complex in which the gene for the VapB protein is out of frame of the 
VapC protein, separation of the antitoxin and toxin is observed when purified 
VapBC protein is run on a SDS-PAGE gel (McKenzie 2011), this is not 
observed in the case of PhoH2alt proteins. 
 
When further PhoH2 proteins were cloned, expressed and purified from 
alternative and annotated start sites (M. smegmatis and T. bispora) it was 
evident that each ran fairly similarly and as a single band on a SDS-PAGE gel 
(Figure 4.6 and Figure 4.7). It was necessary therefore to investigate 
PhoH2alt MTB and PhoH2alt MSMEG. PhoH2alt MTB and PhoH2alt MSMEG were 
therefore tested for their N-terminus at the CPR, University of Otago.  
 
In this approach to identify the N-terminus, both proteins were subjected to a 
two-step chemical modification prior to proteolytic digestion and analysis by 
MALDI TOF/TOF. The sulfonation step aimed to introduce a negatively 
charged sulfonic acid group on the N-terminus of the protein (Chen et al. 
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2004), which can be identified during peptide analysis. In this case the 
N-terminal modification was not identified, however peptides were identified 
both tryptic and non-tryptic, indicating the possibility of an N-terminal 
peptide. As a result the tryptic peptides gained by MALDI TOF/TOF MS each 
protein was analysed by LTQ-Orbitrap with the aim to improve sequence 
coverage. Additional peptide masses were identified which mapped onto the 
PhoH2alt sequence. For PhoH2alt MTB, one peptide was identified within the 
sequence between the alternative and annotated start site with an ion score 
of 45. Additional peptides towards the N-terminus were identified 
significantly (ions score 101 and 65) one with and one without the 
N-terminal modification (Figure 4.25 (blue bar)). It is possible that the other 
N-terminal peptides (grey and green bars) found without their respective 
N-terminal tag had lost their modification due to full tryptic cleavage given 
the positions of lysine (K) and arginine (R) residues near the N-terminus. 
Two peptides were matched between the alternative and annotated start site 
for PhoH2alt MSMEG, neither carried the SPITC N-terminal modification. 
 
Intact mass measurements gained by MALDI TOF/TOF reported a mass for 
PhoH2alt MTB similar to that gained previously (Figure 4.23 and Figure 4.27), 
and for PhoH2alt MSMEG a mass close to the predicted MW (53728.2 Da) for the 
full length construct (54817.07 Da) (Figure 4.28). These results together 
confirm that protein expression of PhoH2alt MTB and PhoH2alt MSMEG can occur 
from the alternative start site.  
 
There are two possible hypotheses that lead to the quaternary structure of 
PhoH2alt proteins. The first is that translation of the alt peptide and PhoH2 
protein is independent leading to the production of two polypeptides that 
interact with one another post-translation. The second is that translation 
occurs from the alternative site and when the ribosome reaches the end of 
the alt transcript it falls off releasing the alt peptide, then binds to the nearby 
Shine-Delgarno sequence and resumes translation of the PhoH2 transcript. In 
both cases it is likely that the two proteins are transcriptionally coupled due 
to the overlap of the stop and start codons. Upstream of the alt peptide 
sequence in both M. tuberculosis and M. smegmatis there is conservation of 
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the -10 promoter sequences (Figure 3.12). After translation, the two proteins 
associate to form a stable complex that survives purification. The presence of 
a peptide identified by MS that matched between the alternative and 
annotated start sites is suggestive of an interaction between the alt peptide 
and the PhoH2 protein. 
 
 
 
Figure 4.29 Schematic of PhoH2alt protein translation 
Schematic depicting the two possible hypotheses for PhoH2alt protein translation. a) The 
ribosome begins translation from the alternative start site and the annotated start site 
leading to the production of two polypeptides that associate with one another 
post-translation. b) The ribosome begins translation from the alternative start site and 
when it reaches the end of the alt peptide the ribosome either releases the peptide and 
falls off, or it releases the peptide and binds to the nearby Shine-Delgarno sequence and 
starts translation from the annotated PhoH2 start site. These hypotheses lead to the 
production of two polypeptides that associate with one another post-translation.   
 
 
The differences observed between PhoH2 and PhoH2alt proteins when 
analysed by Native-PAGE can be accounted for by the translation from the 
alternative start site. The apparent absence of a negative functional effect 
with full translation of PhoH2alt suggests that alt peptide may be susceptible 
to degradation post-translation more rapidly than the PhoH2 protein. The 
mixed population of purified PhoH2alt protein which was identified as the 
same protein but of different lengths identified during mass spectrometry 
analyses also suggest a labile nature of the translated alt peptide.  
 
The extensive attempts made to obtain soluble expression of PhoH2 from 
mycobacteria have provided some information regarding the nature of these 
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proteins. A number of cloning, expression and purification approaches were 
taken to try to gain a variety of soluble protein constructs for function and 
structure studies. The cloning of the Rv1095alt from M. tuberculosis, and either 
MSMEG_5247alt or MSMEG_5247 from M. smegmatis in mycobacterial 
expression cells, led to soluble protein.  
This result enabled characterisation of the biochemical activity of PhoH2 
from mycobacteria, which is the focus of Chapter 5. 
 
Chapter Five   133 
 
 
5 Chapter Five: Functional Activity of 
mycobacterial PhoH2 proteins 
This chapter will focus on the functional characterisation of three 
mycobacterial PhoH2 proteins: PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG.  
 
5.1 Introduction 
The fusion between PIN and PhoH domains is suggestive of functional linkage 
(Marcotte et al. 1999). My hypothesis was that given the conserved motifs 
identified in PhoH2, the biochemical function of the protein is to unwind RNA 
via the PhoH-domain coupled with the hydrolysis of ATP, and cleave the 
single stranded RNA product via the PIN-domain. 
 
From the motif analysis (section 1.4.3), it appears that PhoH2 is missing a 
number of the traditional helicase motifs concerned with nucleic acid binding 
(Ia, Ib, IV, V, VI) (Table 1.2). However, the highly conserved, arginine rich 
RGRTL motif, which forms a loop that projects near the P-loop active site, and 
other conserved motifs, in conjunction with R171 from the adjacent subunit, 
which bound SO4 in the PDB 3B85 structure, indicates that PhoH2 may be 
able to bind RNA (Figure 5.1). R171 (PDB 3B85) could possibly adopt a 
similar role to motif VI of SF1 and 2, which couples NTP hydrolysis with 
helicase activity and therefore translocation of the enzyme along the RNA 
(Bleichert & Baserga 2007). It is also possible with subunit movements 
during an ATP hydrolysis cycle that the loop may protrude into the central 
channel. 
 
A number of proteins containing arginine-rich motifs are known to bind RNA 
(Bayer et al. 2005). The arginine-rich motifs in the PhoH protein structure 
(PDB 3B85) are positioned close to the central channel (Figure 5.1). In other 
helicases such as Rho and E1, a series of loops project into the central pore 
that are responsible for interactions with the incoming substrate (Thomsen & 
Berger 2009).  
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Figure 5.1 Predicted active site of PhoH proteins   
Portion of hexameric PhoH protein showing the interface between two adjacent 
subunits and the positions of conserved residues/motifs Q (green), Walker A (yellow), R 
residue (light grey), RGRTL (dark green), Walker B (magenta), N residue (SI) (orange), R 
residue (SRH) (red), III (black) and R residue (SII) (blue). The highly conserved RGRTL 
motif and R residue (R171) predicted to be involved with RNA recognition are circled. 
 
The RNA binding and substrate specificity of PhoH2 may be determined by 
the PIN-domain. PIN-domain proteins cleave ssRNA in a sequence specific, 
Mg2+/Mn2+ dependent manner (Arcus et al. 2011). Table 5.1 summarises the 
sequence specificity of mycobacterial VapC proteins determined to date 
(Ahidjo et al. 2011; McKenzie et al. 2012a; McKenzie et al. 2012b; Sharp et al. 
2012). 
 
Table 5.1 Specificity of VapC proteins from mycobacteria 
VapC Sequence specificity Reference 
MSMEG_1284 A U A U and A U A A (McKenzie et al. 2012b) 
Rv0065/Rv0617 G/C G G/C G/C/A (Ahidjo et al. 2011) 
Rv0595c A C G C and A C A/U G C (Sharp et al. 2012) 
 
Alternatively, both the PIN and PhoH-domains may coordinate to confer 
substrate specificity. For example, RhlB is a helicase that is part of the RNA 
degradosome that provides substrates suitable for ribonucleases (Chandran 
et al. 2007). For activity, this protein interacts with RNase E which stimulates 
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the unwinding and ATPase activity of RhlB, and provides proximal RNA 
binding sites for RNase E with which it cooperates to unwind RNA. RNase E is 
a 5’-end-dependent endonuclease (Mackie 1998). The proposed site where 
interaction between RhlB and RNase E occurs is at a distance from the 
helicase core (Chandran et al. 2007 ). It is currently unknown how the PIN 
and PhoH-domains are structurally arranged. However their arrangement is 
unlikely to prevent coordination for activity. The interaction between RhlB 
and RNase E is predicted to partially suppress the RNA binding of the 
helicase further indicating coordination of both proteins for activity. This 
strengthens the case that the PIN and PhoH-domain of PhoH2 may work 
cooperatively to recognise, unwind and cleave substrates as these two 
domains that make up PhoH2 are fused to one another. 
 
Some helicases show little substrate specificity when analysed in vitro and 
require a large excess of protein over substrate to observe activity. This may 
be due to the absence of cofactors, low intrinsic affinity for the substrate or 
partial inactivation of the purified protein (Tanner & Linder 2001). 
 
PhoH proteins have reported ATP binding activity (Kim et al. 1993), however 
hydrolysis of ATP has not been experimentally verified. ATPase activity in 
DEAD-box proteins is dependent on RNA (Cordin et al. 2006), although a 
precise RNA substrate is not always required (Rocak & Linder 2004). ATPase 
activity can be greatly increased in the presence of specific RNA substrates 
(Fuller-Pace et al. 1993).  
 
Taken together, the observations made in the literature regarding 
PIN-domain proteins, PhoH proteins and other helicases led to the 
hypothesis that the PhoH-domain of PhoH2 has ATPase activity with 
moderate RNA binding, which relies on the PIN-domain for additional 
substrate specificity, binding, coordination, and degradation. 
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5.2 Results 
5.2.1 ATPase assays 
The first biochemical property of PhoH2 that was investigated was ATPase 
activity. The hydrolysis of ATP by PhoH2 was measured using a modified 
malachite green method (Baykov et al. 1988). This test quantifies the green 
complex that forms between malachite green, molybdate and free 
orthophosphate, which can be measured using a spectrophotometer at 
600-660 nm. 
 
Each of the PhoH2 proteins was screened in a pilot trial and 1.25 µg of 
protein per 100 µl reaction was suitable for sufficient colour development 
using substrate concentrations from 0-6 µM ATP in the presence of 1 mM 
MgCl2 and was incubated for 10 minutes at 37 °C. 
 
Each PhoH2 protein had ATPase activity that was reduced in the presence of 
EDTA (2 mM), indicating that Mg2+ was required for optimal activity (Figure 
5.2). 
  
 
Figure 5.2 ATPase activity of PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG 
a) Typical standard curve obtained for 0 µM - 50 µM phosphate and Michaelis Menten 
plots for 0.25 µM b) PhoH2alt MTB c) PhoH2alt MSMEG and d) PhoH2MSMEG in the presence of 
1 mM MgCl2 and 2 mM EDTA . Error bars represent +/-SD. 
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The kinetic properties calculated for each PhoH2 protein are listed in Table 
5.2. 
Table 5.2 Michaelis Menten kinetics of PhoH2 proteins 
Protein K M (µM) V max (µM/min) k cat (min-1) 
PhoH2alt MTB 0.8 0.8 3.0 
PhoH2MSMEG 1.4 1.0 3.9 
PhoH2alt MSMEG 3.2 1.2 4.8 
 
The effect of total and specific RNA on ATPase activity was tested by adding 
0.0025 µM RNA to each of the reactions containing the same amount of 
protein as in Figure 5.2 (1:100 molar ratio) and comparing the resulting plots 
with reactions that did not contain RNA. Initially, a time course assay which 
included total M. smegmatis mc2155 RNA and 1 µM ATP was performed with 
PhoH2MSMEG and possibly suggested a slight although not significant, increase 
of phosphate release in the presence of RNA (Figure 5.3a). ATPase activity 
was also tested in the presence of a specific RNA oligonucleotide substrate 
(5’3) selected based on its use in the unwinding and ribonuclease assays 
(section 5.2.2) with PhoH2MSMEG and PhoH2alt MTB. Attempts were made to test 
PhoH2alt MSMEG with RNA, however protein purification was unsuccessful. No 
significant difference was observed in ATPase activity with the addition of 
RNA (Figure 5.3b and c). 
 
 
Figure 5.3 The effect of RNA on ATPase activity of PhoH2MSMEG and PhoH2alt MTB 
a) Time course of phosphate released in the presence and absence of total RNA and 
Michaelis Menten plots of b) PhoH2MSMEG and c) PhoH2alt MTB in the presence and absence 
of specific RNA oligonucleotide (5’3). Error bars represent +/-SD. 
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5.2.2 Unwinding and ribonuclease assays 
It is common for helicases to require a ss region for substrate loading, before 
performing unwinding activity on a duplex region, as a result of the initial 
low affinity of helicases for dsRNAs (Tanner & Linder 2001). In addition, 
most helicase proteins also perform helicase activity in specific directions 
(Singleton et al. 2007). SF1/2 and AAA+ have examples of both 5’ to 3’ and 3’ 
to 5’ directionality, SF3 members demonstrate 3’ to 5’ activity and SF4/5 
demonstrate 5’ to 3’ activity. Owing to the combination of conserved motifs 
present in PhoH2 from SFs 1/2/AAA+ and AAA, which adopt both 5’ to 3’ and 
3’ to 5’ unwinding directionality, the unwinding and ribonuclease activity of 
PhoH2 was assayed in vitro by observing the conversion of a range of RNA 
duplexes to monomers and degradation. Short self annealing oligomers with 
identical duplex forming regions and either 5’- or 3’- ss tails and a blunt 
substrate, were tested in the manner used by Chandran (2007) to 
characterise ATP-dependent RNA helicase RhlB. 
 
Initially, 5’-tailed, 3’-tailed, ss and blunt RNA and DNA oligonucleotides were 
tested with each mycobacterial PhoH2 protein at a 1:100 molar ratio. The 
results of these assays demonstrated that PhoH2alt MTB, PhoH2alt MSMEG and 
PhoH2MSMEG had ATP-dependent ribonuclease activity with the 5’-tailed and 
3’-tailed RNA substrates and perhaps slight activity on ss substrates. This 
was shown by the degradation of lower molecular weight material and 
enrichment at the bottom of the gel in the presence of ATP (+ATP) compared 
with the control reactions (-ATP, +EDTA, AMP-PNP) (Figure 5.4a and b). The 
control reactions tested for ATP-dependent activity (-ATP), 
cofactor-dependent activity (+EDTA), and the requirement for ATP 
hydrolysis (AMP-PNP used in place of ATP).  
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Figure 5.4 Ribonuclease activity of PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG 
on 5'-tailed, 3'-tailed, ss and blunt RNA substrates  
a) 5’-tailed RNA b) 3’-tailed RNA c) ss RNA and d) blunt RNA substrates tested with 
PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG at 37 °C for 30 minutes. Labels: First column 
substrates (5’, 3’ ss or blunt), positive control for unwinding (95 °C), reaction performed 
in the absence of ATP (-ATP), reaction performed in the presence of EDTA (+EDTA), 
reaction performed with non-hydrolysable AMP-PNP in place of ATP (AMP-PNP) and 
reaction performed in the presence of ATP (+ATP). White boxes highlight results of 
+ATP reactions where activity has occurred.   
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The hybridisation of the substrates to form 5’-tailed, 3’-tailed or blunt 
substrates was poor as indicated by the number of hybridisation 
intermediates present on the gel. Even with the ss oligonucleotide, a mixed 
population of species was apparent.   For accurate analysis of PhoH2 activity 
on the oligonucleotide substrates, the substrates needed to be more 
homogeneous. Many hybridisation attempts were made to gain the desired 
hybridised substrates, these were unsuccessful with these substrates.  
 
There was no activity of any PhoH2 protein on the equivalent DNA substrates 
(Figure 5.5). The annealing of these substrates was also poor. 
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Figure 5.5 Activity of PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG on 5'-tailed, 
3'-tailed, ss and blunt DNA substrates 
a) 5’-tailed DNA b) 3’-tailed DNA c) ss DNA and d) blunt DNA substrates tested with 
PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG at 37 °C for 30 minutes. Labels: First column 
substrates (5’, 3’ ss or blunt), positive control for unwinding (95 °C), reaction performed 
in the absence of ATP (-ATP), reaction performed in the presence of EDTA (+EDTA), 
reaction performed with non-hydrolysable AMP-PNP in place of ATP (AMP-PNP) and 
reaction performed in the presence of ATP (+ATP).  
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Clearing of lower molecular weight hybridisation intermediates was most 
apparent with the 3’-tailed RNA oligonucleotide (Figure 5.4b). To obtain a 
substrate closer to that preferred by PhoH2, two shortened versions of the 
3’-tailed RNA oligonucleotide were designed (3’-AU  and 3’-UA) that reduced 
the length of the 3’-tail by either two or five RNA bases respectively (Table 
2.12). No activity of any kind was observed by PhoH2 on these substrates and 
again poor hybridisation was achieved (Figure 5.6). 
 
 
Figure 5.6 Activity of PhoH2alt MTB, PhoH2alt MSMEG and PhoH2MSMEG on 3'-AU and 
UA RNA substrates 
a) 3’AU-tailed RNA b) 3’UA-tailed RNA tested with PhoH2alt MTB, PhoH2alt MSMEG and 
PhoH2MSMEG at 37 °C for 30 minutes. Labels: First column substrates (3’-AU or 3’-UA), 
positive control for unwinding (95 °C), reaction performed in the absence of ATP (-ATP), 
reaction performed in the presence of EDTA (+EDTA), reaction performed with 
non-hydrolysable AMP-PNP in place of ATP (AMP-PNP) and reaction performed in the 
presence of ATP (+ATP).   
 
The next substrate designed was 5’-AC. In this substrate, the 5’ terminal 
combination of residues had been changed from GA to AC which aimed to 
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improve radio labelling with adenosine 5’-triphosphate γ-33P and subsequent 
hybridisation. This substrate was more homogenous and with each of the 
PhoH2 proteins ATP-dependent RNA binding of PhoH2 was observed (Figure 
5.7a) as shown by the band shift on the gel. Due to this new mode of activity, 
three further RNA oligonucleotides were screened, 3’-AC which had the 5’-AC 
overhang positioned in the 3’ orientation, a blunt 5’-AC substrate, 5’-ACAA 
which had the 3rd, 4th and 5th residues changed to their complementary RNA 
base, and a DNA equivalent of 5’-AC (Figure 5.7). 
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Figure 5.7 Binding and ribonuclease activity of PhoH2MSMEG on 5’-AC, 3’-AC, 
5’-AC blunt, 5’-ACAA RNA substrates and 5’AC DNA substrate 
a) 5’-AC RNA b) 3’-AC RNA c) 5’AC blunt RNA d) 5’ACAA RNA e) 5’AC DNA substrates 
tested with PhoH2MSMEG at 37 °C for 30 minutes. The same results were obtained for 
PhoH2alt MTB and PhoH2alt MSMEG. Labels: First column substrates (5’-AC, 3’-AC, 3’-AC 
blunt, 5’-ACAA RNA or 5’-AC DNA), positive control for unwinding (95 °C), reaction 
performed in the absence of ATP (-ATP), reaction performed in the presence of EDTA 
(+EDTA), reaction performed with non-hydrolysable AMP-PNP in place of ATP 
(AMP-PNP) and reaction performed in the presence of ATP (+ATP). White boxes 
highlight results of +ATP reactions where activity has occurred.   
 
Binding was observed with 5’-ACAA in addition to 5’-AC (Figure 5.7d) but no 
activity of any kind was seen with any of the other substrates tested, likely 
due to the preference of PhoH2 for 5’-ssRNA overhangs. 
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A time course assay was undertaken with each PhoH2 protein to look at the 
rate of binding. The representative results for PhoH2MSMEG (Figure 5.8) show 
that after 5 minutes the protein has bound up most of the substrate and, over 
a longer time frame, enrichment at the bottom of the gel increased likely due 
to the partial cleavage of the substrate. In the presence of AMP-PNP, the 
substrate was also bound and cleaved, suggesting ATP-independent RNA 
binding and partial cleavage activity of PhoH2. The results for PhoH2alt MTB 
and PhoH2alt MSMEG were essentially the same as for PhoH2MSMEG. 
 
Figure 5.8 Binding and ribonuclease activity of 
PhoH2MSMEG on 5'AC RNA substrate over time  
5’AC RNA time course with PhoH2MSMEG. Labels: First 
column substrate (5’-AC RNA), positive control for 
unwinding (95 °C), reaction performed in the absence of 
ATP (-ATP), reaction performed in the presence of EDTA 
(+EDTA), reaction performed with non-hydrolysable 
AMP-PNP in place of ATP (AMP-PNP) and reaction 
performed in the presence of ATP (+ATP). 
 
 
 
 
PIN-domain proteins are known to bind RNA (Lamanna & Karbstein 2009), 
and binding (in the absence of RNA cleavage) can be an indication that the 
substrate is still far from optimal. For this reason, a more systematic 
approach was taken with the design of the next five RNA substrates (5’ 1-5). 
5’1-5 RNA substrates are modified versions of the 5’AC substrate in which 
the 1st, 2nd, 3rd, 4th, and 5th residues have been sequentially changed to their 
complementary RNA base. These substrates were tested with PhoH2MSMEG, 
and showed in the presence of ATP, full degradation of RNA oligonucleotides 
5’3, 5’4 and 5’5 (Figure 5.9). It was assumed that the substrate was being 
unwound in order for the PIN-domain to degrade all the RNA as all 
PIN-domain proteins characterised thus far cleave only ss material (Arcus et 
al. 2011). Binding and only partial degradation activity of RNA substrates 5’1 
and 5’2 were observed in the presence of ATP (Figure 5.9a and b). With these 
substrates, binding in the presence of AMP-PNP was not observed. 
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Figure 5.9 Unwinding and ribonuclease activity of PhoH2MSMEG on 5'1, 5'2, 5'3, 
5'4 and 5'5 substrates 
a) 5’1-tailed RNA b) 5’2-tailed RNA c) 5’3-tailed RNA d) 5’4-tailed RNA e) 5’5-tailed RNA 
tested with PhoH2MSMEG at 37 °C for 30 minutes. Labels: First column substrate (5’1-5’5 
RNA), positive control for unwinding (95 °C), reaction performed in the absence of ATP 
(-ATP), reaction performed in the presence of EDTA (+EDTA), reaction performed with 
non-hydrolysable AMP-PNP in place of ATP (AMP-PNP) and reaction performed in the 
presence of ATP (+ATP). White boxes highlight results of +ATP reactions where activity 
has occurred.   
 
 
Table 5.3 summarises the activity of PhoH2 on the 5’-AC derived substrates. 
The optimal sequence for unwinding and cleavage can be deduced from these 
results as A C A/U A/U G/C U. A uridine residue at the 6th position is 
important as with 5’ACAA (ACAACAACAUCAGAGUGCGCACUC) an A is 
present at position 6 and binding activity, but not unwinding and cleavage, 
was observed despite the ACAA combination of the first four RNA bases 
(Figure 5.7d).  
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Table 5.3 Summary of activity on 5'AC derived substrates 
Oligonucleotide Sequence 5’-3 (duplex) Activity 
RNA 5’AC ACAUGUACAUCAGAGUGCGCACUC Bind 
3’ AC GAGUGCGCACUCACUACAUGUACA X 
5’ AC blunt ACAUGUACAUCAUGAUGUACAUGU X 
5’ ACAA ACAACAACAUCAGAGUGCGCACUC Bind 
5’1 UCAUGUACAUCAGAGUGCGCACUC Bind 
5’2 AGAUGUACAUCAGAGUGCGCACUC Bind 
5’3 ACUUGUACAUCAGAGUGCGCACUC Unwind/Cleave 
5’4 ACAAGUACAUCAGAGUGCGCACUC Unwind/Cleave 
5’5 ACAUCUACAUCAGAGUGCGCACUC Unwind/Cleave 
 
To test the requirement of ATP hydrolysis for unwinding, a non-hydrolysable 
analogue (AMP-PNP) was used in place of ATP. Unwinding activity was not 
observed suggesting unwinding is stimulated by ATP hydrolysis (Figure 5.9). 
Binding activity was observed with some substrates in the presence of 
AMP-PNP therefore ATP hydrolysis is not required for oligomer binding 
(Figure 5.8). 
 
5.2.3 UTR assays 
RT-PCR revealed that the gene for phoH2 in M. tuberculosis and M. smegmatis 
is part of a longer mRNA transcript (Figure 3.10). As raised in Chapter 3, 
certain RNase enzymes autoregulate their expression by binding directly to 
their 5’ untranslated region. RNase E is one example which acts on a 
cis-acting stem-loop in the rne 5’ untranslated region (Schuck et al. 2009). 
VapBC proteins are also known to autoregulate their expression via the DNA 
binding activity of VapB (Robson et al. 2009).  
 
As discussed in Chapter 3, and owing to the unwinding and ribonuclease 
activity of PhoH2, it was possible that the upstream mRNA transcript 
associated with phoH2 maybe a biochemical target of the PhoH2 protein. To 
test this, the alt transcript (from alternative start site to annotated start site) 
was successfully amplified from vector DNA (Figure 5.10) and transcribed 
from DNA into RNA.  
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Figure 5.10 Amplified alt UTR substrates  
PCR amplified UTR substrates from genomic DNA 
a) MTBalt (156 bp) and b) MSMEGalt (147 bp). 
 
 
 
 
 
 
 
The alt substrates were radio labelled and PhoH2alt MTB was found to have 
ATP-dependent activity on its own alt substrate, but not the alt substrate of 
M. smegmatis (Figure 5.11a and d). PhoH2MSMEG did not show any activity on 
either alt substrate (Figure 5.11b and c). 
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Figure 5.11 Activity of PhoH2alt MTB and PhoH2MSMEG on alt UTR substrates 
a) PhoH2alt MTB activity on MTB alt b) PhoH2MSMEG activity on MTB alt c) PhoH2MSMEG 
activity on MSMEG alt and d) PhoH2alt MTB activity on MSMEG alt. Labels: First column 
substrate (MTB alt, MSMEG alt), reaction performed in the absence of ATP (-ATP), 
reaction performed in the presence of EDTA (+EDTA), reaction performed with 
non-hydrolysable AMP-PNP in place of ATP (AMP-PNP) and reaction performed in the 
presence of ATP (+ATP). 
 
The optimal sequence deduced from the unwinding and ribonuclease assays 
was A C A/U A/U G/C U. The sequence ACAUGU is found twice in the alt 
substrate from M. tuberculosis in a ss loop and in a duplex region (Figure 
5.12). This combination was not identified in the alt sequence from 
M. smegmatis.  
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Figure 5.12 Secondary structure prediction of MTB alt sequence 
The secondary structure for MTB alt substrate taken from the alternative start site to the 
end of the overlap at the beginning of the phoH2 gene was predicted using RNAfold 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). The black open circles show the 
positions of the ACAUGU combination. The free energy prediction is - 76.60 kcal/mol. 
 
5.3 Discussion 
5.3.1 ATPase activity  
In order to perform the ATPase activity assays, each of the proteins had to be 
purified into a non-phosphate buffer. This proved challenging due to the 
instability of the protein in non-phosphate buffers, for example in Na-Hepes 
and Tris buffers the proteins ‘crashed out’ within four hours of IMAC 
purification, and if these proteins were further purified with size exclusion 
chromatography, they appeared to be soluble aggregates as they eluted. 
Assays were therefore carried out immediately following IMAC purification.  
 
The rate of ATP hydrolysis by PhoH2 proteins was relatively slow. When total 
RNA or specific RNA were added to the reactions, no significant difference 
was observed, despite in the literature, there being the general  requirement 
of nucleic acid binding or the association of protein cofactors to stimulate 
ATP hydrolysis (Singleton et al. 2007). This may be due to trace amounts of 
residual RNA present following the IMAC purification. The pre-treatment of 
the proteins with DNase or RNase to remove residual nucleic acids was 
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unfeasible due to the unstable nature of the proteins. This treatment caused 
the proteins to precipitate.  
 
Hexameric helicases are expected to be held together in two ways; either by 
peripheral interactions of the hexameric ring or by interactions with an 
additional ring stacked on top (Ye et al. 2004). The molecular weights 
determined by size exclusion for PhoH2 suggest that the proteins are purified 
in a higher order conformation (Table 4.3). This may explain why ATPase 
activity is similar in the presence of RNA, as the protein is already in a 
conformation suitable for the hydrolysis of ATP. This may suggest, that the 
protein under any circumstances hydrolyses ATP. This is unlikely to occur 
inside a cell where ATP is a precious resource, therefore it is likely that 
additional factors contribute to oligomerisation for activity. 
 
PhoH2alt MTB was sufficiently able to hydrolyse ATP despite being cloned with 
a potential regulatory element. PhoH2alt MSMEG was able to hydrolyse ATP as 
well, albeit the K M was greater than observed for PhoH2MSMEG. If this element 
is acting as an inhibitor like that of VapB, in VapBC systems, then it is likely 
that the regulatory element would inhibit the PIN domain, thus having 
potentially little effect on hydrolysis activity. The two proteins are likely to 
together, therefore an inhibitory effect on the PIN domain should have some 
inhibitory effect on the PhoH domain. 
 
5.3.2 Unwinding and ribonuclease activity 
The unwinding and cleavage activity of PhoH2 in the presence of ATP was 
specific and relied on 5’-tailed duplex RNA substrates with the 5’ terminal 
combination of A C A/U A/U G/C U. The initial substrates tested with each of 
the PhoH2 proteins suggested that there was some activity of PhoH2 on 
substrates that had an overhang. Upon further substrate testing, a difference 
in activity was observed where the substrate was bound and binding was 
apparent with each of the PhoH2 proteins. From this point on, the last 5’1-5’5 
substrates were tested with PhoH2MSMEG only, owing to the more consistent 
purification of this protein compared with PhoH2alt MTB and PhoH2alt MSMEG. It 
is assumed, due to the consistent activity observed with all three proteins, 
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that PhoH2alt MTB and PhoH2alt MSMEG would have the same activity on 5’1-5’5. 
For these substrates very minor changes to the oligonucleotide substrate led 
to unwinding and RNase activity. 
 
There are many reports of substrate specificity of helicases arising through 
interactions of flanking sequences and sequences on the external surface of 
the helicase cores, that serve as sites for interaction with regulatory proteins 
or cofactors, while the catalytic cores of many have a generic substrate 
binding affinity (Tanner & Linder 2001). Protein cofactors are reported to 
promote target recognition and helicase activity, stimulate  ATPase activity, 
confer substrate specificity and increase the affinity of helicases for their 
substrates or inhibit helicase activity (Cordin et al. 2006). In cases in which a 
RNA helicase participates in multiple cellular processes, protein cofactors are 
also likely to act to recruit the helicase to the appropriate complex 
(Silverman et al. 2003). By testing PhoH2 as a whole, full length protein, it is 
unknown if one or both domains of the protein are contributing to substrate 
recognition and binding. Evidence suggests, however that the domains are 
working together, as for the assays where unwinding and cleavage was 
observed there were no degradation products in the absence of ATP. 
Similarly, in the presence of AMP-PNP for some substrates (5’AC), binding 
activity was observed which did not occur in any of the other reactions (-ATP, 
+EDTA). If the PIN-domain was working alone then in the absence of ATP 
(-ATP) activity should have been observed. Further, substrate  recognition is 
likely to be determined by both domains, as with the binding activity of some 
substrates in the presence of ATP (+ATP) some substrate degradation 
occurred, suggesting possibly that some of the substrate is being ‘held up’ by 
the PhoH-domain allowing for cleavage by the PIN-domain. In vivo, PhoH2 is 
likely to act on a particular set of targets whose specificity is determined by 
both domains. 
 
5.3.3 UTR assays 
The activity of PhoH2alt MTB on the MTB alt substrate suggests a possible 
autoregulatory mechanism of this protein at the mRNA level. There was no 
cross specificity of either PhoH2 protein for their opposing alt substrate. This 
Chapter Five   153 
 
 
may be, in part, due to the lack of suitable recognition sites in the 
M. smegmatis alt sequence, or the specificity of PhoH2alt MTB for its own 
upstream region. This mechanism of regulation is similar to that of RNase E, 
which autoregulates its synthesis through binding to a stem-loop in its 5’UTR 
to prevent the transcription of its gene (Schuck et al. 2009). It is interesting 
that PhoH2MSMEG did not have an effect on the MTB alt substrate (Figure 
5.11b), despite the two PhoH2 proteins showing the same specificity for the 
shorter oligonucleotide substrates.  
 
As a result of the binding activity observed with some substrates in the 
unwinding and ribonuclease assays it is plausible that PhoH2 adopts three 
types of activity on its targets: 1) unwinding and cleavage 2) binding and 
cleavage and 3) binding. All of these require ATP as a cofactor. Evidence 
suggests that PhoH2 from M. tuberculosis and M. smegmatis differ in their 
modes of regulation and that the role of the upstream sequence in 
M. smegmatis is not as influential as the upstream sequence of M. tuberculosis.  
 
5.4 Conclusions 
This is the first biochemical characterisation of a PIN-PhoH protein. The 
results of this biochemical investigation of three mycobacterial PhoH2 
proteins can provide data that may be applied to other PhoH2 proteins.  
 
PhoH2 can hydrolyse ATP irrespective of the addition of secondary substrate, 
suggesting assembly of the protein in a higher order conformation that is 
suitable for hydrolysis activity. A number of short self annealing 
oligonucleotides were screened, and the sequence A C A/U A/U G/C U was 
deduced as a specific target of PhoH2 proteins. UTR assays revealed activity 
of PhoH2alt MTB on its respective upstream sequence which was not observed 
for PhoH2MSMEG suggesting a possible autoregulatory role of PhoH2alt MTB. 
Furthermore, this suggests a critical regulatory role of the upstream region of 
phoH2 in M. tuberculosis which is consistent with the requirement of this 
sequence for soluble protein expression and offsetting negative effects of 
conditional over expression on growth and colony formation. 
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6 Chapter Six: Discussion 
PhoH2 proteins are abundant across bacterial and archaeal species. Despite 
this, little work has been done to determine their biological role. 
Biochemically, PIN-domain proteins are RNases, and as the toxic component 
of TA systems, those that have been extensively characterised, are sequence 
specific, and act to tune cellular metabolism (McKenzie et al. 2012b). The 
VapBC TA proteins are overrepresented in organisms that are pathogenic to 
mammals (McKenzie et al. 2012b), implying the involvement of these 
proteins in stress response and persistence (Gerdes 2000; Hayes 2003; Arcus 
et al. 2005; Buts et al. 2005; Gerdes et al. 2005). It is probable that other 
PIN-domain variants, by virtue of their biochemical activity, contribute to the 
adaptive response to environmental stress.  
 
This research has identified that phoH2 from two mycobacterial species is 
transcribed as part of an extensively structured mRNA transcript. Long 
5’UTRs generally play roles in stability of the mRNA transcript, provide 
components for the correct intracellular mRNA localisation, and contain 
cis-acting regulatory elements (Irnov et al. 2010). In M. tuberculosis, evidence 
suggests that a ~152 base segment of this transcript closest to the 
5’-terminus of phoH2 is regulatory, shown to be necessary for ‘normal’ 
growth, colony formation, and protein overexpression of PhoH2, not 
otherwise demonstrated by phoH2 alone.  
 
Most PIN-domain proteins are co-expressed with an inhibitor that forms a 
complex with the PIN-domain protein (VapBC TA) (Arcus et al. 2011). This 
inhibitor allows for successful PIN-domain protein overexpression, and 
offsets the activity of the PIN-domain. These proteins have also been shown 
to affect growth when conditionally expressed in the absence of their 
inhibitor (Robson 2010). Evidence presented here suggests that it is likely 
that the alt peptide interacts with PhoH2. This peptide was required for to 
alleviate negative growth affects observed with PhoH2MTB alone, and was 
required for soluble protein expression.  
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LTQ-Orbitrap MS confirmed that the alt transcript is translated along with 
PhoH2 and can suggest an interaction between these two proteins. A 
difference between this peptide and the inhibitors of PIN-domains in the 
VapBC TA systems is that this peptide appears to not need to be removed in 
order to test for biochemical activity of PhoH2 proteins. The combined 
MALDI TOF/TOF MS and LTQ-Orbitrap analyses performed at the University 
of Otago, suggested that the sample of PhoH2 protein was a pool of the same 
protein but of different lengths. This may suggest a labile nature of the 
regulator of PhoH2 which, therefore, would not be able to prevent the 
activity of the protein.  
 
It is likely transcription and translation of this peptide and of the phoH2 gene 
is regulated. This may be controlled by one or more of the predicted 
transcriptional regulators positioned 1) within the intergenic region of 
Rv1094 and Rv1095 (Rv1990c), 2) further upstream near the start of the full 
length mRNA transcript (Rv0494), 3) further downstream of phoH2 
(Rv3133c), or 4) by negative feedback of the PhoH2 protein, which 
demonstrates activity on the alt RNA transcript (Figure 6.1). 
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Figure 6.1 Model of proposed Rv1095 regulation and PhoH2 activity 
Rv1095 has four predicted transcriptional regulators (Rv0494 x2, Rv1990c, and 
Rv3133c). Solid blue line (mRNA transcript) shows the length of the mRNA transcript 
determined by RT-PCR, this would extend at least to the end of the Rv1095 gene. The 
target of Rv0494 is located approximately half way through the Rv1094 gene. 
Transcriptional regulation by this transcription factor may influence the stability of the 
entire mRNA transcript. Similarly, the position of Rv1990c within the intergenic region 
of Rv1094 and Rv1095, may regulate the transcript from the alt site onward. If the mRNA 
transcript does extend past the 3’ end of Rv1095 then Rv3133c may play an additional 
role in regulation. Once PhoH2alt is transcribed and translated, the lability of the alt 
peptide would leave a pool of PhoH2alt protein and PhoH2 protein. The PhoH2 protein 
would be free to act on its cellular targets and negatively regulate its expression by 
acting on the alt mRNA.    
 
Each of these regulators, either directly or indirectly, respond to oxidative 
stress and phosphate starvation as described in sections 1.5.2, 3.1.2 and 
3.1.3. Homologues to all these regulators are found in M. smegmatis, with the 
exception of Rv1990c, show elevated expression when cultured slowly under 
oxygen limited conditions (0.6 % air), including MSMEG_5247 (Berney & 
Cook 2010). The functional partners identified for phoH2 are similar between 
M. tuberculosis and M. smegmatis, and implicate phoH2 further in the 
oxidative stress response and may suggest involvement in virulence 
associated lipid biogenesis. 
 
The incorporation of the alt sequence was critical for ‘normal’ growth and 
colony formation, and protein overexpression. It is possible then that 
Rv1990c would have the greatest effect of all the three regulators as its 
predicted target position is closest to the 5’ end of the alt transcript. This 
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transcriptional regulator is under control of SenX3-RegX3 in M. tuberculosis, 
which controls expression of phosphate specific transport genes under 
phosphate starvation (Rifat et al. 2009) and contains sensors of oxygen and 
redox state (Parish et al. 2003b; Rickman et al. 2004; Roberts et al. 2011). It 
is also possible that the candidate pseudopalindrome sequence identified by 
Kazakov et al. (2002) located within the alt sequence may be targeted for 
regulation.  
 
PhoH2 from M. smegmatis did not require the cloning of the alt sequence for 
protein overexpression or for ‘normal’ growth or colony formation in 
M. smegmatis cells, likely due to endogenous levels of the alt peptide. PhoH2 
from M. smegmatis in addition may be regulated slightly differently to PhoH2 
in M. tuberculosis. As mentioned, each of the predicted regulators of PhoH2 in 
M. tuberculosis with the exception of Rv1990c (not found in M. smegmatis) 
had elevated expression when cultured in hypoxic conditions. In 
M. smegmatis, SenX3-RegX3 is responsible for expression of genes involved in 
the response to phosphate starvation (Glover et al. 2007) and this two 
component system was also up regulated under hypoxic growth conditions 
(Berney & Cook 2010). Overall, it can be hypothesised that PhoH2 from 
M. tuberculosis and M. smegmatis are under the ultimate control of the 
SenX3-RegX3 or DevRS systems, which respond to phosphate starvation and 
oxidative stress. A flow diagram of predicted PhoH2 regulation in 
M. tuberculosis and M. smegmatis is outlined in Figure 6.2. 
 
Figure 6.2 Overview of predicted regulation of PhoH2 in M. tuberculosis and 
M. smegmatis 
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Biochemically, each PhoH2 protein tested was able to hydrolyse ATP in the 
presence of Mg2+, irrespective of the addition of secondary substrate. PhoH2 
proteins also demonstrated 1) binding, 2) binding and cleavage and 3) 
unwinding and cleavage, of RNA substrates in the presence of Mg2+ and ATP. 
In some cases, binding activity occurred in the presence of AMP-PNP 
suggesting for binding activity the hydrolysis of ATP was not required. For 
full unwinding and cleavage activity, ATP hydrolysis was required, as 
unwinding did not occur with AMP-PNP in place of ATP. PhoH2 from 
M. tuberculosis and M. smegmatis were found to act on the same short RNA 
substrates. The optimal substrate had a 5’-ssRNA overhang composed of the 
sequence A C A/U A/U G/C U. PhoH2 from M. tuberculosis was further 
demonstrated to act on its respective alt transcript, suggesting that it may 
autoregulate its own expression. Other PhoH2 proteins may be able to act on 
longer RNA targets as well, and may rely on the presence of specific 
secondary structural elements within the RNA for activity.  
 
Currently, all characterised PIN-domain proteins, in spite of carrying the 
same set of conserved residues that make up the active site, target different 
specific RNA sequences (Ahidjo et al. 2011; McKenzie et al. 2012a; McKenzie 
et al. 2012b; Sharp et al. 2012). It is possible, given the results presented 
here, that all PhoH2 proteins target the same short sequences, but in vivo 
their biological targets may differ depending under which conditions PhoH2 
is expressed.  
 
The three types of activity displayed by PhoH2 (binding, binding and 
cleavage, and, unwinding and cleavage) can suggest that these proteins may 
target substrates within a gene or within the 5’ or 3’ UTR to destabilise the 
transcript. This type of model has been proposed for other PIN-domain 
proteins where the target sequences have been identified either 5’ or 3’ of the 
gene of interest (McKenzie 2011). Further, the reaction products of PhoH2 
may be targets of other proteins involved with RNA metabolism. 
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6.1 Recommendations for further work 
To elucidate the domain interactions and confirm the higher order 
conformation of PhoH2, a higher resolution structure would need to be 
obtained. This may be achieved by further optimising crystal growth for 
structure determination by crystallography or by further pursuing electron 
microscopy for image data. For both crystallisation and electron microscopy, 
the homogeneity of the protein sample needs to be improved. EM image data 
may be used in conjunction with diffraction data to gain a low resolution 
structure. 
 
A structure would show whether the PIN-domain, in a PIN-PhoH fusion, 
forms a ring and tunnel in its higher order conformation in a similar manner 
to that of PDB 3I8O. Further, whether one or more hexamers work together 
to perform mechanical work, as suggested by PDB 3B85. A structure may also 
reveal where the alt peptide is docking, and help confirm the lability of this 
peptide. The mechanism of activity, may also be uncovered by structures 
obtained with substrates bound at different stages of the ATPase cycle.  
 
To confirm if a single domain is responsible for binding activity, the PIN and 
PhoH domains of PhoH2TBIS, , could be cloned separately and tested in 
expression trials. Each domain could then be tested in 
ATPase/binding/unwinding/ribonuclease assays. These tests would also 
shed light on whether the PIN-domain is responsible for maintaining the 
higher order hexameric conformation of the PhoH-domain. Additionally, 
ATPase assays could be performed in the presence of the PIN-domain to see 
if ATPase activity is increased or whether ATP turnover is carried out 
independently of the PIN-domain. 
 
To test the requirement of PhoH2 in the adaptation to phosphate limiting 
conditions and hypoxia, a qPCR analysis could be performed on samples 
taken during culture under these two conditions. If expression of phoH2 was 
elevated during a shift from phosphate sufficient to phosphate limiting 
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conditions, this would be consistent with phoH (PhoH2) from C. glutamicum 
(Ishige et al. 2003).  
 
To further verify the requirement of PhoH2 for growth under phosphate 
starvation and hypoxic conditions and to study these effects in vivo, a 
deletion mutant would need to be made. If growth was affected by the 
absence of PhoH2, then this protein is involved in these responses. Further, 
mRNA microarray analyses could be performed on the mutant to determine 
which genes are affected by phoH2, and those that are affected, could be 
tested in vitro.  
 
Attempts were made to generate an unmarked deletion of phoH2 in 
M. smegmatis using the method developed for two-step allelic exchange 
mutagenesis in M. tuberculosis (Parish & Stoker 2000), which is based on the 
method of Pelicic et al. (1997). These methods rely on the use of a 
mycobacteria-specific delivery plasmid pX33 (modified pPR23) (Pelicic et al. 
1997; Gebhard et al. 2006) that contains a thermosensitive origin of 
replication and gene sacB, which can be used to promote recombination and 
positive selection of gene replacement events during knockout construction. 
Two recombination events aim to exchange the gene for an insert 
(~1650 bp) composed of ~800 bp of the left and right flank of the gene which 
has been cloned into the delivery vector. The left and right flank PCR 
products of phoH2 were relatively straightforward to obtain after gradient 
cycling parameters were trialled. The overlapping LFRF PCR to gain the LFRF 
product was very challenging to amplify and was not obtained successfully 
despite numerous rounds and re-designing of primers to improve the left and 
right flank used in the second PCR reaction.  
 
To test the hypothesis that PhoH2 from M. tuberculosis is autoregulatory, the 
exact transcriptional start site would need to be obtained for the 
construction of a transcriptional fusion. The fusion could be introduced into 
the mutant background to identify any unregulated expression using systems 
such as lacZ. To verify the exact biochemical target within the alt RNA 
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sequence, the substrate could be split into shorter sequences to determine 
which portion is targeted.  
 
6.2 Concluding remarks 
The two mycobacterial genes investigated here were both transcribed as part 
of a longer mRNA transcript that is most likely to contain regulatory 
elements or sites for regulation.  The sequence taken from alternative start 
site 1 (phoH2alt) was found to be required to alleviate the negative effect of 
PhoH2 protein expression otherwise observed with PhoH2MTB alone and was 
also required to gain soluble protein expression of PhoH2 from 
M. tuberculosis. These results raised the possibility of regulatory elements in 
this sequence required for expression, regulation or translation or a potential 
inhibitory role of this sequence on the activity of PhoH2. It was later 
uncovered that the sequence from the alternative start site was being 
translated along with PhoH2 and that these two proteins interact with one 
another. This MS analysis also suggested that the peptide attachment to 
PhoH2 is labile in nature as a number of intact protein masses were 
identified suggesting a pool of the same protein but of different lengths. This 
protein construct and PhoH2alt MSMEG did not require the active removal of 
this peptide in order to test for biochemical activity, this is likely due to the 
labile nature of the peptide therefore there was enough “free” PhoH2 to 
perform work.  Two hypotheses are presented regarding the translation of 
the alt peptide along with PhoH2, both of which lead to the production of two 
polypeptides that interact with one another post-translation. Biologically, 
PhoH2 proteins are thought to contribute to the adaptive response of 
organisms to phosphate and oxidative stress where they are likely to act on 
specific RNA substrates. 
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7 Appendices 
Appendix A: Bacterial strains, vectors and media 
Table A.1 Bacterial strains and vectors used in this study 
 
Bacterial strain Description 
E. coli  
DB10B (TOP10) F-mcrA Δ(mrr-hsdRMS-mcrBC) Φ80 
dlacZ ΔM15 Δ lacX74 deoR recA1 
araD139 Δ(ara leu)7697 galU galK rpsL 
endA1 nupG 
DH5α (electrocompentent) fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
DH5α (chemically compentent) F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
deoR recA1 endA1 hsdR17(rk -, mk+) 
phoA supE44 thi-1 gyrA96 relA1 λ- 
BL21 (DE3) F- ompT hsdSB (rB-mB-) gal dcm (DE3) 
M. smegmatis  
mc2155 Electrocompetent wild-type strain of 
M. smegmatis 
mc24517 M. smegmatis expression strain with T7 
RNA polymerase, Kmr 
Vectors  
pYUB1049 E. coli mycobacterium shuttle vector 
with T7 promoter and encoding both C- 
and N-terminal His-tags; Hygr 
pDONR221 Donor vector; ColE1 (pUC-type) origin of 
replication; rrnB T1 transcription 
termination sequence; attP 
recombination site; attL recombination 
site, ccdB negative selection gene; 
chloramphenicol resistance gene; Kmr 
pDESTSMG Modified pYUB1049 E. coli 
mycobacterium shuttle vector att 
recombination recognition sequences; 
Hygr 
pDEST17 bla promoter; T7 promoter; attR1 
recombination site; attR2 recombination 
site;  chlorampenicol resistance gene;  
6xHis tag N-terminal; Ampr 
pYUB28b E. coli mycobacterium shuttle vector 
with T7 promoter, MCS pET28b, and 
encoding both C- and N-terminal His-
tags; Hygr 
pET28b-PstI Modified pET28b where the NcoI sites 
has been replaced with PstI site; C- or 
N-terminal His-tags; Kmr 
pMIND Tetracycline inducible expression 
vector; Kmr Hygr  
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Table A.2 Growth media used in this study 
Solid Description 
LB agar 1 % (w/v) bactotryptone, 0.5 % (w/v) 
yeast extract, 1 % (w/v) NaCl, 15 g/L 
agar pH 8 
Low salt LB agar 1 % (w/v) bactotryptone, 0.5 % (w/v)  
yeast extract, 0.5 % (w/v) NaCl, 15g/L 
agar pH 8 
7H10 1.9 g 7H10 powder, 0.5 % (w/v) glycerol 
in 90 ml H2O, autoclaved then 10 ml ADC 
enrichment and 0.05 % (v/v) Tween-80 
added at 50 °C 
Liquid  
LB 1 % (w/v) bactotryptone, 0.5 % (w/v) 
yeast extract, 1 % (w/v) NaCl, pH 8 
Low salt LB 1 % (w/v) bactotryptone, 0.5 % (w/v) 
yeast extract, 0.5 % (w/v)  NaCl 
LBT 1 % (w/v) bactotryptone, 0.5 % (w/v) 
yeast extract, 1 % (w/v) NaCl 0.05 % 
(v/v) Tween-80, pH 8 
7H9 0.47 g 7H9 powder, 0.2 % (w/v) glycerol 
in 90 ml H2O, autoclaved then 10 ml ADC 
enrichment and 0.05 % (v/v) Tween-80 
added at 50 °C 
PA-0.5G 50 mM Na2HPO4, 50 mM KH2PO4, 25 mM 
(NH4)2SO4, 1 mM MgSO4, 0.5 % (w/v) 
glucose, 0.1 x metals mix**, 200 μg/ml 
each of 17 amino acids (no Cys, Tyr or 
Met). Individual components autoclaved 
or sterile filtered before adding to sterile 
H2O 
ZYP-5052 1 % (w/v) bactotryptone, 0.5% (w/v) 
yeast extract, 50 mM Na2HPO4, 50 mM 
KH2PO4, 25 mM (NH4)2SO4, 1 mM MgSO4, 
0.5 % (w/v) glycerol, 0.05 % (w/v) 
glucose, 0.2 % (w/v) α-lactose, 1 x 
metals mix * 
SOC 2 % (w/v) bactotryptone or 
bactopeptone, 0.55 % (w/v) yeast 
extract, 10 mM NaCl, 2.5 mM KCl 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose 
Hartmans de Bont Components added in order given: 1 x 
trace metal stock**, 15 mM (NH4)2SO4, 
0.05 % (v/v) Tween-80, 0.2 % (v/v) 
glycerol, 50 mM MES. Autoclave then 
add 8.9 mM K2HPO4 and 7.08 mM 
NaH2PO4 
 
*Metals mix 1000x, made up from the sterile stock solutions of each 
component to give the following concentrations: 50 μM FeCl3 in 0.12 M HCl 
(filter sterile), 20 μM CaCl2, 10 μM MnCl2, 10 μM ZnSO4, 2 μM CoCl2, 2 μM 
CuCl2, 2 μM NiCl2, 2 μM Na2MoO4, 2 μM Na2SeO3, 2 μM H3BO3 
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** Trace metals stock 100x for HdB media: EDTA (0.1 g), MgCl2.6H2O (1 g), 
CaCl2.2H2O (10 mg), NaMoO4.2H2O (2 mg), CoCl2.6H2O (4 mg), MnCl2.2H2O 
(10 mg), ZnSO4.7H2O (20 mg), FeSO4.7H2O (50 mg), CuSO4.5H2O to 100 ml 
 
Refolding screen 
 Buffer Salt Cation 
2+ 
PEG 
3350 
(% 
w/v) 
Detergent* Chaotrope*1 Polar (P)/ 
Non-polar 
(NP) 
additives 
Oxidising/ 
Reducing 
agents 
1 50 mM tris 
pH 8.2 
250 mM 
NaCl 
1 mM 
EDTA 
0.05 % 0.0 mM 0 mM 0 mM 1 mM DTT 
2 50 mM 
MES 
pH 6.5 
10 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.00 % 0.3 mM 500 mM 0 mM 1 mM GSH 
0.1 mM GSSG 
3 50 mM 
MES  
pH 6.5 
10 mM 
NaCl 
1 mM 
EDTA 
0.05 % 0.0 mM 500 mM 200 mM 
sucrose (NP) 
200 mM L-
arginine (P) 
1 mM GSH 
0.1 mM GSSG 
4 50 mM tris 
pH 8.2 
250 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.00 % 0.3 mM 0 mM 200 mM 
sucrose (NP) 
200 mM L-
arginine (P) 
1 mM DTT 
5 50 mM 
MES  
pH 6.5 
250 mM 
NaCl 
2 mM 
MgCl2 
2 mM 
CaCl2 
0.00 % 0.0 mM 0 mM 200 mM 
sucrose (NP) 
 
1 mM GSH 
0.1 mM GSSG 
6 50 mM tris 
pH 8.2 
10 mM 
NaCl 
1 mM 
EDTA 
0.05 % 0.3 mM 500 mM 200 mM 
sucrose (NP) 
 
1 mM DTT 
7 50 mM tris 
pH 8.2 
10 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.00 % 0.0 mM 500 mM 200 mM L-
arginine (P) 
1 mM DTT 
8 50 mM 
MES  
pH 6.5 
250 mM 
NaCl 
1 mM 
EDTA 
0.05 % 0.3 mM 0 mM 200 mM L-
arginine (P) 
1 mM GSH 
0.1 mM GSSG 
9 50 mM 
MES  
pH 6.5 
250 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.05 % 0.0 mM 500 mM 200 mM 
sucrose (NP) 
 
1 mM DTT 
10 50 mM tris 
pH 8.2 
10 mM 
NaCl 
1 mM 
EDTA 
0.00 % 0.3 mM 0 mM 200 mM 
sucrose (NP) 
 
1 mM GSH 
0.1 mM GSSG 
11 50 mM tris 
pH 8.2 
10 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.05 % 0.0 mM 0 mM 200 mM L-
arginine (P) 
1 mM GSH 
0.1 mM GSSG 
12 50 mM 
MES  
pH 6.5 
250 mM 
NaCl 
1 mM 
EDTA 
0.00 % 0.3 mM 500 mM 200 mM L-
arginine (P) 
1 mM DTT 
13 50 mM tris 
pH 8.2 
250 mM 
NaCl 
1 mM 
EDTA 
0.00 % 0.0 mM 500 mM 0 mM 1 mM GSH 
0.1 mM GSSG 
14 50 mM 
MES 
 pH 6.5 
10 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.05 % 0.3 mM 0 mM 0 mM 1 mM DTT 
15 50 mM 
MES  
pH 6.5 
10 mM 
NaCl 
1 mM 
EDTA 
0.00 % 0.0 mM 0 mM 200 mM 
sucrose (NP) 
200 mM L-
arginine (P) 
1 mM DTT 
16 50 mM tris 
pH 8.2 
250 mM 
NaCl 
2 mM 
MgCl2 
2mM 
CaCl2 
0.05 % 0.3 mM 500 mM 200 mM 
sucrose (NP) 
200 mM L-
arginine (P) 
1 mM GSH 
0.1 mM GSSG 
 
* Dodecyl maltoside *1 Guanidine HCl 
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Appendix B: Gene and protein Information 
Rv1095/BCG_1155 (1302 bp) 
GTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGCGTG
CAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAGCCA
AGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGATCTG
CGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCTGCA
CGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCAACG
ACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTGGTC
AGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGTACCA
CGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCCGCGG
ATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACCGTGT
CACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGCATAA
ACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGC
AGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAA
GCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACG
CACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCT
ACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTC
GAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCT
GCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCAC
AGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTG
GTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCGC
CGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGTG
AGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095/BCG_1155 (433 aa)  
MW 46881.5 Da pI 5.96 
VTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDL
RLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLV
SKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLPC
HTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGGK
AGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTL
EGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRV
VLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR* 
 
Rv1095/BCG_1155 pYUB1049 C-terminal fusion tag (1368 bp) 
GTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGCGTG
CAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAGCCA
AGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGATCTG
CGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCTGCA
CGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCAACG
ACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTGGTC
AGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGTACCA
CGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCCGCGG
ATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACCGTGT
CACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGCATAA
ACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGC
AGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAA
GCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACG
CACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCT
ACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTC
GAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCT
GCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCAC
AGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTG
GTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCGC
CGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGTG
AGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCGCGCG
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GATCCGAATTCGAGCTCCGTCGACAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCA
CTGA 
 
Rv1095/BCG_1155 pYUB1049 C-terminal fusion tag (456 aa) 
MW 49274.0 Da pI 6.02 
VTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDL
RLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLV
SKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLPC
HTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGGK
AGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTL
EGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRV
VLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPRA
DPNSSSVDKLAAALEHHHHHH* 
 
Rv1095/BCG_1155 pYUB1049 N-terminal fusion tag (1365 bp) 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATAT
GGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGCGT
GCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAGCC
AAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGATCT
GCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCTGC
ACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCAAC
GACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTGGT
CAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGTACC
ACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCCGCG
GATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACCGTG
TCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGCATA
AACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAG
CAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAA
AGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGAC
GCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGC
TACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCT
CGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGC
TGCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCA
CAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGT
GGTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCG
CCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGT
GAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCGCTG
A 
 
Rv1095/BCG_1155 pYUB1049 N-terminal fusion tag (455 aa) 
MW 49176.0 Da pI 6.22 
MGSSHHHHHHSSGLVPRGSHMVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEA
KRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSN
DSRILSCAANLAAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASA
DIDALFADGEIDLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAE
QRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELG
YLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEA
QSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRS
ERSPIAALVTEMLEEITGPR* 
 
Rv1095/BCG_1155 pDESTSMG N-terminal fusion tag (1368 bp) 
ATGTCGCATCACCATCACCATCACCTCGAATCACCATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGG
CGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAA
GCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGA
TCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGC
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TGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGC
AACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTT
GGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGT
ACCACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCC
GCGGATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACC
GTGTCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGC
ATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCC
GAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGG
CAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGC
GACGCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTG
GGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACAC
CCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGG
TGCTGCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAG
GCACAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCG
GGTGGTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGG
TCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGC
AGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCG
CTGA 
 
Rv1095/BCG_1155 pDESTSMG N-terminal fusion tag (456 aa) 
MW 49432.3 Da pI 6.2 
MSHHHHHHLESPSTSLYKKAGFVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELE
AKRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDS
NDSRILSCAANLAAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETAS
ADIDALFADGEIDLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSA
EQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQEL
GYLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDE
AQSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLR
SERSPIAALVTEMLEEITGPR* 
 
Rv1095/BCG_1155 pDEST17 N-terminal fusion tag (1368 bp) 
ATGTCGTACTACCATCACCATCACCATCACCTCGAATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGG
CGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAA
GCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGA
TCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGC
TGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGC
AACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTT
GGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGT
ACCACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCC
GCGGATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACC
GTGTCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGC
ATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCC
GAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGG
CAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGC
GACGCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTG
GGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACAC
CCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGG
TGCTGCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAG
GCACAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCG
GGTGGTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGG
TCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGC
AGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCG
CTGA 
 
Rv1095/BCG_1155 pDEST17 N-terminal fusion tag (456 aa) 
MW 49574.5 Da pI 6.2 
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MSYYHHHHHHLESTSLYKKAGFVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELE
AKRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDS
NDSRILSCAANLAAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETAS
ADIDALFADGEIDLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSA
EQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQEL
GYLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDE
AQSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLR
SERSPIAALVTEMLEEITGPR* 
 
Rv1095/BCG_1155 pYUB28b C-terminal fusion tag (1344 bp) 
ATGGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGC
GTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAG
CCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGAT
CTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCT
GCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCA
ACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTG
GTCAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCGGTGGGGCTGGCCGCCGACGAGTA
CCACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGATGCACGAGCTCGAGACCGCTTCCG
CGGATATCGATGCGTTGTTCGCCGATGGCGAGATCGACCTGGTCGAAGCCCGGGACCTACCG
TGTCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCACGCGCTGGGCCGGGTCAATGCGCA
TAAACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCG
AGCAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGC
AAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCG
ACGCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGG
GCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACC
CTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGT
GCTGCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGACTCGTTCGTCATCGTCGACGAGG
CACAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGG
GTGGTGTTGACCCACGACATCGCCCAGCGCGACAACCTGCGGGTCGGCCGCCACGACGGGGT
CGCCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTTCGCCCACATCACCTTGCTGCGCA
GTGAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCACCGGGCCGCGC
AAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
Rv1095/BCG_1155 pYUB28b C-terminal fusion tag (447 aa) 
MW 48532.4 pI 6.14  
MVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDD
LRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTL
VSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLP
CHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGG
KAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDT
LEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSR
VVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR
KLAAALEHHHHHH* 
 
 
Rv1095alt (1454 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGACCGATACCCGCACGTACGTGCTCGACACCT
CTGTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCG
TTGGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCG
CCAGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTC
CGGTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTG
CCCGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGC
CGCCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCG
CGGTGGGGCTGGCCGCCGACGAGTACCACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGG
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ATGCACGAGCTCGAGACCGCTTCCGCGGATATCGATGCGTTGTTCGCCGATGGCGAGATCGA
CCTGGTCGAAGCCCGGGACCTACCGTGTCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCC
ACGCGCTGGGCCGGGTCAATGCGCATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCG
TTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTC
GGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTG
CGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTG
TACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCC
GTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAG
TGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGCTCGTTGCAT
GACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCT
GTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGCGCGACAACC
TGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTG
TTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGAT
GCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095alt (486 aa) 
MW 52053.3 Da pI 6.09 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAP*VTDTRTYVLD
TSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDLRLEHGRLDQP
IPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLVSKDIPLRVKA
AAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLPCHTGIRLLGGG
SHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALAL
CAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAVLE
EVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQRD
NLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR* 
 
Rv1095alt pYUB1049 C-terminal fusion tag (1524 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGAGTGACCGATACCCGCACGTACGTGCTCGAC
ACCTCTGTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGT
TCCGTTGGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCG
CCCGCCAGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCG
ATTCCGGTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGT
GCTGCCCGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACC
TCGCCGCCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCC
GCCGCGGTGGGGCTGGCCGCCGACGAGTACCACGCGCAGGACGTCGTTGTGTCCGGATGGTC
GGGGATGCACGAGCTCGAGACCGCTTCCGCGGATATCGATGCGTTGTTCGCCGATGGCGAGA
TCGACCTGGTCGAAGCCCGGGACCTACCGTGTCACACCGGGATTCGGTTGCTGGGCGGCGGT
TCCCACGCGCTGGGCCGGGTCAATGCGCATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGA
GGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATG
AGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTG
TGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTCCGCCC
GCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGG
GCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAG
GAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGCTCGTT
GCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCTGACCG
TGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGCGCGAC
AACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCC
GTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCG
AGATGCTCGAGGAGATCACCGGGCCGCGCGCGGATCCGAATTCGAGCTCCGTCGACAAGCTT
GCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
Rv1095alt pYUB1049 C-terminal fusion tag (508 aa) 
MW 54445.9 Da pI 6.13 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAP*VTDTRTYVLD
TSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDLRLEHGRLDQP
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IPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLVSKDIPLRVKA
AAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEIDLVEARDLPCHTGIRLLGGG
SHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALAL
CAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAVLE
EVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQRD
NLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPRADPNSSSVDKL
AAALEHHHHHH* 
 
Rv1095alt pYUB1049 N-terminal fusion tag (1514 bp) 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATAT
GGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAAGG
GCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCTCG
AGCGCCGTTAGCTCGAGGAGCGCTCCGTGACCGATACCCGCACGTACGTGCTCGACACCTCT
GTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTT
GGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCC
AGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCG
GTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCC
CGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCG
CCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCCGCCGCG
GTGGGGCTGGCCGCCGACGAGTACCACGCGCAGGACGTCGTTGTGTCCGGATGGTCGGGGAT
GCACGAGCTCGAGACCGCTTCCGCGGATATCGATGCGTTGTTCGCCGATGGCGAGATCGACC
TGGTCGAAGCCCGGGACCTACCGTGTCACACCGGGATTCGGTTGCTGGGCGGCGGTTCCCAC
GCGCTGGGCCGGGTCAATGCGCATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGAGGCGTT
CGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATGAGTCGG
TGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTGTGTGCG
GGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTCCGCCCGCTGTA
CGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGT
GGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAGGAAGTG
CTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGCTCGTTGCATGA
CTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCTGACCGTGCTGT
CCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGCGCGACAACCTG
CGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCCGTTGTT
CGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCGAGATGC
TCGAGGAGATCACCGGGCCGCGCTGA 
 
 
 
Rv1095alt pYUB1049 N-terminal fusion tag (506 aa) 
MW 54216.6 Da pI 6.33 
MGSSHHHHHHSSGLVPRGSHMASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRS
SAVSSRSAP*VTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFA
RQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANL
AAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADGEI
DLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLLDE
SVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMG
PWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTV
LSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTE
MLEEITGPR* 
 
Rv1095alt pDESTSMG N-terminal fusion tag (1520 bp) 
ATGTCGCATCACCATCACCATCACCTCGAATCACCATCAACAAGTTTGTACAAAAAAGCAGG
CTTCATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATG
ACAAGGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTC
CGCTCGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGACCGATACCCGCACGTACGTGCTCGAC
ACCTCTGTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGT
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TCCGTTGGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCG
CCCGCCAGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCG
ATTCCGGTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGT
GCTGCCCGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACC
TCGCCGCCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTTAAGGCC
GCCGCGGTGGGGCTGGCCGCCGACGAGTACCACGCGCAGGACGTCGTTGTGTCCGGATGGTC
GGGGATGCACGAGCTCGAGACCGCTTCCGCGGATATCGATGCGTTGTTCGCCGATGGCGAGA
TCGACCTGGTCGAAGCCCGGGACCTACCGTGTCACACCGGGATTCGGTTGCTGGGCGGCGGT
TCCCACGCGCTGGGCCGGGTCAATGCGCATAAACGTGTTCAGCTGGTGCGAGGTGACCGTGA
GGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCTCGATG
AGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGGCGTTG
TGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTCCGCCC
GCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGG
GCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCGAG
GAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGCTCGTT
GCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCTGACCG
TGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGCGCGAC
AACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGTCATCC
GTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGTCACCG
AGATGCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095alt pDESTSMG N-terminal fusion tag (506 aa)  
MW 54604.2 pI 6.31 
MSHHHHHHLESPSTSLYKKAGFMASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWV
RSSAVSSRSAP*VTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGW
FARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAA
NLAAEGKRVTLVSKDIPLRVKAAAVGLAADEYHAQDVVVSGWSGMHELETASADIDALFADG
EIDLVEARDLPCHTGIRLLGGGSHALGRVNAHKRVQLVRGDREAFGLRGRSAEQRVALDLLL
DESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEK
MGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLL
TVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALV
TEMLEEITGPR* 
 
 
 
Rv1095alt alt (165 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGA 
 
Rv1095alt alt (52 aa)  
MW 5189.8 pI 7.78 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAP* 
 
Rv1095alt alt pYUB28b C-terminal fusion tag (95 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGAAGCTTGCGGCCGCACTCGAGCACCACCACCAC
CACCACTGA 
 
Rv1095alt alt pYUB28b C-terminal fusion tag (65 aa) 
MW 6709.5 Da pI 7.87 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAPKLAAALEHHHH
HH* 
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Rv1095 PIN-domain (396 bp) 
GTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGCGTG
CAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAGCCA
AGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGATCTG
CGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCTGCA
CGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCAACG
ACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTGGTC
AGCAAGGACATTCCGCTGCGCGTT 
 
Rv1095 PIN-domain (132 aa)  
MW 14652.6 Da pI 5.94 
VTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDL
RLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLV
SKDIPLRV 
 
Rv1095 PIN-domain pDESTSMG N-terminal fusion tag (465 bp) 
ATGTCGCATCACCATCACCATCACCTCGAATCACCATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGG
CGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAA
GCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGA
TCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGC
TGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGC
AACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTT
GGTCAGCAAGGACATTCCGCTGCGCGTTTAG 
 
Rv1095 PIN-domain pDESTSMG N-terminal fusion tag (154 aa) 
MW 17203.4 Da pI 6.48 
MSHHHHHHLESPSTSLYKKAGFVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELE
AKRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDS
NDSRILSCAANLAAEGKRVTLVSKDIPLRV* 
 
Rv1095 PIN-domain pDEST17 N-terminal fusion tag (465 bp) 
ATGTCGTACTACCATCACCATCACCATCACCTCGAATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGG
CGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAA
GCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGA
TCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGC
TGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGC
AACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTT
GGTCAGCAAGGACATTCCGCTGCGCGTTTAG 
 
Rv1095 PIN-domain pDEST17 N-terminal fusion tag (155 aa) 
MW 17345.6 Da pI 6.48 
MSYYHHHHHHLESTSLYKKAGFVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELE
AKRHHHELGWFARQALRLFDDLRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDS
NDSRILSCAANLAAEGKRVTLVSKDIPLRV* 
  
Rv1095 PIN-domain pYUB28b C-terminal fusion tag (438 bp) 
GTGACCGATACCCGCACGTACGTGCTCGACACCTCTGTGCTGCTGTCCGATCCGTGGGCGTG
CAGCCGGTTCGCCGAACACGATGTGGTGGTTCCGTTGGTGGTGATCAGCGAGCTAGAAGCCA
AGCGCCACCACCACGAGCTGGGATGGTTCGCCCGCCAGGCGTTGCGTCTGTTCGACGATCTG
CGCCTAGAACACGGGCGGTTGGATCAGCCGATTCCGGTTGGCACCCAAGGCGGTACGCTGCA
CGTCGAACTCAATCACACCGACCCGGCGGTGCTGCCCGCAGGCTTTCGCACCGACAGCAACG
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ACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGCCGCCGAGGGCAAGCGGGTCACGTTGGTC
AGCAAGGACATTCCGCTGCGCGTTAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCA
CTGA 
 
Rv1095 PIN-domain pYUB28b C-terminal fusion tag (146 aa) 
MW 16303.5 Da pI 6.33 
MVTDTRTYVLDTSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDD
LRLEHGRLDQPIPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTL
VSKDIPLRVKLAAALEHHHHHH* 
 
Rv1095 PhoH-domain (654 bp)  
GAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCTCGA
TGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGGCGT
TGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTCCGC
CCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAAGAT
GGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGCTCG
AGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGCTCG
TTGCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCTGAC
CGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGCGCG
ACAACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGTCAT
CCGTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGTCAC
CGAGATGCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095 PhoH-domain (218 aa)  
MW 23407.0 Da pI 6.43 
EAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVFR
PLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGRS
LHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKGH
PLFAHITLLRSERSPIAALVTEMLEEITGPR* 
 
Rv1095 PhoH-domain pDESTSMG N-terminal fusion tag (720 bp) 
ATGTCGCATCACCATCACCATCACCTCGAATCACCATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGC
TCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTG
GCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTT
CCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGA
AGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTG
CTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCG
CTCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGC
TGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAG
CGCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGG
TCATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGG
TCACCGAGATGCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095 PhoH-domain pDESTSMG N-terminal fusion tag (240 aa) 
MW 25957.8 Da pI 6.9 
MSHHHHHHLESPSTSLYKKAGFEAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSAL
ALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAV
LEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQ
RDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR* 
 
Rv1095 PhoH-domain pDEST17 N-terminal fusion tag (720 bp) 
ATGTCGTACTACCATCACCATCACCATCACCTCGAATCAACAAGTTTGTACAAAAAAGCAGG
CTTCGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGC
TCGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTG
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GCGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTT
CCGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGA
AGATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTG
CTCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCG
CTCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGC
TGACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAG
CGCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGG
TCATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGG
TCACCGAGATGCTCGAGGAGATCACCGGGCCGCGCTGA 
 
Rv1095 PhoH-domain pDEST17 N-terminal fusion tag (240 aa) 
MW 26100.0 Da pI 6.9 
MSYYHHHHHHLESTSLYKKAGFEAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSAL
ALCAGLEAVLERRTHRKVVVFRPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAV
LEEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQ
RDNLRVGRHDGVAAVIEKLKGHPLFAHITLLRSERSPIAALVTEMLEEITGPR* 
 
Rv1095 PhoH-domain  pYUB28b C-terminal fusion tag (696 bp) 
ATGGAGGCGTTCGGTCTGCGTGGCCGCTCCGCCGAGCAGCGGGTGGCGCTGGATTTGCTGCT
CGATGAGTCGGTGGGCATCGTGTCGCTGGGCGGCAAAGCCGGCACGGGCAAGTCCGCTTTGG
CGTTGTGTGCGGGTCTGGAAGCCGTGCTGGAGCGACGCACCCACCGCAAGGTGGTGGTCTTC
CGCCCGCTGTACGCGGTCGGCGGCCAGGAGCTGGGCTACCTGCCCGGTAGCGAGAGCGAGAA
GATGGGCCCGTGGGCGCAGGCGGTCTTCGACACCCTCGAGGGGCTGGCCAGCCCGGCGGTGC
TCGAGGAAGTGCTGTCCCGTGGCATGCTCGAGGTGCTGCCGCTGACCCACATCCGGGGCCGC
TCGTTGCATGACTCGTTCGTCATCGTCGACGAGGCACAGTCGCTGGAGCGCAATGTGTTGCT
GACCGTGCTGTCCCGGTTGGGGACCGGTTCCCGGGTGGTGTTGACCCACGACATCGCCCAGC
GCGACAACCTGCGGGTCGGCCGCCACGACGGGGTCGCCGCGGTGATCGAGAAGCTCAAAGGT
CATCCGTTGTTCGCCCACATCACCTTGCTGCGCAGTGAGCGCTCGCCGATCGCCGCGCTGGT
CACCGAGATGCTCGAGGAGATCACCGGGCCGCGCAAGCTTGCGGCCGCACTCGAGCACCACC
ACCACCACCACTGA 
 
Rv1095 PhoH-domain  pYUB28b C-terminal fusion tag (232 aa) 
MW 25057.9 Da pI 6.67 
MEAFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTHRKVVVF
RPLYAVGGQELGYLPGSESEKMGPWAQAVFDTLEGLASPAVLEEVLSRGMLEVLPLTHIRGR
SLHDSFVIVDEAQSLERNVLLTVLSRLGTGSRVVLTHDIAQRDNLRVGRHDGVAAVIEKLKG
HPLFAHITLLRSERSPIAALVTEMLEEITGPRKLAAALEHHHHHH* 
 
Rv1095 PIN-domainalt (548 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGACCGATACCCGCACGTACGTGCTCGACACCT
CTGTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGTTCCG
TTGGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCGCCCG
CCAGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCGATTC
CGGTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGTGCTG
CCCGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACCTCGC
CGCCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTT 
 
Rv1095 PIN-domainalt (183 aa)  
MW 19824.4 Da pI 6.28 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAP*VTDTRTYVLD
TSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDLRLEHGRLDQP
IPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLVSKDIPLRV 
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Rv1095 PIN-domainalt pYUB28b C-terminal fusion tag (594 bp) 
ATGGCTAGCGACATGCTCTGCTGCCAGGGCGGCACCTTCCGTCACGACGGCTGTCATGACAA
GGGCAGGACCGGCCCCGGTCCTGGTGTCGCTGCCCCCGCCGACATGCTCGGGTGGGTCCGCT
CGAGCGCCGTTAGCTCGAGGAGCGCTCCGTGAGTGACCGATACCCGCACGTACGTGCTCGAC
ACCTCTGTGCTGCTGTCCGATCCGTGGGCGTGCAGCCGGTTCGCCGAACACGATGTGGTGGT
TCCGTTGGTGGTGATCAGCGAGCTAGAAGCCAAGCGCCACCACCACGAGCTGGGATGGTTCG
CCCGCCAGGCGTTGCGTCTGTTCGACGATCTGCGCCTAGAACACGGGCGGTTGGATCAGCCG
ATTCCGGTTGGCACCCAAGGCGGTACGCTGCACGTCGAACTCAATCACACCGACCCGGCGGT
GCTGCCCGCAGGCTTTCGCACCGACAGCAACGACTCGAGGATCTTGAGTTGCGCCGCCAACC
TCGCCGCCGAGGGCAAGCGGGTCACGTTGGTCAGCAAGGACATTCCGCTGCGCGTTAAGCTT
GCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
Rv1095 PIN-domainalt pYUB28b C-terminal fusion tag (198 aa)  
MW 21344.1 Da pI 6.55 
MASDMLCCQGGTFRHDGCHDKGRTGPGPGVAAPADMLGWVRSSAVSSRSAP*VTDTRTYVLD
TSVLLSDPWACSRFAEHDVVVPLVVISELEAKRHHHELGWFARQALRLFDDLRLEHGRLDQP
IPVGTQGGTLHVELNHTDPAVLPAGFRTDSNDSRILSCAANLAAEGKRVTLVSKDIPLRVKL
AAALEHHHHHH* 
 
MSMEG_5247 (1314 bp) 
GTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTTGCTGTCAGATCCCTG
GGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCGTCATCAGTGAGTTGG
AGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCCTTGCGGATGTTCGAC
GACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGGAACACAGGGCGGCAC
ACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCGGGTTCCGCAACGACA
GCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAGGGCAAGCACGTCACG
TTGGTGAGCAAGGACATCCCGCTGCGCGTCAAGGCCGGTGCGGTGGGCCTGGCGGCCGACGA
GTACCACGCACAGGACGTCGTGGTGTCCGGGTGGACGGGCATGACCGAGATGGACGTCGCAG
GCGAGGACATCGACACGCTGTTCGCCGACGGTGAGATCGACCTGGCCGAGGCGCGGGATCTG
CCGTGCCACACAGGCATTCGGTTGCTCGGTGGCACCTCGCACGCGCTGGGACGGGTGAACGC
GGCCAAGAAGGTGCAGCTGGTCCGTGGTGATCGCGAAGTGTTCGGCCTCCGGGGAAGGTCAG
CCGAACAGCGCGTCGCCCTCGACCTGCTGCTCGACGAGTCCGTCGGCATCGTGTCACTCGGC
GGCAAGGCCGGCACCGGCAAGTCGGCGCTCGCGCTGTGCGCGGGCCTGGAGGCCGTGCTGGA
GCGCCGCACGCAGCGCAAGGTCGTGGTGTTCCGCCCGCTGTATGCCGTGGGCGGTCAGGATC
TCGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTGTTCGAC
ACCCTCGAAGGGCTCGCGAGCCCCGCGGTGCTCGACGAGGTGCTCTCCCGCGGCATGCTCGA
AGTGCTGCCCCTGACCCACATCCGGGGCCGCTCACTGCACGACTCGTTCGTGATCGTCGACG
AGGCGCAGTCGCTCGAACGCAACGTGCTGCTGACGGTGCTGTCCCGGCTGGGTGCCGGGTCC
CGCGTGGTGCTCACCCACGACGTCGCCCAGCGCGACAACCTGCGGGTGGGACGCCATGACGG
CGTGGCCGCGGTGATCGAGAAGCTCAAGGGGCACCCGCTGTTCGCCCACGTGACGTTGCAGC
GCAGCGAACGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCAGCCCCGGC
GCCCTGCCCTGA 
 
MSMEG_5247 (438 aa) 
MW 47137.8 Da pI 5.66 
VTEQAVRTYVLDTSVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMFD
DMRLEHGRLDQPVPVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHVT
LVSKDIPLRVKAGAVGLAADEYHAQDVVVSGWTGMTEMDVAGEDIDTLFADGEIDLAEARDL
PCHTGIRLLGGTSHALGRVNAAKKVQLVRGDREVFGLRGRSAEQRVALDLLLDESVGIVSLG
GKAGTGKSALALCAGLEAVLERRTQRKVVVFRPLYAVGGQDLGYLPGSESEKMGPWAQAVFD
TLEGLASPAVLDEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGAGS
RVVLTHDVAQRDNLRVGRHDGVAAVIEKLKGHPLFAHVTLQRSERSPIAALVTEMLEEISPG
ALP* 
 
MSMEG_5247 pYUB28b C-terminal fusion tag (1353 bp) 
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GTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTTGCTGTCAGATCCCTG
GGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCGTCATCAGTGAGTTGG
AGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCCTTGCGGATGTTCGAC
GACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGGAACACAGGGCGGCAC
ACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCGGGTTCCGCAACGACA
GCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAGGGCAAGCACGTCACG
TTGGTGAGCAAGGACATCCCGCTGCGCGTCAAGGCCGGTGCGGTGGGCCTGGCGGCCGACGA
GTACCACGCACAGGACGTCGTGGTGTCCGGGTGGACGGGCATGACCGAGATGGACGTCGCAG
GCGAGGACATCGACACGCTGTTCGCCGACGGTGAGATCGACCTGGCCGAGGCGCGGGATCTG
CCGTGCCACACAGGCATTCGGTTGCTCGGTGGCACCTCGCACGCGCTGGGACGGGTGAACGC
GGCCAAGAAGGTGCAGCTGGTCCGTGGTGATCGCGAAGTGTTCGGCCTCCGGGGAAGGTCAG
CCGAACAGCGCGTCGCCCTCGACCTGCTGCTCGACGAGTCCGTCGGCATCGTGTCACTCGGC
GGCAAGGCCGGCACCGGCAAGTCGGCGCTCGCGCTGTGCGCGGGCCTGGAGGCCGTGCTGGA
GCGCCGCACGCAGCGCAAGGTCGTGGTGTTCCGCCCGCTGTATGCCGTGGGCGGTCAGGATC
TCGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCGCAGGCGGTGTTCGAC
ACCCTCGAAGGGCTCGCGAGCCCCGCGGTGCTCGACGAGGTGCTCTCCCGCGGCATGCTCGA
AGTGCTGCCCCTGACCCACATCCGGGGCCGCTCACTGCACGACTCGTTCGTGATCGTCGACG
AGGCGCAGTCGCTCGAACGCAACGTGCTGCTGACGGTGCTGTCCCGGCTGGGTGCCGGGTCC
CGCGTGGTGCTCACCCACGACGTCGCCCAGCGCGACAACCTGCGGGTGGGACGCCATGACGG
CGTGGCCGCGGTGATCGAGAAGCTCAAGGGGCACCCGCTGTTCGCCCACGTGACGTTGCAGC
GCAGCGAACGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAGGAGATCAGCCCCGGC
GCCCTGCCCAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
MSMEG_5247 pYUB28b C-terminal fusion tag (451 aa) 
MW 48657.5 Da pI 5.9 
VTEQAVRTYVLDTSVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMFD
DMRLEHGRLDQPVPVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHVT
LVSKDIPLRVKAGAVGLAADEYHAQDVVVSGWTGMTEMDVAGEDIDTLFADGEIDLAEARDL
PCHTGIRLLGGTSHALGRVNAAKKVQLVRGDREVFGLRGRSAEQRVALDLLLDESVGIVSLG
GKAGTGKSALALCAGLEAVLERRTQRKVVVFRPLYAVGGQDLGYLPGSESEKMGPWAQAVFD
TLEGLASPAVLDEVLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGAGS
RVVLTHDVAQRDNLRVGRHDGVAAVIEKLKGHPLFAHVTLQRSERSPIAALVTEMLEEISPG
ALPKLAAALEHHHHHH* 
 
MSMEG_5247alt (1453 bp) 
ATGGCTAGCGACCTGCTCTGCTGTCCGGGCGGTACCGATCGTTTCGATCACGAAAGGACCGG
CCCCGGTCCTGCCGCAGTGTCCACCGAGCAATTCGTGTGGGGCCGCATGAAGAGCGCCGTTC
CCCTAGGAGCGCCACGTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTT
GCTGTCAGATCCCTGGGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCG
TCATCAGTGAGTTGGAGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCC
TTGCGGATGTTCGACGACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGG
AACACAGGGCGGCACACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCG
GGTTCCGCAACGACAGCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAG
GGCAAGCACGTCACGTTGGTGAGCAAGGACATCCCGCTGCGCGTCAAGGCCGGTGCGGTGGG
CCTGGCGGCCGACGAGTACCACGCACAGGACGTCGTGGTGTCCGGGTGGACGGGCATGACCG
AGATGGACGTCGCAGGCGAGGACATCGACACGCTGTTCGCCGACGGTGAGATCGACCTGGCC
GAGGCGCGGGATCTGCCGTGCCACACAGGCATTCGGTTGCTCGGTGGCACCTCGCACGCGCT
GGGACGGGTGAACGCGGCCAAGAAGGTGCAGCTGGTCCGTGGTGATCGCGAAGTGTTCGGCC
TCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCTGCTGCTCGACGAGTCCGTCGGC
ATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGGCGCTCGCGCTGTGCGCGGGCCT
GGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTGGTGTTCCGCCCGCTGTATGCCG
TGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCG
CAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCGCGGTGCTCGACGAGGTGCTCTC
CCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGGGGCCGCTCACTGCACGACTCGT
TCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGTGCTGCTGACGGTGCTGTCCCGG
CTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCGCCCAGCGCGACAACCTGCGGGT
GGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTCAAGGGGCACCCGCTGTTCGCCC
Appendices  188 
 
 
ACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAG
GAGATCAGCCCCGGCGCCCTGCCCTGA 
 
MSMEG_5247alt (450 aa) 
MW 52208.5 Da pI 5.65 
MASDLLCCPGGTDRFDHERTGPGPAAVSTEQFVWGRMKSAVPLGAPRD*VTEQAVRTYVLDT
SVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMFDDMRLEHGRLDQPV
PVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHVTLVSKDIPLRVKAG
AVGLAADEYHAQDVVVSGWTGMTEMDVAGEDIDTLFADGEIDLAEARDLPCHTGIRLLGGTS
HALGRVNAAKKVQLVRGDREVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALC
AGLEAVLERRTQRKVVVFRPLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDE
VLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDN
LRVGRHDGVAAVIEKLKGHPLFAHVTLQRSERSPIAALVTEMLEEISPGALP* 
 
 
MSMEG_5247alt  pYUB28b C-terminal fusion tag (1492 bp) 
ATGGCTAGCGACCTGCTCTGCTGTCCGGGCGGTACCGATCGTTTCGATCACGAAAGGACCGG
CCCCGGTCCTGCCGCAGTGTCCACCGAGCAATTCGTGTGGGGCCGCATGAAGAGCGCCGTTC
CCCTAGGAGCGCCACGTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTT
GCTGTCAGATCCCTGGGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCG
TCATCAGTGAGTTGGAGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCC
TTGCGGATGTTCGACGACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGG
AACACAGGGCGGCACACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCG
GGTTCCGCAACGACAGCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAG
GGCAAGCACGTCACGTTGGTGAGCAAGGACATCCCGCTGCGCGTCAAGGCCGGTGCGGTGGG
CCTGGCGGCCGACGAGTACCACGCACAGGACGTCGTGGTGTCCGGGTGGACGGGCATGACCG
AGATGGACGTCGCAGGCGAGGACATCGACACGCTGTTCGCCGACGGTGAGATCGACCTGGCC
GAGGCGCGGGATCTGCCGTGCCACACAGGCATTCGGTTGCTCGGTGGCACCTCGCACGCGCT
GGGACGGGTGAACGCGGCCAAGAAGGTGCAGCTGGTCCGTGGTGATCGCGAAGTGTTCGGCC
TCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCTGCTGCTCGACGAGTCCGTCGGC
ATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGGCGCTCGCGCTGTGCGCGGGCCT
GGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTGGTGTTCCGCCCGCTGTATGCCG
TGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAGCGAGAAGATGGGCCCGTGGGCG
CAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCGCGGTGCTCGACGAGGTGCTCTC
CCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGGGGCCGCTCACTGCACGACTCGT
TCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGTGCTGCTGACGGTGCTGTCCCGG
CTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCGCCCAGCGCGACAACCTGCGGGT
GGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTCAAGGGGCACCCGCTGTTCGCCC
ACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGCGCTGGTCACCGAGATGCTCGAG
GAGATCAGCCCCGGCGCCCTGCCCAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCA
CTGA 
 
MSMEG_5247alt pYUB28b C-terminal fusion tag (498 aa) 
MW 53728.2 Da pI 5.88 
MASDLLCCPGGTDRFDHERTGPGPAAVSTEQFVWGRMKSAVPLGAPRD*VTEQAVRTYVLDT
SVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMFDDMRLEHGRLDQPV
PVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHVTLVSKDIPLRVKAG
AVGLAADEYHAQDVVVSGWTGMTEMDVAGEDIDTLFADGEIDLAEARDLPCHTGIRLLGGTS
HALGRVNAAKKVQLVRGDREVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALC
AGLEAVLERRTQRKVVVFRPLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDE
VLSRGMLEVLPLTHIRGRSLHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDN
LRVGRHDGVAAVIEKLKGHPLFAHVTLQRSERSPIAALVTEMLEEISPGALPKLAAALEHHH
HHH* 
 
MSMEG_5247 PIN-domain (402 bp) 
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GTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTTGCTGTCAGATCCCTG
GGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCGTCATCAGTGAGTTGG
AGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCCTTGCGGATGTTCGAC
GACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGGAACACAGGGCGGCAC
ACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCGGGTTCCGCAACGACA
GCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAGGGCAAGCACGTCACG
TTGGTGAGCAAGGACATCCCGCTGCGCGTC 
 
MSMEG_5247 PIN-domain (134 aa) 
MW 14903.9 Da pI 5.86 
VTEQAVRTYVLDTSVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMFD
DMRLEHGRLDQPVPVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHVT
LVSKDIPLRV 
 
MSMEG_5247 PIN-domain  pYUB28b C-terminal fusion tag (447 bp)  
ATGGTGACTGAGCAAGCTGTCCGTACCTATGTGCTCGACACCTCGGTGTTGCTGTCAGATCC
CTGGGCATGCACCCGGTTCGCCGAGCACGAGGTGGTGGTCCCGCTGGTCGTCATCAGTGAGT
TGGAGGCCAAACGGCACCATCACGAACTCGGCTGGTTCGCGCGGCAGGCCTTGCGGATGTTC
GACGACATGCGACTCGAACACGGCCGCCTGGATCAACCGGTCCCGGTCGGAACACAGGGCGG
CACACTGCACGTCGAGCTGAACCACAGCGACCCGTCGGTGCTGCCCGCCGGGTTCCGCAACG
ACAGCAACGACGCCAGGATCCTCACGGTCGCGGCCAATCTCGCCGCCGAGGGCAAGCACGTC
ACGTTGGTGAGCAAGGACATCCCGCTGCGCGTCAAGCTTGCGGCCGCACTCGAGCACCACCA
CCACCACCACTGA 
 
MSMEG_5247 PIN-domain pYUB28b C-terminal fusion tag  (149 aa) 
MW 16554.8 Da pI 6.24 
MVTEQAVRTYVLDTSVLLSDPWACTRFAEHEVVVPLVVISELEAKRHHHELGWFARQALRMF
DDMRLEHGRLDQPVPVGTQGGTLHVELNHSDPSVLPAGFRNDSNDARILTVAANLAAEGKHV
TLVSKDIPLRVKLAAALEHHHHHH* 
 
MSMEG_5247 PhoH-domain +1 ( 660 bp) 
GAAGTGTTCGGCCTCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCTGCTGCTCGA
CGAGTCCGTCGGCATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGGCGCTCGCGC
TGTGCGCGGGCCTGGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTGGTGTTCCGC
CCGCTGTATGCCGTGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAGCGAGAAGAT
GGGCCCGTGGGCGCAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCGCGGTGCTCG
ACGAGGTGCTCTCCCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGGGGCCGCTCA
CTGCACGACTCGTTCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGTGCTGCTGAC
GGTGCTGTCCCGGCTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCGCCCAGCGCG
ACAACCTGCGGGTGGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTCAAGGGGCAC
CCGCTGTTCGCCCACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGCGCTGGTCAC
CGAGATGCTCGAGGAGATCAGCCCCGGCGCCCTGCCCTGA 
 
MSMEG_5247 PhoH-domain +1 (219 aa) 
MW 23466.0 DapI 6.11 
EVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTQRKVVVFR
PLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDEVLSRGMLEVLPLTHIRGRS
LHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDNLRVGRHDGVAAVIEKLKGH
PLFAHVTLQRSERSPIAALVTEMLEEISPGALP* 
 
MSMEG_5247 PhoH-domain +1 pYUB28b C-terminal fusion tag (702 bp) 
ATGGAAGTGTTCGGCCTCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCTGCTGCT
CGACGAGTCCGTCGGCATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGGCGCTCG
CGCTGTGCGCGGGCCTGGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTGGTGTTC
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CGCCCGCTGTATGCCGTGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAGCGAGAA
GATGGGCCCGTGGGCGCAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCGCGGTGC
TCGACGAGGTGCTCTCCCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGGGGCCGC
TCACTGCACGACTCGTTCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGTGCTGCT
GACGGTGCTGTCCCGGCTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCGCCCAGC
GCGACAACCTGCGGGTGGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTCAAGGGG
CACCCGCTGTTCGCCCACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGCGCTGGT
CACCGAGATGCTCGAGGAGATCAGCCCCGGCGCCCTGCCCAAGCTTGCGGCCGCACTCGAGC
ACCACCACCACCACCACTGA 
 
MSMEG_5247 PhoH-domain +1 pYUB28b C-terminal fusion tag (233 aa) 
MW 25116.9 Da pI 6.46 
MEVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTQRKVVVF
RPLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDEVLSRGMLEVLPLTHIRGR
SLHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDNLRVGRHDGVAAVIEKLKG
HPLFAHVTLQRSERSPIAALVTEMLEEISPGALPKLAAALEHHHHHH* 
MSMEG_5247 PhoH-domain +2 (666 bp)  
GATCGCGAAGTGTTCGGCCTCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCTGCT
GCTCGACGAGTCCGTCGGCATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGGCGC
TCGCGCTGTGCGCGGGCCTGGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTGGTG
TTCCGCCCGCTGTATGCCGTGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAGCGA
GAAGATGGGCCCGTGGGCGCAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCGCGG
TGCTCGACGAGGTGCTCTCCCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGGGGC
CGCTCACTGCACGACTCGTTCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGTGCT
GCTGACGGTGCTGTCCCGGCTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCGCCC
AGCGCGACAACCTGCGGGTGGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTCAAG
GGGCACCCGCTGTTCGCCCACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGCGCT
GGTCACCGAGATGCTCGAGGAGATCAGCCCCGGCGCCCTGCCCTGA 
 
MSMEG_5247 PhoH-domain +2 (221 aa) 
MW 23737.3 Da pI 6.1 
DREVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTQRKVVV
FRPLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDEVLSRGMLEVLPLTHIRG
RSLHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDNLRVGRHDGVAAVIEKLK
GHPLFAHVTLQRSERSPIAALVTEMLEEISPGALP* 
 
MSMEG_5247 PhoH-domain +2 pYUB28b C-terminal fusion tag (708 bp) 
ATGGATCGCGAAGTGTTCGGCCTCCGGGGAAGGTCAGCCGAACAGCGCGTCGCCCTCGACCT
GCTGCTCGACGAGTCCGTCGGCATCGTGTCACTCGGCGGCAAGGCCGGCACCGGCAAGTCGG
CGCTCGCGCTGTGCGCGGGCCTGGAGGCCGTGCTGGAGCGCCGCACGCAGCGCAAGGTCGTG
GTGTTCCGCCCGCTGTATGCCGTGGGCGGTCAGGATCTCGGCTACCTGCCCGGTAGCGAGAG
CGAGAAGATGGGCCCGTGGGCGCAGGCGGTGTTCGACACCCTCGAAGGGCTCGCGAGCCCCG
CGGTGCTCGACGAGGTGCTCTCCCGCGGCATGCTCGAAGTGCTGCCCCTGACCCACATCCGG
GGCCGCTCACTGCACGACTCGTTCGTGATCGTCGACGAGGCGCAGTCGCTCGAACGCAACGT
GCTGCTGACGGTGCTGTCCCGGCTGGGTGCCGGGTCCCGCGTGGTGCTCACCCACGACGTCG
CCCAGCGCGACAACCTGCGGGTGGGACGCCATGACGGCGTGGCCGCGGTGATCGAGAAGCTC
AAGGGGCACCCGCTGTTCGCCCACGTGACGTTGCAGCGCAGCGAACGCTCGCCGATCGCCGC
GCTGGTCACCGAGATGCTCGAGGAGATCAGCCCCGGCGCCCTGCCCAAGCTTGCGGCCGCAC
TCGAGCACCACCACCACCACCACTGA 
 
MSMEG_5247 PhoH-domain +2 pYUB28b C-terminal fusion tag (235 bp) 
MW 25388.2 Da pI 6.46 
MDREVFGLRGRSAEQRVALDLLLDESVGIVSLGGKAGTGKSALALCAGLEAVLERRTQRKVV
VFRPLYAVGGQDLGYLPGSESEKMGPWAQAVFDTLEGLASPAVLDEVLSRGMLEVLPLTHIR
GRSLHDSFVIVDEAQSLERNVLLTVLSRLGAGSRVVLTHDVAQRDNLRVGRHDGVAAVIEKL
KGHPLFAHVTLQRSERSPIAALVTEMLEEISPGALPKLAAALEHHHHHH* 
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TBIS_3092 optimised for E. coli protein expression (1323 bp) 
CTGCAGATGGTTGCAGTTAGCAGCAGCAATCCGACCCAGACCCGTACCTATGTTCTGGATAC
CAGCGTTCTGCTGGCAGATCCGGCAAGCATGAGCCGTTTTGCAGAACATGAAGTTGTTATTC
CGATTGTGGTGATCAATGAACTGGAAGCAAAACGTCATCATCCGGAACTGGGTTATTTTGCA
CGTGAAGCACTGCGTTTTCTGGATGATCTGCGTGTTCGTCATGGTCGTCTGGATCAGCCGGT
TCCGATTGGTGAAGGCACCATTCGTGTTGAACTGAATCATAGCGATCCGGCAGTTCTGCCTG
CCGGTCTGCGTAGCGGTGATAATGATAGCCGTATTCTGACCGTTGCACAGAATCTGGCAGCC
GAAGGTCGTGATGTTGTTCTGGTTAGCAAAGATCTGCCGATGCGTCTGAAAGCAGCAAGCCT
GGGTCTGAATGCCGAAGAATATCGTGCAGGTATGGTTATTGAAAGCGGTTGGACCGGTATGG
CCGAACTGCAAGTTACCGATGATGACCTGCGTATGCTGTTTGAACATGGCACCATTGAACTG
GCCGAAGCACGTGATCTGCCGTGTCATACAGGTCTGCGTCTGCTGAGCACCCGTGGTAGCGC
ACTGGGTCGTGTTACACCGGATAAAAGCGTTCGTCTGGTTCGTGGTGATCGTGAAGTTTTTG
GTCTGCGTGGTCGTAGCGCAGAACAGCGTATTGCACTGGATCTGCTGATGGATCCGGAAATT
GGTATTGTTAGCATTGGTGGTCGTGCAGGCACCGGTAAAAGTGCACTGGCACTGTGTGCAGG
TCTGGAAGCAGTTCTGGAACGTCGTCAGCATCGTAAAATCATTGTTTTTCGTCCGCTGTATG
CAGTTGGTGGCCAAGAACTGGGCTATCTGCCTGGCACCGAAAATGATAAAATGGGTCCGTGG
GCACAGGCAGTTTATGATACCCTGGGTGCAGTTACCAGTCCGGAAGTTATTGAAGAAGTGCT
GGATCGCGGTATGCTGGAAGTTCTGCCGCTGACCCATATTCGTGGTCGTTCACTGCATGATG
CATTTGTTATTGTTGATGAAGCACAGAGCCTGGAACGTGGTGTTCTGCTGACCGTTCTGAGC
CGTATTGGTAGCAATAGCCGTGTGGTTCTGACCCATGATGTTGCACAGCGTGATAATCTGCG
CGTTGGTCGTCATGATGGTGTTGTTGCAGTTGTTGAAAAACTGAAAGGTCATCCGCTGTTTG
CACATATTACCCTGACCCGTAGCGAACGTAGCCCGATTGCAGCACTGGTTACCGAAATGCTG
CAAGATATTACCATCAAGCTT 
 
TBIS_3092 optimised for E. coli protein expression (441 aa) 
MW 48248.4 pI 6 
LQMVAVSSSNPTQTRTYVLDTSVLLADPASMSRFAEHEVVIPIVVINELEAKRHHPELGYFA
REALRFLDDLRVRHGRLDQPVPIGEGTIRVELNHSDPAVLPAGLRSGDNDSRILTVAQNLAA
EGRDVVLVSKDLPMRLKAASLGLNAEEYRAGMVIESGWTGMAELQVTDDDLRMLFEHGTIEL
AEARDLPCHTGLRLLSTRGSALGRVTPDKSVRLVRGDREVFGLRGRSAEQRIALDLLMDPEI
GIVSIGGRAGTGKSALALCAGLEAVLERRQHRKIIVFRPLYAVGGQELGYLPGTENDKMGPW
AQAVYDTLGAVTSPEVIEEVLDRGMLEVLPLTHIRGRSLHDAFVIVDEAQSLERGVLLTVLS
RIGSNSRVVLTHDVAQRDNLRVGRHDGVVAVVEKLKGHPLFAHITLTRSERSPIAALVTEML
QDITIKL 
 
TBIS_3092 pET28b-PstI C-terminal fusion tag (1353 bp) 
ATGGTTGCAGTTAGCAGCAGCAATCCGACCCAGACCCGTACCTATGTTCTGGATACCAGCGT
TCTGCTGGCAGATCCGGCAAGCATGAGCCGTTTTGCAGAACATGAAGTTGTTATTCCGATTG
TGGTGATCAATGAACTGGAAGCAAAACGTCATCATCCGGAACTGGGTTATTTTGCACGTGAA
GCACTGCGTTTTCTGGATGATCTGCGTGTTCGTCATGGTCGTCTGGATCAGCCGGTTCCGAT
TGGTGAAGGCACCATTCGTGTTGAACTGAATCATAGCGATCCGGCAGTTCTGCCTGCCGGTC
TGCGTAGCGGTGATAATGATAGCCGTATTCTGACCGTTGCACAGAATCTGGCAGCCGAAGGT
CGTGATGTTGTTCTGGTTAGCAAAGATCTGCCGATGCGTCTGAAAGCAGCAAGCCTGGGTCT
GAATGCCGAAGAATATCGTGCAGGTATGGTTATTGAAAGCGGTTGGACCGGTATGGCCGAAC
TGCAAGTTACCGATGATGACCTGCGTATGCTGTTTGAACATGGCACCATTGAACTGGCCGAA
GCACGTGATCTGCCGTGTCATACAGGTCTGCGTCTGCTGAGCACCCGTGGTAGCGCACTGGG
TCGTGTTACACCGGATAAAAGCGTTCGTCTGGTTCGTGGTGATCGTGAAGTTTTTGGTCTGC
GTGGTCGTAGCGCAGAACAGCGTATTGCACTGGATCTGCTGATGGATCCGGAAATTGGTATT
GTTAGCATTGGTGGTCGTGCAGGCACCGGTAAAAGTGCACTGGCACTGTGTGCAGGTCTGGA
AGCAGTTCTGGAACGTCGTCAGCATCGTAAAATCATTGTTTTTCGTCCGCTGTATGCAGTTG
GTGGCCAAGAACTGGGCTATCTGCCTGGCACCGAAAATGATAAAATGGGTCCGTGGGCACAG
GCAGTTTATGATACCCTGGGTGCAGTTACCAGTCCGGAAGTTATTGAAGAAGTGCTGGATCG
CGGTATGCTGGAAGTTCTGCCGCTGACCCATATTCGTGGTCGTTCACTGCATGATGCATTTG
TTATTGTTGATGAAGCACAGAGCCTGGAACGTGGTGTTCTGCTGACCGTTCTGAGCCGTATT
GGTAGCAATAGCCGTGTGGTTCTGACCCATGATGTTGCACAGCGTGATAATCTGCGCGTTGG
TCGTCATGATGGTGTTGTTGCAGTTGTTGAAAAACTGAAAGGTCATCCGCTGTTTGCACATA
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TTACCCTGACCCGTAGCGAACGTAGCCCGATTGCAGCACTGGTTACCGAAATGCTGCAAGAT
ATTACCATCAAGCTTGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
TBIS_3092 pET28b-PstI C-terminal fusion tag (451 aa) 
MW 49285.5 Da pI 6.13 
MVAVSSSNPTQTRTYVLDTSVLLADPASMSRFAEHEVVIPIVVINELEAKRHHPELGYFARE
ALRFLDDLRVRHGRLDQPVPIGEGTIRVELNHSDPAVLPAGLRSGDNDSRILTVAQNLAAEG
RDVVLVSKDLPMRLKAASLGLNAEEYRAGMVIESGWTGMAELQVTDDDLRMLFEHGTIELAE
ARDLPCHTGLRLLSTRGSALGRVTPDKSVRLVRGDREVFGLRGRSAEQRIALDLLMDPEIGI
VSIGGRAGTGKSALALCAGLEAVLERRQHRKIIVFRPLYAVGGQELGYLPGTENDKMGPWAQ
AVYDTLGAVTSPEVIEEVLDRGMLEVLPLTHIRGRSLHDAFVIVDEAQSLERGVLLTVLSRI
GSNSRVVLTHDVAQRDNLRVGRHDGVVAVVEKLKGHPLFAHITLTRSERSPIAALVTEMLQD
ITIKLAAALEHHHHHH* 
 
 
